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UNIVERSITY OF SOUTHAMPTON 
 
ABSTRACT 
FACULTY OF MEDICINE, HEALTH 
& LIFE SCIENCES 
SCHOOL OF HEALTH SCIENCES 
 
Master of Philosophy 
 
A PRELIMINARY INVESTIGATION INTO THE RISK FACTORS 
ASSOCIATED WITH CELLULITIS OF THE LOWER LIMB 
 
by Carol Collins 
 
Cellulitis is an infective/inflammatory skin condition costing 426,000 bed days per year. 
The legs are most frequently affected and 18-20% of patients suffer from recurrent 
attacks. Bacteria are thought to be causal but are rarely identified, therefore antibiotic 
treatment is empirical and currently the only means of prophylaxis.  
  Previous studies have cited athlete’s foot , skin vulnerability and oedema as risk factors 
for cellulitis and there may also be a relationship with the immune response. This 
preliminary study was designed to evaluate these risk factors and identify areas for further 
investigation. 
  Patients were matched with controls (N = 12 + 12 controls) by age, sex and mobility. 
Participants attended twice (during treatment and again 6 weeks after clinical resolution). 
Foot scrapings were cultured to examine the flora and blood samples taken to determine 
white cell types and numbers, cytokine levels and markers specific to fungal infection. 
Physiological measurement techniques were used to assess skin function. Psychological 
stress levels were evaluated and medical history recorded. 
Fewer dermatophytes were grown from the feet of patients as compared to matched 
controls. Amongst patients blood profiling showed evidence of increased neutrophil count 
post episode and levels of IL-12 and IL-8 also reached near significance in this group. 
Physiological tests for skin blood flow, water loss and pH produced results consistent with 
cellulitic skin but persisting oedema was significantly higher in the patient group and 
characterised by loss of structure in the dermal tissues. Ipsilateral injuries, allergies, 
history of other bacterial infections, excessive life time prescription of antibiotics and levels 
of psychological stress, evaluated by a questionnaire, were also found to be significantly 
higher in the patient group. No evidence was produced to show any differences between 
acute and recurrent populations.  
This preliminary study into the potential risk factors for cellulitis indicates that some factors 
merit further investigation. Larger studies are required to substantiate results.   3
 
TABLE OF CONTENTS 
              page 
LIST  OF  ILLUSTRATIONS           6 
             
L I S T   O F   T A B L E S             8 
 
LIST  OF  APPENDICES           9 
 
AUTHORS  DECLARATION        11 
 
ACKNOWLEDGEMENTS         12 
 
A B B R E V I A T I O N S           13 
    
 
CHAPTER 1: INTRODUCTION 17 
1.1  Cellulitis the problem  18   
 
CHAPTER 2: LITERATURE REVIEW   25   
2.1  The skin   25   
2.1.1  Skin structure   25 
2.1.2  Skin function   27 
2.1.3  The skin immune system   31   
2.1.3.1  T and B lymphocytes   31 
T cells   32 
B cells   33   
2.1.3.2  Infective/inflammatory responses in skin   34 
2.1.3.3 Hypersensitivities    36 
Superantigens   36 
2.2  Dermatophytes          37 
  2.2.1  Cellulitis and dermatophytosis   39 
2.3 Stressors    42 
  2.3.1  Effects of stressors on the skin   43 
  2.3.1.1  The skin environment   43 
  2.3.1.2  Skin pH   44 
  2.3.1.3  The skin microcirculation   46 
  2.3.1.4  Venous function   46 
  2.3.1.5  Skin properties   47 
2.4  Rationale and aims of study   49 
  2.4.1   Study aims   49 
    
CHAPTER 3: STUDY DESIGN   52 
3.1  Choice of methods   54 
  3.1.1  Investigation for dermatophytosis   54 
  3.1.2  Investigation for skin structure and physiology       56 
    3.1.2.1  Skin water loss          5 6  
    3.1.2.2  Skin  pH           57 
    3.1.2.3  Oedema         58 
                    4
CHAPTER  3:  STUDY  DESIGN  (cont)       page 
       Thickness  measurements            60 
      Validation  of  the  Dermascan measurement system     64 
       Image  analysis              66 
   3.1.2.4  Skin  blood  flow              6 7  
    3.1.2.5  Venous  incompetence           69 
  3.1.3  Immunological  Outcomes             70 
    3.1.3.1  Blood  profiles              71 
    3.1.3.2  Serum cytokine profiles             71 
  3.1.4  Stress  factors               74 
    3.1.4.1  Patient  history              74 
    3.1.4.2  Stress  questionnaire             74 
3.2  Expected  results               77 
 
CHAPTER 4: MATERIALS and METHODS            7 9  
4.1  List  of  materials               79 
4.2  Plan  of  Investigation               79 
  4.2.1  Participants               80 
  4.2.2  Sample  size               81 
  4.2.3  Recruitment  and  attendance             81 
  4.2.4  Data                  82 
  4.2.5  The  protocol               82 
4.3  Methods                  85 
  4.3.1  Investigation for dermatophytosis             85 
    4.3.1.1  Initial  culture              85 
    4.3.1.2  Microscopy              85 
    4.3.1.3  Reculture              88 
  4.3.2  Investigation of skin structure and physiology         88 
    4.3.2.1  Skin water loss              8 8  
    4.3.2.2  Skin  pH               89 
    4.3.2.3  Oedema             89 
       L i m b   v o l u m e               8 9  
        Skin structure and thickness            89 
   4.3.2.4  Skin  blood  flow              9 0  
    4.3.2.5  Venous  incompetence           90 
  4.3.3  Immunological  outcomes             92 
    4.3.3.1  Blood  profiles              92 
       Analysis  of  IgE              93 
      T H 1 and TH2 cytokine analysis           93 
  4.3.4  Stress  factors               96 
    4.3.4.1  Medical  History            96 
    4.3.4.2  Stress  Questionnaire             96 
                 
CHAPTER 5: RESULTS               9 9  
5.1  Recruitment                  99 
  5.1.1  Participants               99 
5.2  Statistics              100 
5.3  Results  by  category           101 
  5.3.1  Results of culture, microscopy & IgE to Trichophyton Rubrum   102 
   5
CHAPTER 5: RESULTS (cont)        page 
    5.3.1.1  Culture  results            102 
       Dermatophytes          102 
       Opportunists            103 
       B a c t e r i a              1 0 7  
       Y e a s t s              1 0 8  
    5.3.1.2  Results for specific IgE to  Trichophyton Rubrum (TR)    108 
  5.3.2  Results relating to skin structure and physiology        108 
    5.3.2.1  Skin water loss            1 0 8  
    5.3.2.2  Skin  pH             112 
    5.3.2.3  Oedema           114 
       Leg  circumference  measurements         114 
       Ultrasound            117 
       Image  analysis            123 
   5.3.2.4  Skin  blood  flow            1 2 3  
        Parameters for normal resting flow         126 
    5.3.2.5  Assessment of venous incompetence        129 
  5.3.3  Immunological  outcomes           132 
    5.3.3.1  Routine  blood  results           132 
    5.3.2.2  Cytokine  results           135 
    5.3.3.3  IgE  results            137 
  5.3.4  Stress  investigations            138 
      5.3.4.1  Medical  history           138 
      5.3.4.2  Stress  questionnaire         139 
5.4  Summary  of  results             141 
 
CHAPTER 6: DISCUSSION            1 4 6  
6.1  The  study                148 
6.2  Dermatophytosis             151 
6.3  Prophylaxis                153 
6.4  Skin  physiology             155 
6.5  Oedema                157 
6.6  Immunology  and  stress  factors           159 
6.7  Limitations/Benefits             160 
6 . 8   S u m m a r y                 1 6 1  
6.9  Conclusion                162 
 
CHAPTER 7: FUTURE WORK            1 6 4  
 
APPENDIX                 1 6 6  
 
REFERENCES                2 2 0    
 
 
 
 
   6
LIST OF ILLUSTRATIONS page 
 
Figure 1  Presentation of cellulitis and erysipelas    19 
 
Figure 2  a) Skin structure    26 
    b) Skin microcirculation 
 
Figure 3  TH1 and TH2 cytokines in association with    35 
    proinflammatory, IH, DTH and anaphylactic reactions   
      
Figure 4  Possible relationships between cellulitis, stress factors     50 
     and skin and immune functions   
 
Figure 5  Skin samples on InTray DM x 10     55 
 
Figure 6  a) High frequency ultrasound image of normal skin     61 
    b) Measurement of area A and area B from A-scan profile   
 
Figure 7  a) Ultrasound scan head and support mechanism     62 
    b) Ultrasound stand 
    c) Scan window positioned on the lower leg 
 
Figure 8  Ultrasound appearances of the epidermis, papillary and      63 
 reticular dermis and subcutaneous layers  
 
Figure 9  Validation of ultrasound measurements     65 
 
Figure 10  Principles of the LDI Imager     68 
 
Figure 11  Study investigations     83 
 
Figure 12  Area of investigation (AOI)     84 
 
Figure 13  Picture of cellulitic leg to show AOI     84 
 
Figure 14  InTray Dermatophyte Medium with sample     86 
 
Figure 15  Arrangement of DM trays in the rack     86 
 
Figure 16  Trichophyton Rubrum (TR) growing on InTray DM     87 
 
Figure 17  TR and penicillium growing on      87 
    Sabouraud Dextrose agar   
 
Figure 18  Measurement of venous refilling time     91 
 
Figure 19  Cytokine positions in the base of each well     94 
 
Figure 20  Set up for 96 well MSD plate     94 
   7
ILLUSTRATIONS (cont) page 
 
Figure 21  Numbers of patients and controls recruited to the study     99 
 
Figure 22  Opportunistic dermatomycoses    104 
 
Figure 23  Morphological appearance of Rhodotorula    105 
   and  Pseudomonas   
 
Figure 24  Microscopic appearance of Trichophyton Rubrum and     106 
   Trichophyton  Interdigitale 
 
Figure 25  Graph of results for specific IgE to Trichophyton Rubrum    109 
 
Figure 26  Graph of TEWL results    110 
 
Figure 27  Graph of pH results    112 
 
Figure 28  Graph of circumference results taken at the upper calf    115 
 
Figure 29  Graph of ultrasound measurements area b (dermis)    118 
 
Figure 30  Acute oedema a) during cellulitic episode    120 
    b) 6 weeks post episode   
 
Figure 31  Images and A-scans of patient 5    121 
 
Figure 32  Images and A-scans of control 5    122 
 
Figure 33  Graph of LDI mean flux results    124 
 
Figure 34  LDI perfusion scans    127 
 
Figure 35  Graph of LDI results after categorisation    128 
 
Figure 36  LDF exercise traces a) competent veins    130 
     b) incompetent veins 
 
Figure 37  Graph of results for venous refilling times    131 
 
Figure 38  Blood profiles a) acute episode days 1 - 25    134 
      b) P8 days 1 – 9 and 47 
 
Figure 39  Graph of IgE results    138 
 
Figure 40  Graph of result scores from the stress questionnaire    142 
 
 
 
   8
LIST OF TABLES page 
 
Table 1  Risk factors and related tests     53 
 
Table 2    Comparison of Dermascan and micrometer measurements     64 
    
Table 3  Some of the origins and effects of the cytokines/chemokines     73 
included in the TH1/TH2 MSD assay  
 
Table 4  Risk factors, associated tests and expected results     76 
 
Table 5  MSD reagent preparation and protocol     95 
 
Table 6  Medical history   97 
 
Table 7  Patient characteristics    100   
 
Table 8  Numbers of patients and controls who grew dermatophytes  103 
  opportunists, bacteria and yeasts 
 
Table 9  Significance tests for results of dermatophyte cultures  107 
      
Table 10  Significance tests for TEWL results  111 
    
Table 11  Significance tests for pH results    113 
  
Table 12  Significance tests for measurements taken at the upper calf    116   
 
Table 13  Significance tests for ultrasound area b    119   
 
Table 14  Significance tests for LDI mean flux     125   
 
Table 15  Criteria for categorising resting blood flow     126 
 
Table 16  Significance tests for VRT     131 
 
Table 17  a) Significance tests for lymphocytes     133 
  b) Significance table for neutrophils   
 
Table 18  Minimum and maximum values of detected cytokines     135 
 
Table 19  Significance tests for IL-8     136 
 
Table 20  Significance tests for IL-12p70     136 
 
Table 21  Significance tests for medical history     140 
 
Table 22   Significance tests for stress results     141 
 
Table 23  Summary of results     143   9
LIST OF APPENDICES   page 
 
Appendix 1  Stress questionnaire    166 
 
Appendix 2      167 
  Distribution of data from culture and microscopy   
Appendix 9      174 
 
Appendix 10  Significance tests for opportunists    175 
 
Appendix 11  Significance tests for bacteria    176 
 
Appendix 12  Significance tests for yeasts    177 
 
Appendix 13  Significance tests for IgE to Trichophyton Rubrum      178 
 
Appendix 14  Raw data for results of IgE to Trichophyton Rubrum    179 
 
Appendix 15  Raw data for results of TEWL measurements    180 
 
Appendix 16  Distribution of TEWL data    181 
 
Appendix 17  Raw data for results of pH measurements    182 
 
Appendix 18  Distribution of pH data    183 
 
Appendix 19  Distribution of measurements taken at the ankle      184 
 
Appendix 20  Distribution of measurements taken at mid calf        185 
 
Appendix 21  Distribution of measurements taken at the upper calf    186 
 
Appendix 22  Significance tests for measurements taken at the ankle  187   
 
Appendix 23  Significance tests for measurements taken at mid calf   188 
 
Appendix 24  Raw data for results of patient leg measurements    189 
 
Appendix 25  Raw data for results of control leg measurements    190 
 
Appendix 26  Raw data for ultrasound measurements    191   
 
Appendix 27  Distribution of ultrasound measurements area a    192 
 
Appendix 28  Significance table for ultrasound measurements area a  193 
 
Appendix 29  Distribution of ultrasound measurements area b    194 
 
Appendix 30  Raw data for LDI mean flux    195 
   10
LIST OF APPENDICES (cont)    page 
 
Appendix 31  Distribution of LDI mean flux    196 
 
Appendix 32  Raw data for LDI scores    197 
 
Appendix 33  Raw data for venous refilling times    198   
 
Appendix 34  Distribution of venous refilling times    199 
 
Appendix 35  Raw data for venous incompetence scores    200 
 
Appendix 36  Raw data for patient blood results    201 
 
Appendix 37  Raw data for control blood results    202 
 
Appendix 38  Distribution for CRP and WBC    203 
 
Appendix 39   Distribution for neutrophils and lymphocytes    204 
 
Appendix 40  Significance results for CRP and WBC    205 
 
Appendix 41  Raw data for cytokines    206 
 
Appendix 42  Distribution for IFN-γ and IL-1β   207 
 
Appendix 43  Distribution for IL-2 and IL-4    208 
 
Appendix 44  Distribution for IL-5 and IL-8    209 
 
Appendix 45  Distribution for IL-10 and IL-12p70    210 
 
Appendix 46  Distribution for IL-13 and TNFα   211 
 
Appendix 47  Significance tests for IFN-γ and IL-1    212 
 
Appendix 48  Significance tests for IL-2 and IL-4    213 
 
Appendix 49  Significance tests for IL-5 and IL-10    214 
 
Appendix 50  Significance tests for IL-13 and TNFα   215 
 
Appendix 51  Raw data for IgE results    216 
 
Appendix 52  Distribution for IgE    217 
 
Appendix 53  Significance tests for IgE    218 
 
 
   11
 
 
 
DECLARATION OF AUTHORSHIP 
 
 
 
I, ……CAROL COLLINS………………………………………………………………………., 
[please print name] 
 
declare that the thesis entitled [enter title] 
 
A Preliminary Investigation into the Risk Factors Associated with Cellulitis of the 
Lower Limb……….………………………………………………………………………… 
 
………………………………………………………………………………………………… 
and the work presented in the thesis are both my own, and have been generated 
by me as the result of my own original research.  I confirm that: 
 
 
  this work was done wholly or mainly while in candidature for a research 
degree at this University; 
 
  where any part of this thesis has previously been submitted for a degree or 
any other qualification at this University or any other institution, this has been 
clearly stated; 
 
  where I have consulted the published work of others, this is always clearly 
attributed; 
 
  where I have quoted from the work of others, the source is always given. With 
the exception of such quotations, this thesis is entirely my own work; 
 
  I have acknowledged all main sources of help; 
 
  where the thesis is based on work done by myself jointly with others, I have 
made clear exactly what was done by others and what I have contributed 
myself; 
 
  none of this work has been published before submission. 
 
 
 
 
Signed: ………  
 
Date:……………  
   12
 
 
 
ACKNOWLEDGEMENTS 
 
My thanks the staff of the Ambulatory Care Unit and the Wellcome Trust Clinical 
Research Facility at Southampton General Hospital for their help in facilitating the 
study, to Dr Ruth Pickering for advice with statistics and to Mr Clive Porter (FILMS) 
for guidance with the interpretation of the culture results. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   13
ABBREVIATIONS 
 
The abbreviations used throughout this thesis have been defined when they 
appear for the first time. Whenever possible the standard abbreviation has been 
used. 
 
ACU    Ambulatory Care Unit 
 
AOI    Area of investigation 
 
APC    Antigen presenting cell 
 
B cell    B lymphocyte 
 
CABG   Coronary Artery Bypass Graft 
 
CD   Cluster  of  Differentiation 
 
CNS    Central nervous system 
 
CRH    Corticotrophin-releasing hormone  
 
CRP C-reactive  protein 
 
CT Computerised  tomography 
 
CVI  Chronic venous insufficiency 
 
DTH  Delayed hypersensitivity reaction 
 
DMT InTray  Dermatophyte  Medium 
 
DVT  Deep vein thrombosis 
 
EDTA Ethylenediaminetratraacetic acid 
 
ELISA  Enzyme-linked immunosorbant assay 
 
ELISPOT Enzyme-linked  immunospot 
 
FACS  Fluorescence Activated Cell Sorting 
 
GP General  Practitioner 
 
HLA  Human leucocyte antigen system 
 
HRUS  High resolution ultrasound 
   14
ABBREVIATIONS (cont) 
 
ICD-9 International  Classification of Diseases version 9 
 
IFN-γ Interferon  gamma 
 
Ig Immunoglobulin 
 
IH Immediate  hypersensitivity  reaction 
 
IL-1 Interleukin  1 
 
IL-2 Interleukin  2 
 
IL-4 Interleukin  4 
 
IL-5 Interleukin  5 
 
IL-6 Interleukin  6 
 
IL-8 Interleukin  8 
 
IL-10 Interleukin  10 
 
IL-12 Interleukin  12 
 
IV Intravenous 
 
LCs Langerhans  Cells 
 
LDF  Laser Doppler Flowmeter 
 
LDI  Laser Doppler Imager 
 
LPS Lipopolysaccharide 
 
MHC  Major Histocompatibility Complex 
 
MRI  Magnetic Resonance Imaging 
 
MSD  Meso Scale Discovery 
 
MWU  Mann-Whitney U  test 
 
OPAT  Out Patient Antibiotic Therapy 
 
PATCH  Prophylactic Antibiotics for the Treatment of Cellulitis at Home 
 
PC Personal  computer 
   15
ABBREVIATIONS (cont) 
 
pH potenz  Hydrogen 
 
PT  Paired T test 
 
RCT  Randomised Controlled Trial 
 
SA Staphylococcus  aureus 
 
SAB  Sabouraud Dextrose Agar 
 
SC Stratum  Corneum 
 
SD Standard  deviation 
 
SGH Southampton  General Hospital 
 
SSTI  Skin and soft tissue infections 
 
Tc
99 Technetium  99 
 
T cell  T lymphocyte 
 
TC cell  Cytotoxic T cell 
 
TH cell  T helper cell 
 
TCPO2   Transcutaneous partial pressure of oxygen 
 
TcR  T cell receptor 
 
TEWL Transepidermal  water  loss 
 
TGF-β  Transforming growth factor β 
 
TNFα  Tumour necrosis factor alpha 
 
TI Trichophyton  Interdigitale 
 
TR Trichophyton  Rubrum 
 
US Ultrasound 
 
WBC  White cell count 
 
WSR    Wilcoxon Signed Ranks Test 
 
X
133 Xenon  133 
   16
 
 
 
 
 
 
 
 
 
 
 CHAPTER  1 
 
INTRODUCTION  17
 
1 INTRODUCTION 
 
Cellulitis is an infective/inflammatory skin condition that can affect any part of the 
body but the extremities and the face are most commonly involved with the 
majority of cases occurring in the lower limbs (Choo 2004, Ronnen et al 1985). 
Symptoms include fever and malaise accompanied by swelling and redness of the 
affected part; large areas of skin become inflamed and patients experience 
extreme pain, often for several weeks. While some cellulitic episodes resolve with 
minimal medication others require intensive antibiotic therapy. Cellulitis is classed 
as a skin and soft tissue infection (SSTI) within class 681 and 682 of the 
International Classification of Diseases (ICD) version 10; the number of UK 
recorded episodes in 2005/2006 was 74,000 and the percentage of cases 
requiring hospital admission in the UK (2005/6) was 73% with an overall total of 
426,000 bed days (HES online 2007). At a local level the number referred to the 
Ambulatory Care Unit (ACU) within Southampton General Hospital (SGH) is 
approx 350 lower limb cases per annum. Recurrence rates are estimated to be 
between 18% and 30% and some patients experience several attacks within a 
year (Dermatology Clinical Trials Network ONLINE 2007, Choo 2004, Sjöblom et 
al 1993, Jorop-Rönstöm and Britton 1987, Baddour and Bisno 1984). Currently, 
the reason for predisposition to recurrent attacks remains unclear. 
Locally, the introduction of new referral procedures and protocols by a combined 
programme of hospital and community care, has decreased the risk of more 
serious infection and reduced the number of bed days. Despite this the percentage 
of patients with recurrent infection leaves cause for concern. The clinical problems 
are difficulties with identifying the causal pathogens, the enduring prescription of 
antibiotic medication whose continual use may render subsequent courses 
ineffective and the concomitant burden placed upon the NHS resource. From the 
patient perspective the episodes are not only painful and debilitating but provoke 
considerable stress generated by the uncertain cause and the unpredictable timing 
of subsequent episodes. Many feel particularly vulnerable because no proven 
preventable measures have yet been identified and prophylactic antibiosis, with its 
attendant risk, remains the only currently available option. 
   18
1.1  Cellulitis the Problem 
Cellulitis is a diffuse spreading skin infection characterised by swelling and 
erythema and accompanied by high fever. Although skin involvement is 
progressive the infection is usually confined to one anatomic region and distal foci 
are uncommon. Cellulitis involves the deep dermal and subcutaneous layers of the 
skin, frequently it is confused with erysipelas, which is confined to the upper 
dermal layers and characterised by well defined borders and attendant blisters; the 
contrast is well illustrated by Ashton and Leppard (2005) in figure 1 but in practice 
differentiation is often difficult and the two conditions are invariably treated as a 
single entity (Hay and Adrianns 2004). The red swollen appearance can be 
deceptive and it is important to exclude deep vein thrombosis (DVT) as well as to 
differentiate from other inflammatory skin conditions such as varicose eczema 
Quartey-Papafio (1999) and necrotizing fasciitis (Schmid at al 1998).  
Cellulitis is thought to result when bacteria gain access to the dermal skin layers 
through a puncture or wound and the most likely causal agents are streptococci 
(Ashton and Leppard 2005) or commensal organisms such as staphylococcus 
aureas (SA) (Fung et al 2003, Hook et al 1986). This is difficult to confirm because 
swabs/fluid aspirations taken from the affected site frequently produce negative 
results (Mills and Chen 2005, Perl et al 1999, Leppard et al 1985), so the 
diagnosis is largely empirical, based on clinical appearance and confirmed by 
increased levels of inflammatory markers present in peripheral blood. 
Compression ultrasonography can be used to rule out DVT by confirming vein 
patency (Mani et al 1995) and additionally to demonstrate fast virtually uniphasic 
venous flow and concomitant enlarged lymph nodes which are frequently present 
in patients suffering from infective/inflammatory episodes. Where necrotizing 
fasciitis is suspected, an MRI scan can provide the differential diagnosis (Schmid 
at al 1998). 
The mainstay of the treatment for cellulitis is antibiotic therapy. The choice and 
duration of the treatment relies mainly on the empirical judgement of the clinician 
although it is generally accepted that the pharmacological agents should be active 
against both streptococci and staphylococcus aureus (SA) (Fung et al 2003). 
General Practitioners (GPs) normally commence treatment with oral medication 
and assess patients frequently to monitor progress, but slow or negative    19
 
Figure 1 - Presentation of cellulitis and erysipelas 
  (© Ashton, Richard and Leppard, Barbara, Differential Diagnosis in 
 Dermatology  3
rd edition. Oxford: Radcliffe Publishing; 2005. Reproduced 
  with the permission of the copyright holder.) 
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responses may lead to the prescription of many and various antibiotic courses and 
failure to improve ultimately results in hospital referral and a switch to intravenous 
(IV) administration. Ongoing assessment includes clinical evaluation, blood 
markers such as C Reactive protein (CRP) (Isaacman and Burke 2002), WBC and 
differential count (Sachs 1990) and the time to when the cellulitis fails to advance 
(Corwin et al 2005). Monitored improvement informs the change from IV back to 
oral therapy. In addition to antibiosis, treatment for cellulitis includes pain control, 
reduction of oedema and care of the skin. Analgesia is administered as required 
and this is important not only to ensure patient comfort but also to encourage 
mobilisation of the limb, which assists in the reduction of oedema.  
Estimated recurrence rates range from 18% at SGH to 29% (Sjöblom et al 1993, 
Jorop-Rönstöm and Britton 1987) and the use of prophylactic antibiotics is usually 
considered for patients with predisposing factors such as chronic co-morbidities or 
frequent attacks. There is a paucity of evidence to support the effectiveness of 
prophylactic therapy; studies are few and the numbers recruited are small. Jorop-
Rönstöm and Britton (1987) evaluated 90 patients with recurrences and reported 
that in the short term prophylactic treatment was probably cost effective, Kremer et 
al (1991) and Sjöblom et al (1993) conducted Randomised Controlled Trials 
(RCTs) involving 40 patients and concluded that prophylactic antibiotic treatment 
appeared to reduce or prevent recurrent episodes but that more and larger trials 
were needed to provide a sufficient evidence base. As the problems surrounding 
the use of antibiotic therapy become apparent (Goossens et al 2005, Little 2005) 
the understanding behind the use of such prophylaxis requires a firm foundation. 
An RCT co-ordinated by the UK Dermatology Clinical Trials Network commenced 
in April 2006. Two studies (PATCH 1 and 2) are running concurrently to evaluate 
the impact of 6 and 12 months prophylactic antibiotic therapy on subsequent 
episodes of cellulitis of the legs. (Dermatology Clinical Trials Network ONLINE). 
The co-ordinators hope to recruit around 700 patients from hospitals within the UK 
before 2009. Results from this study should inform future management but the 
ongoing effects associated with long-term antibiotic use must also be considered. 
The origin of any infective/inflammatory condition is questionable if no causal 
pathogen or pathway can be positively identified. This together with the 
unpredictable course of some episodes and the frequency of recurrence are major   21
problems for the management and prophylaxis of cellulitis. Under normal 
conditions commensal flora and pathogens are unable to breech the intact barrier 
or progress far in broken skin if the immune system is functioning properly. In 
cellulitis, it appears that this mechanism is disrupted causing an enhanced 
infective response and/or prolonged period of inflammation. Patients with cellulitis 
frequently display deviations from the expected infective/inflammatory responses 
to localised skin insult. Those most commonly encountered are listed below: 
•  Swabs/aspiration from the infected site rarely produce positive cultures 
(Karakas et al 2002, Sachs 1991) 
•  Although extensive areas of skin are involved the number of organisms 
obtained from positive cultures is often very low (Shelley 1995) 
•  A portal of entry is not always identified (Choo 2004, Bernard et al 1989) 
•  Although blood markers provide proof of systemic inflammation the skin 
infection is usually confined to one anatomical site (Stryjewski et al 2007) 
•  Recurrences predominantly occur at the same site (Badour and Bisno 
1984) 
•  Some episodes require many courses of antibiotic therapy to achieve 
resolution (Stulberg 2002) 
•  The time lapse between recurrent episodes is variable; can be days, 
weeks, months or years (Karakas et al 2002, Badour and Bisno 1984) 
Identification of the causal pathogens and entry sites is key to successful 
treatment and some research has already been done in this area. Sachs (1991) 
showed that aspiration at the affected site only produced positive culture results 
when performed within the first 24 hours of the infective event. Bernard et al 
(1989) and Shelley et al (1995) used punch biopsies and immunofluorescence in 
order to demonstrate the presence of bacteria deep within the reticular dermis 
after negative results from surface cultures. In a more recent study of 111 patients 
by Choo (2004) only 12% of cultured surface samples were positive, less that 1% 
were identified as streptococci and the remainder were all commensal flora: 
furthermore 39% of patients are unable to recall any predisposing factors or 
provide evidence of skin breech. Negative results may simply be due to low 
density of micro organisms (Semel et al 1996) but alternative theories suggest that   22
causal factors other than bacteria could be responsible for the inflammatory 
response (Hook et al 1986).  
Seventy years ago Traub and Tolmach (1937) and Sulzberger et al (1937) 
identified a group of patients who were unable to associate an episode of skin 
breech with their cellulitic-like symptoms. Lesions in these patients were found to 
be in close proximity to areas of microscopically demonstrated fungal skin disease 
(dermatophytosis). Many initially experienced frequent recurrent episodes but 
application of topical fungicides appeared to alleviate the problem without further 
recourse to antibiotic therapy. More recently, studies by Dupuy et al (1999) and 
Roujeau (2004) have reported dermatophytosis as a risk factor for cellulitis and 
Björnsdóttir et al (2005) found a strong association between cellulitis of the lower 
limb and the presence dermatophytes in the toe web spaces. Similar associations 
have been implied by others (Roldan et al 2000, Koutia et al 1999, Day et al 1996, 
Kremer 1991) and are supported by local findings from SGH where recurrent 
cellulitic attacks appear to be more frequent in patients with dermatophytosis who 
fail to adhere to topical antifungal treatment. 
Infective/inflammatory skin conditions such as cellulitis, may occur and recur 
because the skin and/or immune system fail to function effectively (Maleszka et al 
2001, Woodfolk et al 1998) in response to one or more stressors arising from co-
morbidities or other physiological, psychological or environmental factors 
(O'Sullivan et al 1998). Dermatophytosis represents one potential stressor, which 
is not only ubiquitous in its presence (Broughton 1955, Sugimoto1955) but also 
has an affinity for skin and an ability to elicit diverse responses from the immune 
system. Links with skin physiology have been suggested by Cox (2006), 
Björnsdóttir et al (2005), Roujeau (2004) and Dupuy et al (1999) who report 
associations between cellulitis and oedema. In addition Cox (2006) and Naguib et 
al (2004) implicate vascular disorders, in particular venous incompetence. As 
venous incompetence is strongly associated with oedema this particular aspect of 
skin physiology would appear to be important. These same studies also propose 
associations with immune related co-morbidities such as diabetes and malignancy 
suggesting implications for immunological mechanisms although as yet there is no 
evidence to support this theory. 
One common feature links the proposed causal factors described above; their 
presence adds a stress burden to the system providing the potential to challenge   23
homeostasis and affect the course and outcome of other disease processes 
(Tracey 2002, O'Sullivan et al 1998). It may be in their role as stressors and by 
mechanisms as yet unknown that they contribute to the cellulitic process.  
In the next chapter the literature concerning the relationship between cellulitis, skin 
/immune physiology and stress factors will be reviewed. It begins with detailed 
accounts of skin structure and function and an explanation of the expected 
infective/inflammatory response to skin insult. The evidence to support links 
between causal factors, skin function and immune responses will be discussed. It 
concludes by identifying the proposed areas of research, which could contribute to 
a better understanding of the problem. 
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2 LITERATURE  REVIEW 
 
2.1  The Skin  
Skin forms the interface between the external environment and the internal body 
structures; together with the external appendages (hair, nails, sebaceous and 
sweat glands) it forms the integumentary system which is the largest organ of the 
body. Its functions are diverse and vital and include roles in protection, 
homeostasis, immunoregulation, sensation and display. Despite being composed 
of structurally distinct areas the skin is co-ordinated and integrated so that it 
operates as a single functional unit. 
2.1.1 Skin  structure 
Structurally skin consists of two regions; the epidermis or outer layer, in contact 
with the environment, and beneath this a thicker supportive layer known as the 
dermis. Although structurally separate the epidermis and the dermis communicate 
via a semi permeable basement membrane, which forms the interface between a 
system of downward projecting epidermal ridges and upward projecting dermal 
counterparts. The dermis interfaces with the underlying fascia via a layer of loose 
connective tissue and fat known as the hypodermis. 
The epidermis consists of several layers of cells in various processes of 
differentiation and derived from a basal layer, which is continually engaged in 
mitosis (Figure 2a). Cells generated by the basal layer are known as 
keratinocytes, they are living, nucleated and form columns which move upwards, 
synthesising keratin and lipids and differentiating as they pass through the spinous 
and granular layers (Fuchs 2007). As they progress and approach the skin surface 
they become enucleated, flattened and tightly packed and consist mainly of 
insoluble keratin. These dead cells, now known as corneocytes, occupy the 
uppermost layer of the epidermis known as the Stratum Corneum (SC). Although 
tough this outer layer remains supple due to the presence of lipids synthesised in 
the granular layer (Madison 2003) which together with secretions from the 
sebaceous and sweat glands form an emulsion permeating the intercellular 
spaces (McEwan Jenkinson 1993).  
The skin appendages all derive from the ectodermal embryological germ layer and 
are therefore epidermal structures (Moore and Persaud 1998). Most sebaceous   26
 
Figure 2a - Structure of the skin  
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glands arise from an associated hair follicle and form a pilosebacious unit. Sweat 
glands are coiled epidermal downgrowths and nails are keratinised epidermal 
invaginations situated on the distal dorsal surface of each finger and toe.  
The dermis consists mainly of collagen and elastin fibres secreted by the 
predominant cells known as fibroblasts. Fibres and cells are embedded in a matrix 
of glycosaminoglycans composed largely of hyaluoronic acid and dermatan 
sulphate forming a connective tissue mesh subdivided into two strata; the upper 
loosely packed papillary dermis and the lower reticular dermis which is thicker and 
denser. 
Vascular input for both epidermal and dermal layers of the skin is supplied by 
vessels within the papillary and reticular dermis. The circulatory arrangement with 
respect to the skin regions is shown in figure 2b. Dermal papillary loops follow the 
outline of the epidermal ridges thus increasing the diffusible surface area and 
providing closer contact with the cells of the avascular epidermis. The lymphatic 
plexus lies deep to the arteriovenous microcirculation, it is similarly arranged but 
devoid of papillary loops. 
The skin as a whole supports an active immune and surveillance system. Within 
the epidermis this is provided by immune system activators (Langerhans' and mast 
cells) and interspersed T lymphocytes (T cells). Protective pigment cells 
(melanocytes) and sensory co-ordinating (Merkel) cells are also found adjacent to 
the basement membrane. Within the dermis nerve fibres and immune cells are 
found in close association with the microcirculation. Macrophages and phagocytic 
cells (similar to epidermal Langerhans cells) are abundant in the papillary dermis 
and large numbers of mast cells and T cells are present throughout (Spellberg 
2000).  
2.1.2 Skin  function 
In its protective function skin provides a barrier between the internal organs and 
the environment minimising damage resulting from insults such as trauma, 
chemicals and ultraviolet light and providing protection from desiccation and the 
intrusion of pathogenic microbes which compromise health and obstruct healing. 
As a first line of defence the stratum corneum (SC) is tough and resilient and 
offers a continuous and substantial shield against insult and invasion. Integration  
with the other skin layers, particularly the tough reticular dermis, creates an 
effective cushion which absorbs initial impact and disseminates transmitted force   28
by distribution through the sliding action of the loosely attached hypodermis. Skin 
mechanical properties vary with anatomical site. There are differences in 
thickness, elasticity and distensibility, which relate to functional and gravitational 
adaptations. Thus the skin in the gaiter region of the ankle is stiffened to withstand 
gravitational stress (Gniadecka et al 1994), and the stratum corneum of the heel is 
much thickened to endure the forces applied to the weight bearing lower extremity. 
In many mammals hair plays a major part in the protective process. In some, such 
as rodents, dense hair covering is important to protect from trauma and 
consequently the thickness of the underlying epidermis is much reduced. In 
humans, dense hair cover is restricted to a small proportion of total body area; the 
remainder is devoid of hair (glaborous) or only sparsely covered. The role of 
human hair in mechanical protection is therefore minimal but it does assist in 
protection against pathogens by acting as a foil to prevent microbes reaching the 
skin surface (McEwan Jenkinson 1993).  
In order to maintain skin health and provide good protective function it is important 
that the skin layers should be adequately hydrated while the surface remains dry. 
The skin organ as a whole acts as a fluid reservoir for the body. Water is stored in 
the dermis by attraction to proteoglycans (hyaluronic acid in particular), which are 
present in the matrix and can be utilised if fluid levels become low. 
Regulation of skin water content is crucial for efficient and effective skin function. 
Water constitutes an essential component of interstitial fluid; part of which is 
immobile or 'bound' and part of which is free. The quantity of free fluid is variable 
but is normally maintained close to homeostasis by the lymphatic system (Courtice 
1984). In the inflammatory state fluid content between skin layers is greatly 
increased due to an influx of water and plasma proteins, which exit the small blood 
vessels and pool in the extravascular space. Clearance of this protein laden fluid 
or exudate depends on the efficiency of the lymphatic system and 10 times the 
normal lymph flow may be measured (Hurley 1984). If the lymphatic system 
becomes obstructed or overloaded, fluid builds up within the tissues and results in 
oedema. The type of oedema which resolves is regarded as acute; other types of 
long term fluid retention and associated persistent swelling are classified as 
chronic oedema and lymphoedema. The former is associated with changes in 
posture or pressure, vascular and/or endocrine dysfunction and certain metabolic 
disorders. The latter, linked with congenital defects, filariasis, cancer, radiotherapy   29
and surgery, results from anomalies/damage to lymphatic pathways (Browse and 
Stewart 1985) and requires specific physiological tests to establish a differential 
diagnosis. 
Changes in water content are therefore partially responsible for variations in skin 
thickness (Eisenbiss et al 2001). Water entry from the surface and water loss from 
underlying layers is controlled by the intercellular lipid matrix within the SC, which 
maintains the external surface in a dry but pliable state (Tagami et al 2001). The 
rate at which water is transferred between the skin and the atmosphere is known 
as transepidermal water loss (TEWL). Disruption of the lipid barrier creates 
increases in TEWL causing skin to become cracked and brittle, conversely, 
occlusion or hyperhydration impede TEWL with the effect that the skin surface 
may become macerated.  
All microbes possess the ability to become pathogenic if they are allowed to 
proliferate without control and/or infiltrate the tissues beyond their normal range 
(Sprunt et al 1971). Changes in skin physiology together with trauma or disease 
states can affect the morphology of the skin surface facilitating access, offering 
sites for colonisation and favourable conditions for growth. To counter this, the 
intercellular epidermal matrix contains antimicrobial peptides known as 
cathelidicins and β-defensins which have been shown to confer a degree of 
natural prophylaxis against bacteria and fungi (Nizet 2007, Nizet et al 2001, 
Ricketts at al 1951). An additional antibiotic peptide has also been identified in 
sweat (Schittek at al 2001) and the constituents of sweat and sebum together with 
the products of lipid degradation (Huraib et al 1994) help to maintain an acidic pH 
at the skin surface. Despite these defences healthy skin is colonised by an 
indigenous population of commensal bacteria, which play a major role in 
maintaining the ecological balance that exists at the skin surface (Sprunt et al 
1971). Commensal bacteria have the ability to thrive under varying conditions of 
pH, temperature and humidity and this favours numerical dominance over 
transient pathological species, which tend to be more sensitive (Holland 1993, 
Amonette and Rosenburg 1973). Further advantages are achieved by secretion of 
toxins and bacteriocins (Selwyn 1975), lipid degradation and maintaining the 
immune system in a constantly primed state (Scheffel 1979). 
The balance is delicate and easily upset. Disruption may arise from localised 
changes such as the use of detergents, which alter factors such as pH and lipid   30
control (Korting and Braun-Falco 1996) or more generalised changes concomitant 
with co-morbid disease. Added to this is the increasing and continuous use of 
antibiotic therapy which has been shown to disrupt the normal pattern of bacterial 
flora providing the potential for overgrowth of normally subordinate pathogens and 
possibly contributing to antibiotic resistance in later years (Weinstein 1947). 
Desquamation (shedding of cells from the SC) is an ongoing process and is the 
final step and an integral part in the differentiation of keratinocytes that have 
travelled upwards through the layers of the epidermis. The turnover of cells varies 
with anatomical site (on average 12-14 days) and abnormalities in the shedding of 
skin scales occur as a result of disruptive skin physiology (Millstone 2004, 
Madison 2003); this has been demonstrated in patients with exfoliative dermatitis 
and related conditions (Palmer et al 2006, Thody and Friedmann 1986). 
Desquamation is thought to have evolved to facilitate repair and regeneration, 
evict toxins and maintain the balance of microbes at the skin surface; it is also 
considered to be part of the innate (inherited) mechanism for clearing pathogens 
including fungal organisms from the epidermis (Millstone 2004). Exfoliation is an 
integral part of infective/inflammatory diseases such as scalded skin syndrome 
(Chiller et al 2001) and has also been shown to feature in some patients 
recovering from episodes of cellulitis (Badour and Bisno 1984). 
In order to function effectively the skin requires and adequate and efficient blood 
supply; this is provided by a complex network of anastomosing arterioles and 
venules, which constitute the microcirculation. Oxygen and nutrients travel to the 
reticular dermis and to the papillary loops of the dermis where they diffuse through 
the thin capillary walls to supply the living cells of the epidermis. The resting rate of 
flow is controlled by minute intermittent contractions known as vasomotion, 
governed by the opening and closing of sphincters at the entrance to the arterioles 
and acting in response to the oxygen concentration in the adjacent tissues 
(Guyton and Hall 2000). When demand for oxygen is high the arterioles dilate and 
blood flow to the capillaries increases; this mechanism, which also serves to 
facilitate the dissipation of body heat through the skin, is under the control of the 
autonomic nervous system. The arterio-venus microcirculation works in 
conjunction with the lymphatic plexus to maintain a delicate pressure balance 
controlling the amount of fluid within the tissues, which would otherwise lead to the 
formation of oedema.    31
Arguably the most important part of the skin defence mechanism is the immune 
response; a complex system incorporating primitive mechanisms and therefore 
capable of raising responses to a catalogue of antigens (molecules and organisms 
regarded as non self by the body) both evolutionary and novel (Alberts et al 1983). 
There are two systems of defence which work in concert to combat antigens: firstly 
the local or innate system which consists of body membranes and their unique 
populations of immune cells; the second or adaptive system includes cells which 
mature in specialised immunological tissues and which can mobilise to specific 
body sites via the vasculature. 
2.1.3  The skin immune system 
All immune cells originate in the bone marrow from either myeloid and lymphoid 
progenitor cells. Myeloid precursors give rise to erythrocytes, platelets, dendritic 
cells, monocytes and polymorphonuclear leukocytes (eosinophils, neutrophils, 
basophils and mast cells). Lymphoid precursors differentiate into Natural Killer 
(NK) cells and lymphocytes. Lymphocytes further undergo a maturation phase 
either in bone marrow or thymus and are then referred to as B and T cells 
(Benjamini et al 1996). Some cells are predominantly resident in skin, these 
include dendritic (Langerhans) cells, Natural Killer Cells, Macrophages, memory T 
cells and mast cells while others, leukocytes and T and B lymphocytes, are 
recruited from circulating peripheral blood and lymph organs when required. 
Immune cells have two major functions, the first is to ingest or phagocytose alien 
cells and destroy them with toxins; this process, which is a key first line of defence, 
is enhanced by substances present in blood serum collectively known as 
complement. The second role is to denature antigenic material and express it at 
the cell surface for recognition by T and B cells; a process known as antigen 
presentation.  
Mast cells facilitate vascular permeability, release histamine and initiate allergic 
responses. They also participate in phagocytosis but their role in this is minimal. 
2.1.3.1  T and B lymphocytes 
T and B lymphocytes are the only cells responsible for specific cell mediated 
antigenic immunity. Some T lymphocytes can interact directly with the protein 
components of intracellular antigen, others have a role in regulating the immune 
response. B cells interact with antigen via antibodies called immunoglobulins and   32
in association with T cells. Both T and B lymphocytes must be matured and then 
primed to elicit the appropriate responses.  
 T cells 
T cells mature in the thymus gland and may be broadly categorised as either CD8 
or CD4 cells by reference to adhesion and signal transduction glycoproteins 
present on the cell surface. CD8 cells are also known as cytotoxic (TC) cells 
whereas CD4 cells may also be called helper (TH) cells. Each mature T cell 
possesses a unique T-cell receptor (TcR) capable of interaction with a specific 
antigenic determinant or epitope (Benjamini et al 1996, Male et al 1996) but needs 
to be primed before it becomes fully functional. Priming takes place in peripheral 
lymphoid  tissue (spleen, lymph nodes, Peyers patches etc) and requires that each 
T cell must simultaneously encounter its specific antigen together with a discrete 
body cell marker which is individually unique and recognised as 'self'. Self markers 
are a group of glycoproteins known as Major Histocompatibility Complex 1 and 2 
(MHC1, MHC2). CD4 cells must engage in conjunction with MHC2 while CD8 cells 
require MHC1.  
Following activation some T cells enter the circulation and become available to 
move to sites of injury in a process known as trafficking. Once inside the injured 
tissues TH (CD4) cells are able to stimulate other immune cells to proliferate and 
mobilise while TC (CD8) cells can attack infected cells directly and destroy them 
along with the infective agents that they contain. As the immune reaction proceeds 
chemical messengers (cytokines and chemokines) produced by the participating 
cells bring about changes in the milieu, which influence both the secreting cells 
(autocrine effect) and also those in close proximity (paracrine effect). These 
changes are responsible for the further differential development of T helper cells 
and for variations in immune responses, which subsequently ensue (Marieb 2004, 
Male et al 1996).  
TH cells may differentiate into either a TH1 or a TH2 phenotype. The TH1 subset is 
associated with the stimulus for acute inflammation by also has a role the 
differentiation of cytotoxic CD8 cells, delayed type (DTH) hypersensitivity reactions 
and chronic inflammation (Male et al 1996). Cytokines such as Interleukin 12 (IL-
12) and Interferon Gamma (IFN-γ) promote this process, which results in the 
synthesis of Interleukin 2 (IL-2) and IFN-γ. The TH2 subset promotes antibody   33
responses from B cells and may be associated with immediate type (IH) allergic 
reactions. It is driven by Interleukin 4 (IL-4) and produces a predominance of IL-4 
and IL-5 (Benjamini 1996, Romagnani 1996). 
An additional T cell subset (the regulatory TH3 cell or Treg) is produced by 
negative selection in the thymus. Treg cells control the amplitude of the immune 
response and later curtail the episode to restore homeostasis. They require the 
stimulation of IL-2 and are thought to suppress by action of anti-inflammatory 
cytokines IL-10 and TGF-β (Robertson 2007, Taylor et al 2007). 
Following an inflammatory episode a pool of activated T cells creates a memory 
bank. These cells make their way to designated tissues by a process similar to 
trafficking known as homing. Large numbers of such memory cells are resident in 
skin and play an important role in the prompt initiation of future inflammatory 
responses.  
B cells 
B cells pass through a series of maturation stages in the bone marrow. They 
produce antibodies called immunoglobulins whose structure is similar to the TcR 
and co-receptors CD4 and CD8 expressed on T cells. Immunoglobulins are bound 
to the surface of B cells and are also present in plasma and some secretory fluids. 
Their purpose is to fix and bind complement and cross link receptor sites on 
soluble molecules, pathogens and toxins thus facilitating and enhancing 
phagocytosis and inflammation. There are five major classes of immunoglobulin 
(Ig) designated IgM, IgA, IgD, IgG, and IgE. The structure of the Ig molecule 
allows for genetic variation of the antigen binding region allowing progeny B cells 
to be antigen specific within their Ig class. 
Immature B cells inherently express IgM and IgD. Activation takes place in the 
secondary lymphoid tissues where encounters with antigen take place and further 
differentiation then becomes milieu dependant. B cells may clone and become 
plasma cells or, under the influence of T cell derived cytokines, switch isotypes 
and begin to synthesise IgG, IgA or IgE.  
IgD and IgM in their monomer forms act as antigen receptors. IgM in its pentamer 
form circulates in plasma where it acts as an efficient agglutinator and activator of 
complement. IgG represents the largest proportion of plasma Ig with the longest 
half life and has major and diverse roles including agglutination, opsonization, 
activation of complement, neutralisation of toxins and immobilisation of bacteria.   34
IgA is present in body secretions and helps to prevent the attachment of 
pathogens to epithelial surfaces. IgE is secreted by plasma cells in epithelial 
tissues, including skin, and some lymph organs. It has the ability to adhere and 
illicit a reaction from cells such as basophils, eosinophils and mast cells, 
participating in the allergic reaction and causing excessive release of histamine 
and concomitant increased vascular permeability. Serum levels of IgE in normal 
healthy individuals are very low < 300 iu/mL but in severe allergic reactions 
readings in excess of 10,000 iu/mL may be obtained (Ownby 1998, Rihoux 1993, 
Grundbacher 1975)  
Initial exposure to infection produces a primary response with a lag time of several 
days during which B cells proliferate and levels of first IgM and then IgG rise 
sharply. Some of the B cells produced in this primary response are selected and 
retained. Because these cells are already primed subsequent identical challenges 
result in shorter reaction times and amplified responses. 
2.1.3. 2  Infective/inflammatory responses in the skin 
When skin is attacked by insult or infection the innate response is instigated by 
keratinocytes and the inflammatory process begins. On the skin surface this is 
characterised by swelling, redness, heat and pain with concomitant decrease in 
local mobility function. Acute phase proteins C-Reactive protein (CRP) in particular 
are released by the liver, the complement system is activated. Initially leukocytes 
are recruited and the WBC rises as large numbers of neutrophils arrive; lysis and 
phagocytosis of microorganisms begins. Immune system residents relay and 
amplify the response and achieve co-operation and co-ordination between cells by 
the production of cytokines and chemokines particularly IL-1, IL-6 and TNF-α (See 
figure 3). Both cellular activity and chemical production operate within feed back 
loops through links between local nerve fibres and the central nervous system 
(CNS), which is therefore intelligent and involved in the direction and control of the 
episode (Tracey 2002). 
If the episode fails to resolve chemokines induce the onset of the adaptive immune 
response. Influx of T and B cells from the peripheral circulation is mediated by the 
vascular endothelium whose cell receptors bind leukocytes which then pass 
through the vessel wall by a process known as diapedesis and follow the 
chemokine gradient toward the site of injury (Spellburg 2000). The chemical milieu    35
Figure 3 - Simple graphical representations to identify the different TH1 and TH2 
type cytokines associated with proinflammatory, IH, DTH and anaphylactic 
reactions. 
(IL-6 has been included for completeness to highlight its important role in the 
proinflammatory response) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FEVER 
 
TISSUE 
DAMAGE 
 
TOXIC SHOCK 
TNF-α 
++, IL-1 
++, IL-6 
++ 
SUPERANTIGENS 
 
Bacterial toxins interact 
directly with T cells  IL-1     IL-6, TN-α, IL-8 
           IFN-γ, IL-2 
            ↓ 
       IL-12 
           ↓ 
TH1 (proinflammatory) 
IH 
 ↓        Systemic anaphalyxis 
TH2++        
    IgE++        Cutaneous               
      ↓                anaphalyxis  
IL-4, IL-5, IL-10   ↓ 
(wheal and flare) 
TH1++
 
 
 
IL-2, IFN-γ 
 
TH1 
 
 
IL-12 
DTH  36
from which lymphocytes are recruited and to which they are introduced strongly 
influences the ensuing immune response and has important consequences for the 
outcome. The processes involved should be aggressive enough to combat the 
pathogens but also controlled so that the system shuts down when the desired 
effect has been achieved. Failures in this mechanism can lead to exaggerated or 
inappropriate responses with the potential for damaging effects upon the tissues. 
2.1.3.3 Hypersensitivities 
The various types of hypersensitivity (allergy) are examples of exaggerated or 
inappropriate responses and are thought to have evolved as protection against 
parasites or other organisms, too large to be destroyed by phagocytosis alone, 
and where extreme responses may be required to prevent infestation (Benjamini 
et al 1996). Basically hypersensitivities can be divided into two groups depending 
on their time course and whether antibodies or T cells are involved. 
Immediate type hypersensitivities (IH) commence within seconds of allergen 
contact and involve a predominance of the TH2 subset (figure 3) and concomitant 
increased levels of IgE antibody (Al Hansan at al 2004, Sato and Tagami 2003, 
Leung 1999, Blake et al 1991, Jones et al 1973) with subsequent mast cell 
degranulation, leading to an excessive histamine induced inflammation which 
typically manifests in skin as a 'wheal and flare' response (Benjamini et al 1996, 
Church et al 1999). Extreme episodes may result in systemic allergic reaction 
(anaphylaxis) with attendant risk of mortality (Simons et al 2007). 
Delayed type hypersensitivities (DTH) have longer onset and are regulated by the 
TH1 subset of helper T cells with the co-operation of the cell mediated effect of 
macrophages (figure 3). This type of hypersensitivity occurs in response to antigen 
such as allografts, intracellular parasites or fungi; manifesting in skin as erythema 
and induration (raised thickening) appearing around 48 hours after challenge. If 
the reaction succeeds in combating the antigen no untoward effects are observed; 
in many cases however the antigen is able to persist provoking prolonged 
macrophage activation with attendant tissue destruction. Moreover antigenic 
material may never be completely eliminated allowing the possibility that further 
challenge may reactivate the process.  
Superantigens 
Exaggerated responses to antigens are not confined to hypersensitivity reactions. 
Unprimed T cells can sometimes be activated by antigens without involving   37
antigen presenting cells (APCs). Such antigens, including some bacterial toxins, 
are able to bypass the normal binding constraints and simultaneously activate 
large numbers of T cells leading to the production of huge quantities of cytokines 
especially, IL-6, IlL-1 and TNF-α (figure 3). Otherwise harmless commensal 
bacteria such as Staphylococcus Aureas (SA) are capable of producing such 
responses in certain circumstances; the toxins responsible are categorised as 
‘superantigens’. The effects can initiate an immediate hypersensitivity (IH) 
reaction, which in extreme cases can result in anaphylaxis (Manders 1998).  
It is well accepted that many infective/inflammatory diseases have both a toxic and 
an allergic component (Sulzberger et al 1937). The toxin is a metabolite produced 
by the pathogen while the allergic component arises from its physiological 
constituents eg; lipopolysaccharide (LPS) from the cell wall. Conditions such as 
diphtheria, tuberculosis and dermatophytosis are examples where varying 
contributions may be made by both infective and allergic components. In patients 
with dermatophytosis, an allergic skin reaction resembling cellulitis or erysipelas, 
was sometimes observed at the site of infection (Sultzberger et al 1937, Traub 
Tolmach 1937). In addition, isolated foci with similar appearances were noted at 
other anatomical locations. Because associations between these findings are 
plausible but as yet unproven, such reactions are described as idiopathic or by the 
shortened form "id ", (Rippon 1974, Sultzberger et al 1937, Traub Tolmach 1937). 
With respect to the toxic component a study by Carratalà (2003) analysed the 
outcomes of 332 patients hospitalised for episodes of cellulitis. No studies had 
previously analysed the risk factors for mortality resulting from cellulitic episodes. It 
was found that toxic shock at presentation caused mortality in seven of the eight 
patients who died within the first 72 hours of admission. Various pathogenic 
bacteria including pseudomonas were assumed to be responsible, but in two 
cases staphylococcus aureas (SA), a skin commensal, was thought to be the 
cause.  
2.2 Dermatophytes 
Dermatophyte fungi have evolved from soil dwelling species that have adapted to 
use the keratinised layers of the skin together with its appendages (hair, fur and 
nails) for their nutrition (Hay and Baran 2004). Infections affecting the superficial 
layers of the epidermis are known as Dermatomycoses while those that have 
penetrated more deeply are described as Dermatophytoses. The term   38
onycomycosis encompasses all fungal nail disease. Dermatomycoses include 
Trichophyton Nigra (Cladosporium), and other opportunistic moulds such as 
Penicillium, Paecillomyces, Scopulariopsis and Acremonium. The Dermatophyte 
group is divided into three genera (Microsporum, Trichophyton and 
Epidermophyton); within these groups the most clinically relevant species are 
Trichophyton Rubrum, Trichophyton Mentagrophytes (Interdigitale), Trichophyton 
Tonsurans and Microsporium Canis. Other frequently used terms for these 
conditions are ringworm and tinea (Rippon, 1974) frequently with the addition of 
the body part eg, tinea pedis (tinea affecting the foot), tinea capitis (tinea affecting 
the head). Athlete's foot is commonly used as an alternative to tinea pedis.  
Fungi are ecologically important as they form the basis for all biological recycling. 
Although their life form remains primitive their life cycles are complicated and their 
morphological appearances diverse, in addition they can proliferate/survive in 
sexual/asexual forms, combination types or as resistant spores. Microscopically 
they present in tissues as string like collections of cells (hyphae), which combine 
to form dense mats or mycelia. Reproduction commonly involves fragmentation of 
individual hyphae to produce satellites (arthroconidia) from which new colonies 
arise, and the production of spores (conidia), which are able to exist in a dormant 
state before germinating into new organisms. Classification is based on the 
morphology of these asexual spores (Clayton and Midgley 1989), but spores are 
only produced if the chosen culture medium and the growing environment (heat, 
humidity etc) meet species requirements. Confident identification therefore 
requires long periods of observation to assess the macroscopic shape and colour 
of the colony, both in obverse and reverse view, together with the microscopic 
appearance of the hyphae and the shape and arrangement of the spores (Rippon, 
1974).  
Fungal infections of the skin may involve any part of the body but the majority of 
cases occur in moist enclosed areas and the feet are particularly at risk, especially 
for those who predominantly wear boots or other enclosed footwear 
(Ananthakrishnan et al 2004). Fungal presence in skin is often unremarkable and 
organisms may reside undetected in areas such as the foot sole and the nails so 
the prevalence is unknown but is thought to be between 30-70% within the total 
population (Woodfolk and Platts-Mills 1998, Fitzpatrick 1994, Jones at al 1973). 
This is unsurprising as the proportion of shed skin scales with potential microbial   39
attachment, in airborne particles, could be as high as 10% (Mc Ewan Jenkinson 
1993) and studies have shown that dermatophytes can be cultured from footwear, 
laundered socks, floors and the contents of vacuum cleaners, even after elapse of 
months or years (Broughton 1955, Sugimoto1955).  
Dermatomycoses are opportunistic organisms and their presence is most relevant 
in the mucosae where application or inhalation of significant numbers may lead to 
serious disease (eg Farmers Lung). In most other cases the opportunists only 
become clinically relevant in the immunocompromised patient and skin is 
sometimes involved ( Rippon 1974) 
Dermatophytes are the major perpetrators of fungal skin disease and capable of 
populating the skin of both vulnerable and healthy individuals alike. Mild infections 
are considered benign but excessive fungal proliferation leads to changes that 
threaten the skin environment. If fungi access the deep skin through open wounds 
they may disseminate via the blood stream and subsequent related disease has 
been demonstrated particularly in immunocompromised patients (transplants etc) 
and in guinea pigs (Seçkin 2004, Sulzburger 1928). Normally the numbers of 
dermatophytes residing in the superficial skin layers is controlled by the process of 
desquamation, which eliminates the fungus as the dead skin scales are shed 
(Blake et al 1991) however if fungal proliferation exceeds the rate of skin turnover 
the immune system intervenes. Dermatophytes signal their presence to the 
immune system by diffusion of toxins produced from their sloughed cell wall 
eliciting a delayed type hypersensitive skin response (DTH) and concomitant 
increase in the desquamation process. There is no innate immune response 
mechanism Rippon 1974), the DTH (cell mediated response) is the only 
designated pathway known to confer immunity; this can be confirmed by the 
presence of significant titres of specific antibodies in the serum. Abnormality or 
absence of the DTH response allows the fungus to proliferate (Al Hassan et al 
2004, Woodfolk and Platts-Mills 1998, McGregor et al 1992) altering the skin 
environment in favour of bacteria. Subsequently bacteria in turn become dominant, 
the numbers of active fungi decline, produce spores and enter a dormant phase 
(Hay 1993). 
2.2.1  Cellulitis and dermatophytosis 
Research by Day et al (1996) has shown that uncontrolled dermatophytosis results 
in increased alkalinity at the skin surface, concomitant progressive skin debilitation   40
and a gradual change from a preponderance of gram positive to gram negative 
bacterial colonisation. This change, which assists the overgrowth of organisms 
such as pseudomonas and klebsiella, is clinically recognised as gram-negative 
cellulitis, and is particularly important in immunocompromised patients and those 
with neuropathy because delay in averting its rapid progress can lead to 
necrotizing faciitis or gas gangrene with subsequent loss of limb. These 
observations suggest that dermatophytes promote cellulitis by creating changes in 
the skin surface environment, which favour transient pathological bacterial 
species. Other studies however, suggest that their primary role is to provide a 
portal of entry by which any bacteria may gain access to the deeper layers of the 
skin. Dupuy et al (1999) studied 167 patients with clinically diagnosed erysipelas 
of the leg and 294 controls. Their results showed toe web intertrigo (fissures 
between the toes) to be a risk factor for developing cellulitis that increased with the 
number of toe spaces involved, however the presence of dermatophytosis was 
only assumed as no cultures were performed. In (2004) Roujeau et al studied 243 
cases of acute clinically diagnosed cellulitis and 467 controls. In this study 
dermatophytosis was confirmed by culture and found to be present in 42.5% of 
cases compared with 24.1% of controls. Björnsdóttir et al (2005) used both culture 
and microscopy to demonstrate dermatophytes and types of pathogenic bacteria 
in the toe web spaces of 100 hospitalised patients with cellulitis and 200 
hospitalised controls. They used odds ratios to calculate the risk factors 
associated with various attributes and concluded that dermatophytosis was high 
risk (OR,3.86; 95% CI, 1.32-11.27) but only in the absence of proven bacterial 
infection. As it was impossible to confirm either fungi or bacteria as causal they 
recommended improved management of foot care particularly toe web intertrigo, 
as a means of reducing the incidence of cellulitic episodes. 
In all these studies acute and recurrent cases were analysed together and 
although previous history was recorded and cited as a risk factor for future cellulitic 
attacks there is a paucity of data relating to long term outcomes in such patients. 
Only one study was found which specifically addressed this issue (Baddour and 
Bisno 1984). It relates to a group of patients who were recalled for surveillance 
following coronary artery bypass grafts (CABG); some of which suffered repeated 
attacks of cellulitis at the donor site after saphenous vein harvesting. The attacks 
were unpredictable and irregular and ranged from hours to weeks or months post   41
operation. Within this group seven patients suffered from concomitant 
dermatophytosis of the feet and it was found that in two cases the recurrent 
attacks ceased following antifungal medication.  
The above studies suggest a link between cellulitis and dermatophytosis and 
favour the theory that dermatophytes provide a portal of entry through which 
bacteria may enter and infect the skin, however this does not explain why 
dermatophytes breech the stratum corneum when their presence should be 
contained within the uppermost layers of cornified cells.  
It has been shown that a DTH reaction speeds the desquamation process 
eliminating fungal bodies and priming the immune system to confer long lasting 
protection. However it has also been shown that some individuals produce an IH 
response to dermatophyte invasion, which results in an initial exaggerated 
reaction, absent or incomplete skin shedding and allows fungi and spores to be 
retained (Woodfolk and Platts-Mills1998). There are also a group who fail to mount 
any type of response and these are classed as anergic (McGregor 1992). In 
addition individuals have been shown to produce varying immunological 
responses to the same fungal species on subsequent occasions (Woodfolk et al 
1998) despite displaying the expected immunological outcomes in response to 
other non fungal antigenic material (Svejgaard 1985).  
Attempts have been made to understand the mechanisms responsible for these 
differing responses. Walters (1974) recruited patients suffering with acute and 
chronic dermatophyte infections and demonstrated that serum taken from patients 
with chronic Trichophyton Rubrum infection had the ability to block their own cell 
mediated responses. Maleszka (2001) studied 35 patients with onychomycosis 
(fungal nail disease) and 20 controls and showed decreased lymphocyte 
trafficking, lymphoproliferation and differentiation during dermatophyte infestation. 
In vitro experiments conducted by Baldo (1997) demonstrated precipitative 
reactions between fungal 'C' substances and C-reactive protein with the potential 
to cause thrombus like formations within the vessels of the microcirculation. Such 
observations are endorsed by Cermak et al (1993) who postulate that changes in 
the microcirculation, during and subsequent to inflammatory events, may occur 
because of interactions between CRP and lipopolysaccharide (LPS) and manifest 
from modification to the coagulation cascade. These findings suggest that immune 
responses elicited by dermatophytes could have implications for the   42
immunological control of other infective organisms. The mechanisms are as yet 
unknown but have been variously attributed to factors within the milieu at the 
infection site or serum (Maleszka 2001), the severity of dermatophyte infection 
(Woodfolk and Platts-Mills 1998), host factors (Hay 1993) and cross reactivity 
between fungal species (Hopfer 1975).  
It is also possible that changes in skin structure and/or physiology favour fungal 
proliferation and assist their progress into the deeper layers of the skin or that 
defects in the normal desquamation process favour retention of fungi or spores. 
The evidence therefore suggests that dermatophytes could play a more major part 
in the infective process than just providing a portal for bacterial to enter (Kremer et 
al 1991). Spore production assures a substantial source of successive 
dermatophytes and this together with inhibition of lymphoproliferation, conferred by 
their continuing presence, may predispose vulnerable individuals to repeated 
episodes of bacterial infection (Blake 1991). 
2.3 Stressors 
Stress may be defined as force acting against resistance. When stress is imposed 
a reaction is provoked; this reaction is described as strain. In a medical context 
stress can be defined as any disruptive factor that threatens the homeostasis of 
the body (Boon and Christensen 1997). 
Factors including injury, disease or worry as well as environmental effects such as 
temperature, pollution and malnutrition are all therefore potential stressors. It is 
now well accepted that the effect of stressors both physiological and psychological 
affect the course of disease by links with the endocrine and immune systems 
(Tracey 2002, (Maleszka et al 2001) and in conjunction with attributes which result 
from differences in genotype (Korte et al 2005, Cheng et al 2004, Kustima et al 
2004, Leung 1999). While acute stress has been shown to be beneficial by 
priming, testing and effecting responses, deleterious effects are produced when 
the stressor is exerted for long periods resulting in a cumulative stress burden 
known as allostatic load (Korte et al 2005, McEwen 2003, Schulkin et al 1998). 
The effects are initially manifested indirectly through events that manipulate the 
chemical environment, promoting changes in cellular function, which then translate 
into disturbances within more integrated processes (blood pressure etc). The 
disease process emerges as a consequence of these precursors and thereafter   43
plays a major role in this self perpetuating progression (Choi et al 2005, Dhabhar 
2003, Vanitallie 2002, Denda et al 2000, Harris 1996). 
2.3.1  Effect of stressors on the skin 
Because the skin is responsible for protecting the entire body surface against the 
hazards of the outside world any detrimental change to its morphology or 
physiology is likely to have an effect upon its function. Small changes are 
important (Hay 1993) as they may cause subtle differences in host defence that 
over time render the skin more vulnerable to invasion by pathogens from either 
external or internal sources (Tagami et al 2001, Finch 1988). Implications 
associated with the ubiquitous presence of dermatophytosis have already been 
discussed. Conditions such as psoriasis and eczema are thought to be associated 
with psychological stress (O’Sullivan et al 1998), manifested through manipulation 
of the cytokine environment, modulation of the skin immune function and delays in 
recovery in the skin barrier (Nakano 2004, O'Sullivan et al 1998). Other stressors 
such as trauma, surgery, diabetes, smoking and systemic vascular disorders 
together with the ageing process have all been shown to affect skin function 
presenting as changes in skin thickness, decreased skin vascularity and 
modification to the surface environment (Ryan 2005, Clark et al 2003, Harrison et 
al 1993, Tur et al 1992). Aside from abnormalities resulting from arterial delivery, 
malfunctions in the venous system resulting from faulty venous valves, may initiate 
microcirculatory defects, which are later displayed in skin variations such as 
oedema and lipodermatosclerosis (Topham and Mortimer 2002, Ryan 2002).  
The above findings suggest that a wide range of potential stressors have the 
ability to affect skin structure and physiology and increase its vulnerability. With 
respect to cellulitis and the potential links with dermatophytosis, some factors are 
particularly important; these include the skin environment, pH at the skin surface, 
changes to the microcirculation and variations in skin structure. 
2.3.1.1    The skin environment 
In order to maintain skin health and provide good protective function it is important 
that the skin layers should be adequately hydrated while the surface remains in a 
dry but pliable state. Many factors including skin lipid content, transepidermal 
water loss (TEWL) and sweating affect this balance and the environment that 
exists close to the skin surface is a major influencing factor with implications for 
infection and inflammation. Dehydration encourages cracks and fissures to form   44
allowing microbes to penetrate below the surface; hyperhydration promotes 
maceration, which breaks down the protective barrier dissuading the growth of 
natural flora in favour of more pathogenic forms (Day 1996, Mc Bride 1993). In 
1978 Leyden and Kligman used plastic bags to simulate a moisture laden 
environment around the feet of persons suffering from dermatophytosis and 
controls. Their experiments showed that in the presence of hyperhydrosis, 
dermatophytosis simplex was transformed to dermatophytosis complex with 
concomitant change from the normal gram positive flora to their more pathogenic 
gram negative counterparts. At the start of the experiment, skin colonisation in the 
patient group showed a bacterial/fungal mix with gram negative dominance 
dependant on the severity of the dermatophyte infection. After 2-3 days the 
enclosed skin became macerated and malodorous with greatly increased numbers 
of gram negative bacteria and biopsies were required to demonstrate the fungal 
presence, which had migrated to the lowest level of the SC. A return to the original 
floral mix was observed once again when the experimental hyperhydrosis had 
resolved. By contrast, the flora of control individuals was normal at the beginning, 
increased with accompanying mild maceration during the experiment, and rapidly 
returned to the original state post episode. These findings suggest that fungi and 
bacteria are able to coexist in equilibrium on the skin if the surface humidity is 
within the normal range. Excessive moisture appears to facilitate/accelerate the 
overgrowth of pathogenic bacteria but the presence of dermatophytes also seems 
to be required. This theory is supported by evidence from studies of populations 
(soldiers, construction workers etc), whose feet are predominantly enclosed inside 
boots or substantial shoes (Ananthakrishnan et al 2004, Fitzpatrick 1994), where 
the presence of untreated dermatophytosis has been shown to lead to serious 
bacterial complications. It therefore appears likely that dermatophytosis, skin 
humidity and wearing confined footwear have implications for patients with 
cellulitis, although at present the mechanisms are unclear.  
2.3.1.2 Skin  pH 
The symbol pH is used to indicate the concentration of hydrogen (H
+) ions in 
solution and is normally recorded as a logarithm. A recorded pH of 7 is regarded 
as neutral; values below this are acidic and those above are alkaline. The reported 
pH range for normal human skin varies from 3 – 7.0 (Matousek and Campbell 
2002), this falls within the acid range and the skin surface is often referred to as   45
the 'acid mantle'. Maintenance of acidity is attributed to contributions made by the 
constituents of sweat and sebum together with the products of lipid degradation 
(Huraib et al 1994).  
Chikakane and Kenichiro (1995) demonstrated that in skin diseases such as 
eczema and atopic dermatitis pH values were alkaline (pH above 7.0); in healing 
ulcer tissue high initial pH values were shown to fall as the wound volume reduced 
(Roberts et al 2002). Except for babies and the very elderly, age does not seem to 
affect skin pH neither does anatomical site appear to influence pH values except in 
areas of moist occlusion such as the toe web (Parra and Paye 2003).  
Authors such as Spellberg (2000) and Sprunt et al (1971) suggest that an acidic 
pH is important because it provides optimal conditions to maintain growth of the 
commensal organisms responsible for discouraging the expansion of transient 
pathological species. However a different view is expressed by McBride (1993) 
who maintains that the change in electrostatic charge generated on the skin 
surface, due to changes in pH, may be the effector mechanism for either 
attracting, releasing, or mobilising the prevailing flora. Variations in pH are also 
considered to have an impact on the rate of desquamation, which in turn may 
affect the colonisation at the skin surface (Rippke et al 2004).  
Disruption of pH may arise from localised changes resulting from the use of 
detergents (Korting and Braun-Falco 1996), germicidal soaps (Amonette and 
Rosenburg 1973) or antibiotics (Sprunt et al 1971) but the presence of 
dermatophytes can also produce the same effect. In (1956) Goldfarb and 
Herrmann cultured dermatophytes and other saphrophytes on Sabouraud
`s 
medium and recorded levels of pH by observing colour changes in the medium 
around the colonies. All eleven species of dermatophyte produced pH changes in 
the alkaline range while the saprophytes produced varying degrees of acidity. 
Ryall (1980) reports similar observations in vitro emphasising that although 
dermatophytes may grow freely on contact with an acidic medium, the substrate 
rapidly becomes alkaline due to release of ammonia by their metabolism. In 1995 
Chikakane and Takahashi studied pH values on the hands and feet of 68 patients 
with athletes foot as compared to 19 control subjects. They found that the mean 
skin surface pH values recorded on the feet of the patient group was significantly 
higher than those of controls (Patients = 6.1 ± 0.6, controls 5.2 ± 0.5 respectively) 
but no significant differences were demonstrated on the hands.   46
These findings taken together suggest that the pH value at the skin surface may 
have implications for microbial colonisation and may therefore have a role in 
cellulitic episodes.  
2.3.1.3   Skin  microcirculation 
One important function of the microcirculation is to elicit an effective response 
during episodes of infection and inflammation. This is achieved by 
communication/co-ordination between cells of the immune and microvascular 
systems. The start of an infective/inflammatory response generates cytokines and 
neuropeptides, which diffuse through the skin layers to alert the cells of the dermal 
endothelium and initiate the feed back system via the brain. Interaction between 
endothelial cells and neuropeptides cause microvascular vessels to dilate, while 
further action by mast cell induced histamine, causes them to become more 
porous. Increasing dilation and porosity allows serum to leak into the interstitium, 
decreasing vascular pressure, lowering shear forces, and permitting blood flow to 
slow and facilitate diapedesis of immune cells into the tissues. These changes 
promote the well recognised signs of inflammation; erythema, heat, swelling and 
pain.  
The ability to mobilise immune cells and effect immune responses is therefore 
highly dependant upon both afferent and efferent physiology of the skin 
microvascular system but an efficient, effective lymphatic system is also required 
to carry away excess interstitial fluid and convey antigen and antigen presenting 
cells to the lymphatic tissues. In conjunction with lymphatic drainage the role of the 
deep and superficial venous systems must also be considered.  
2.3.1.4   Venous  function 
Venous function has been shown to be an important factor in the aetiology of 
diseases affecting the lower limbs (Wollina et al 2006, Khan and Newton 2003, del 
Mar Sāez et al 2001) and chronic venous insufficiency (CVI) is a key factor in the 
initial decline in skin health leading to conditions such as lipodermatosclerosis, 
oedema and ulceration (Cox 2006, Naguib et al 2004, Jones et al 2004). CVI 
results from defects in venous return to the right atrium. The most important cause 
of venous insufficiency is damage to the venous valves, either in the deep or 
superficial venous systems and commonly as a result of thrombophlebitis or DVT 
(Haneke 1991, Ciocon 1993, Thomas 1988, Killewich et al 1985). Impaired venous 
flow results in venous reflux, sending pressure back through the venous system to   47
the capillaries, disturbing the microcirculation and leading to oedema (see section 
2.3.1.5), which impedes the diffusion of nutrients and gases and disrupts normal 
cellular functioning.  
The microcirculation plays a vital role in the effectiveness of immunological 
outcomes. Its responses must be prompt at the outset, efficient in delivery and 
curtailed at the appropriate time. Defects in this sequence have the potential to 
hinder or prolong the inflammatory process and this may have important 
implications with respect to the extended course of some cellulitic episodes. No 
studies were found which specifically address the role of the microcirculation in 
cellulitic attacks but CVI was cited as a risk factor in the study by Roujeau et al 
(2004). It was found to be significant when entered into conditional logistic 
regression analysis (p = < 0.1), however this finding is difficult to evaluate as the 
defining criteria for CVI was based on clinical findings alone and no laboratory 
investigations were performed.  
2.3.1.5  Skin  properties 
Skin varies in thickness and mechanical properties according to anatomical site 
and in conjunction with functional and gravitational adaptations. Variations in 
thickness also reflect the influence of age, sex, hormones and circadian rhythms. 
The thickness of the epidermis is maintained by spontaneous desquamation 
(Milstone 2004) a process, which normally increases in response to a variety of 
insults including dermatophytosis (Jones 1974). In the study by Badour and Bisno 
(1984) desquamation was observed at the affected cellulitic site in the days 
following cessation of antibiotic treatment but no studies were carried out to 
measure the changes in skin thickness that occurred.  
The thickness of the dermal layers varies in response to the amount of free fluid 
transitional in the tissues (Eisenbiss et al 2001); in health this fluid is maintained 
close to homeostasis by the lymphatic system (Courtice 1984). In the inflammatory 
state fluid content between skin layers is greatly increased due to an influx of 
water and plasma proteins, which exit the small blood vessels and pool in the 
extravascular space. The increasing volume of fluid soon exceeds the capacity of 
the lymphatic vessels and the tissues begin to swell, a condition known as acute 
oedema (Browse and Stewart 1985). This type of oedema usually resolves as the 
inflammation subsides but if excess fluid production persists the lymphatic system 
becomes permanently overloaded and the oedema becomes chronic. Such   48
chronic oedema is a ubiquitous complaint and the consequence of diverse clinical 
conditions including heart failure, immobility, dependency and endocrine 
dysfunctions. 
Lymphoedema is another form of oedema which results in tissue swelling but the 
underlying cause in this case is disease/anomaly of the lymphatic vessels brought 
about by changes initiated by parasites, cancer, surgery or Radiotherapy (Topham 
and Mortimer 2002, Browse and Stewart 1985), thus fluid retention, in this 
instance, results from failure in the transport system by which it is removed.  
Because most oedema contains an element of lymphoedema and the clinical 
presentation is often similar, the terms are often used synonymously. Physiological 
tests and invasive imaging modalities are required to establish a differential 
diagnosis (Burnand et al 2002, Topham and Mortimer 2002, Duewell et al 1992, 
Mortimer 1990, Vaughan 1990, Partsch 1988, Mortimer 1986), these are 
expensive, time consuming and not without risk but may be necessary because 
the differing underlying physiologies should be understood when considering the 
role of oedema in conjunction with other medical conditions.  
Studies by Depuy et al (1999) and Roujeau et al (2004) assessed swollen legs as 
risk factors for cellulitic episodes by reference to lymphoedema and oedema. In a 
case controlled study of 167 patients and 294 controls Dupuy et al showed 
lymphoedema to be a major risk factor for cellulitis while oedema was found to be 
insignificant. In a similar but later study (243 patients and 467 controls) Roujeau el 
al  (2004) found significance for the presence of oedema per se. Cox (2006) 
performed a retrospective study on 143 patients with assumed streptococcal 
cellulitis of the lower leg. Medical history and questionnaire was used to record 
complications and identifiable risk factors for further episodes and to establish the 
frequency of post cellulitic oedema. Oedema (defined only as persistent leg 
asymmetry), was found to be strongly correlated with recurrent cellulitis (P = 
0.0002) but onset of asymmetry and its temporal relationship with the original 
cellulitic episode was not established.  
In all these studies oedema and lymphoedema were assessed clinically; linear 
measurements, physiological tests, scoring systems and imaging modalities were 
not used. Although persistent oedema appears to be associated with cellulitic 
attacks, more thorough investigations are required to provide conclusive proof.   49
It is not known whether residual oedema is retained once the cellulitic episode has 
resolved, whether the epidermal thickness remains stable or whether differences 
in these parameters exist between those who suffer acute as opposed to recurrent 
attacks. Such information may be significant as it may substantiate the evidence 
for the role of oedema in the cellulitic process and/or implicate abnormalities in the 
normal desquamation process.  
2.4  Rationale and aims of study 
Cellulitis is a debilitating infective/inflammatory skin disorder with a high rate of 
recurrence. Definitive diagnosis is difficult and treatment is therefore largely 
empirical. Doubts as to the aetiology of any infective/inflammatory condition must 
always exist if no causal pathogen can be positively identified and this, together 
with the unpredictable course of some episodes and the frequency of recurrence, 
are major problems for the management and prophylaxis of cellulitis. The diversity 
of individual response suggests that although pathogens play a major role, other 
influencing factors may also be important.  
Previous research suggests that infective/inflammatory skin conditions such as 
cellulitis may occur and recur because the skin and/or immune system fail to 
function properly and an association with dermatophytosis could be implicated. 
There is some evidence that stressors (physiological/co-morbidity/psychological/ 
environmental) may be involved. The relationships are complex but represented in 
a simplified form in figure 4. Much work has been done, but some aspects, such 
as the characterisation of the immune response and quantification of vulnerability 
factors within the skin, have not been fully investigated in this context. There is a 
need to determine the frequency of dermatophytosis in patients with cellulitis, to 
understand the effects that this might have upon skin function and the immune 
response, and to examine the role that might be played by other stressors. The 
methodology for this study has been devised to examine these associations. 
2.4.1 Study  aims 
This study was intended to provide a preliminary investigation into the risk factors 
associated with cellulitis of the lower limb. The following aims were identified as 
important : 
•  To investigate the frequency of dermatophytosis amongst patients with 
clinically diagnosed cellulitis of the lower limb as compared with matched 
controls.   50
•  To investigate the risk factors relating to skin structure and physiology in 
patients with clinically diagnosed cellulitis of the lower limb as compared 
with matched controls. 
•  To compare blood profiles and types of immunological responses in 
patients with clinically diagnosed cellulitis of the lower limb and matched 
controls. 
•  To consider the role of other potential stressors within the context of these 
findings. 
•  To compare the above with respect to acute and recurrent cases 
In order to address these aims a case controlled pilot study was designed and 
suitable methodology and testing procedures selected. The subsidiary aim was  
•  To establish the suitability, feasibility and reliability of the proposed tests 
and to provide data on which to base a realistic sample size for a 
subsequent larger scale study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Figure 4  
Possible relationships between stress factors, skin function and the 
immune response 
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3 STUDY  DESIGN 
This pilot study was designed to investigate the risk factors associated with 
cellulitis of the lower limb and consider the possible relationships. The subsidiary 
aim was to establish the suitability, feasibility and reliability of the proposed tests 
and to provide data on which to base a realistic sample size for a subsequent 
larger scale study. Those tests to be included in the main study were therefore 
dependent upon the outcomes of the pilot study and those found to be unsuitable, 
unfeasible or unreliable would be removed.  
The risk factors may be regarded as stressors acting to predispose or in 
conjunction with the principle cause of pathology  ie: bacterial infection. They are 
divided into four groups as follows: 
Microorganisms other than bacteria  - specifically dermatophytes 
Factors relating to skin structure and physiology 
Immunological outcomes 
Additional stress factors 
The risk factors to be assessed and the related tests are outlined in table 1. 
Initially it was decided to recruit patients with cellulitis confined to one leg so that 
within patient comparisons could be made between legs. However, this made no 
provision for control comparisons with respect to frequency of microorganisms or 
immunological outcomes and a case control study design was therefore adopted. 
Within patient comparisons were made between the affected (cellulitic leg) and the 
unaffected (contralateral leg) and patient control comparisons were made between 
the cellulitic leg and the control cellulitic leg (matched by left or right). Where 
appropriate, comparisons were also made between the patient contralateral leg 
and the control contralateral leg (eg: numbers of dermatophytes cultured). All tests 
were repeated on a second occasion approximately one month after the cessation 
of antibiotic therapy. This second visit was crucial to establish whether results from 
cellulitic patients returned to normal values post episode as no previous studies 
had been identified which presented such data. The timing selected for this 
second visit is explained in section 4.2.2.   
Because comparisons were required between patients and controls at each visit, 
between visits and also between patients suffering from acute and recurrent    53
 
Table 1 – Risk factors and related tests 
 
Category Risk  factor  Mechanism  Test selected for use 
in the study 
Microorganism 
 
Dermatophytosis 
Portal for bacterial 
entry 
Changes in skin 
morphology 
Defects in 
desquamation  
Allergic reaction 
 
Specimen collection, 
culture and 
microscopy 
 
 
 
Serum immunoglobulin 
to Trichophyton 
Rubrum (IgE to TR) 
Skin structure 
and 
physiology 
Changes in skin water 
loss 
Changes in skin 
surface 
environment, 
vulnerability to 
bacterial/fungal 
proliferation 
Measurement of 
Transepidermal water 
loss (TEWL) 
Skin structure 
and 
physiology 
Changes in pH balance 
at the skin surface 
Changes in skin 
surface 
environment,  
bacterial/fungal 
proliferation 
Measurement of  
skin pH 
Skin structure 
and 
physiology 
Oedema 
Skin vulnerability 
Impeded immune 
response 
 
Leg circumference 
measurements 
Ultrasound tissue 
measurements 
Skin structure 
and 
physiology 
Changes in skin blood 
flow 
Changes in skin 
nutrition, function 
and immune 
response 
Measurement of skin 
blood flow Laser 
Doppler Imager (LDI) 
Skin structure 
and 
physiology 
Venous incompetence 
 
Precursor to 
oedema 
 
Photoplethysmography
Laser Doppler 
flowmeter (LDF) 
Immunological 
outcomes 
Abnormal 
haematological 
response to 
inflammation/infection 
Deviation from the 
expected 
patterns/sequences 
of cell responses to 
inflammation 
Blood profiles 
Immunological 
outcomes 
Exaggerated immune 
response 
Serum cytokine 
profiles 
Immunological 
outcomes  Allergic response 
Predominance of  
T-helper 2 (TH2) 
subset    ↓ 
        > serum IgE  Serum immunoglobulin
(IgE) 
Stress factors 
Previous episode 
Co-morbidity 
Previous surgery etc 
Skin vulnerability 
Immune defects  Patient history 
Stress factors  Psychological stress  Skin vulnerability 
Immune defects  Stress questionnaire 
   54
 
episodes, the statistical analysis was complicated. A systematic approach was 
therefore adopted and this is explained in section 5.2. 
3.1  Choice of methods 
Patients suffering from cellulitis present with high fever, attendant malaise and 
large areas of infected skin. Investigative methods should therefore be quick, 
minimally invasive with low risk of infection and tolerable to sick individuals. In 
addition they should be appropriate, reliable, reproducible and validated. All of the 
tests chosen for use in this study are currently in use in either a clinical or a 
research setting; in some cases the methodology has been refined in order to 
more closely fit the intended purpose. 
3.1.1  Investigation for dermatophytosis. 
The basis of mycological diagnostic tests is the identification of fungal elements 
present in samples taken from the skin at the affected site. Diagnosis may be 
difficult because the samples obtained may lack hyphae or spores, fungal 
concentration may be too small to support viable colonies or similarities in 
appearance may make it impossible to interpret between species (Lawry 2000, 
Taplin 1969).  For these reasons and because individuals may be asymptomatic, 
cases often remain undiagnosed.   
Foot scraping or tape stripping are the methods currently used by podiatrists to 
obtain skin samples from the feet but these were unsuitable for use in this study 
because they were considered to be too invasive in the presence of infection. A 
sample collection method was required which would ensure a good success rate 
whilst being fairly quick and well tolerated by those whose cellulitis included their 
feet. Initially samples were obtained by applying pressure to the foot sole and 
interdigital spaces using a soft toothbrush and pressing the bristles into an agar 
medium, however microscopic observation revealed that few skin scales had been 
collected by this method indicating that it was not sufficiently aggressive. 
Subsequently emery boards were applied with a firm rubbing motion and the fine 
dust generated was collected onto coloured paper and evenly distributed on the 
surface of the agar.  When viewed microscopically this process revealed large 
numbers of skin scales (including aggregates), together with crystalline deposits 
from the emery board (figure 5). As this method was consistently found to produce 
adequate quantities of skin scales from both the foot sole and the interdigital   55
spaces and was also well tolerated by the patients, it was adopted as the method 
of choice for the duration of the study. 
Culture mediums for dermatophytes and bacteria can be made in house or 
purchased ready made to suit specific organisms. After considering the options, a 
commercially available dextrose agar system (IN TRAY 
TM DM (Biomed 
Diagnostics, USA) was obtained. This system consists of individual agar coated 
trays with transparent lids, which are used to seal the tray when the sample has 
been inserted and thereafter provide an inspection window. The sealed tray is low 
risk for infection and is designed for use at room temperature and without 
reference to culture and microscopy departments. The medium changes from 
yellow to pink in response to changes in pH, denoting the presence of 
 
Figure 5 – Skin samples on DM x 10 
 
 
 
 
dermatophytes (Pariser and Opper 2006, Taplin et al 1969). This system was 
tested using identified dermatophyte cultures from the Microbiology Department 
within Southampton General Hospital. It was found to be highly sensitive but low 
on specificity as other organisms (moulds, bacteria and yeasts) produced similar 
colour changes.  
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Further experimentation proved that it was possible to discriminate between 
organisms when morphological observations of tray sample cultures were 
evaluated in conjunction with microscopic appearance. When these methods 
proved inconclusive organisms were recultured onto Sabouraud dextrose agar 
(SAB) to encourage further growth (Evans and Richardson 1989); observations 
were then compared with documented morphology for that media. In difficult cases 
advice was sought from a mycologist from the Microbiology Department within 
Southampton General Hospital. 
3.1.2  Investigations of skin structure and physiology 
Changes in morphology and/or physiology of the skin may have important 
implications for diseases such as cellulitis and dermatophytosis. Initially these 
diseases may occur as a result of insult or injury but subsequent attacks may arise 
because the skin remains vulnerable. Morphological changes provide access for 
pathogenic and commensal organisms allowing them to penetrate beyond the 
stratum corneum and infiltrate the dermal layers. Physiological changes may affect 
homeostasis and/or alter the microenvironment favouring growth and prolonging 
the presence of microorganisms within the skin. Defects in the microcirculatory 
system may contribute to these processes but its role in the delivery of the 
immune response must also be considered.  
In this study non invasive tests were selected to assess some skin attributes which 
might favour growth of microorganisms, facilitate their entry or compromise the 
skin immune response. Measurement of skin water loss, skin pH, oedema, skin 
thickness, venous incompetence and skin blood flow were selected. Comparisons 
between these functions in normal as opposed to cellulitic skin could indicate 
factors that may be associated with increased vulnerability.  
3.1.2.1  Skin water loss 
Hydration at the skin surface depends on external humidity, internal water loss and 
whether the area is directly exposed to the atmosphere or confined within an 
occlusive cover such as a bandage or a shoe. The temperature gradient is also an 
important factor. The water content of the stratum corneum at any one time affects 
the skin surface humidity and visa versa and this has implications for both 
microbial colonisation and skin surface physiology.  The rate at which water is 
transferred between the skin and the atmosphere is known as transepidermal 
water loss (TEWL). Under controlled conditions (avoiding excessive humidity   57
which causes sweating or extremes of cold which cause skin circulation to 
decrease) the rate of water loss through the stratum corneum is estimated at 6-11 
g/hr/cm
2  (Nilsson 1977) in most body parts including the legs, while in inflamed 
skin much higher rates are recorded (Tagami et al 2001).  
The universally accepted method for the measurement of TEWL is the 
measurement of evaporative water loss, calculated by determining the vapour 
pressure gradient between two sensors positioned within a cylinder in a vertical 
line above the skin surface. The gradient between the two readings is calculated 
with reference to temperature and the result is proportional to the amount of water 
vapour evaporating from the skin surface in unit time (Nilsson 1977). This holds 
true providing that the cylinder is open ended and exposed to the atmosphere and 
that measurements take place in a draught free environment within the stated 
temperature range. TEWL measurements have been shown to increase as the 
outer layers of the SC are stripped away (Morgan et al 2003, Kalia et al 1996), for 
this reason and in order effect good comparisons as well as minimise infection, 
measurement sites were confined to intact skin.  
3.1.2.2  Skin pH 
The symbol pH is used to indicate the concentration of H
+ ions in a solution, 
expressed as the logarithmic reciprocal and reflecting its relative alkaline, neutral 
or acidic attributes. A recorded pH of 7 is regarded as neutral; values below this 
are acidic and those above are alkaline. Repeated studies on healthy human skin 
reveal pH levels maintained below 7 pH (between 3 - 6.5) and therefore in the acid 
range (Matousek and Campbell 2002, Chikakane and Takahashi1995, McBride 
1993). This has been attributed to contributions made by the constituents of sweat 
and sebum together with the products of lipid degradation. The only study found to 
specifically address the calf skin was conducted on school children (11 – 16 years) 
where the mean pH was found to be 5.6 (Noble 1968). With respect to 
dermatophytosis the pH value on the foot sole has been shown to be significantly 
higher in sufferers as opposed to healthy controls (Chikakane and 
Takahashi1995); for those with cellulitis, variations in pH values are thought to 
have relevance for the balance of the microflora at the skin surface (McBride 
1993). 
Early experimenters measured pH by colorimetric methods (Anderson 1951) but 
latterly a technique employing a hand held glass probe, containing a combined   58
active and reference pH electrode, has been universally adopted (Parra and Paye 
2003, Korting and Braun-Falco 1996). The pH value can be read directly from an 
integral pH meter or recorded continuously via a PC interface. Because the skin is 
not a solution measurements must be made with a damp electrode tip and time 
must be allowed for the reading to settle in order to record a reliable 
measurement. Care must be taken with the protocol and the results interpreted 
with caution because pH values are greatly affected by changes in temperature 
and any applications made to the skin surface. Comparisons must also consider 
that pH is a logarithmic scale so that small unit changes actually represent large 
differences (Matousek and Campbell 2002).  
In this study calibration was carried out at regular intervals over the expected pH 
range (4 and 7pH values). As alcohol wipes were required to disinfect the probe 
between readings and there was some concern that this would affect the response 
times to subsequent readings, experiments were conducted in fluids of known pH 
with alternating disinfection to evaluate the effects. Neither sharp variations in pH 
or disinfection made any effect on the accuracy of the readings or the time taken 
to stabilise the results.  
3.1.2.3  Oedema 
Skin thickness varies with different areas of the body together with the influence of 
age, sex, hormones and circadian rhythms. Variations in epidermal thickness may 
be due to functional adaptation but has also been shown to relate to defects in the 
desquamation process with consequent effects for the microfloral ecosystems at 
the skin surface (Milstone 2004, McEwan Jenkinson 1993). In the dermis transient 
or permanent changes in thickness primarily result from variation in the amount of 
fluid present in the tissue spaces (Eisenbiss et al 2001) and manifest as tissue 
swelling defined as oedema. Infection/inflammation of the skin promotes acute 
oedema which normally resolves post episode, chronic dermal oedema is long 
lasting and associated with impedances in healing, oxygen delivery and 
elimination processes (Cox 2006, Koutia 1999) and therefore has implications for 
recurring skin infections such as cellulitis. Epidermal and dermal thickness 
measurements therefore provide one parameter by which to assess changes to 
the stratum corneum and evaluate the presence and persistence of dermal 
oedema.    59
Circumferential limb measurements were used to compare swelling between legs, 
between visits and between participants. Measurements were recorded for the 
lower leg and taken just below the knee, at mid calf level and at the ankle. Precise 
circumferential measurements can be obtained by various modalities using light 
alignment techniques but for this study the disposable tape measure provided a 
quick and easy method with low risk of infection. 
Several methodologies are available for visualising and measuring the layers of 
the skin. The biopsy is the most comprehensive as it has the potential to provide 
information on both measurement and histology (Whitton and Everall 1973) 
however excised tissue is subject to shrinkage artefact, which makes comparisons 
with in vivo measurements subject to bias. Other techniques include the various 
types of light microscopy (Abramovits and Stevenson 2003), computerised 
tomography (CT) (Vaughan 1990), magnetic resonance imaging (MRI) (Schmid et 
al 1998) and ultrasound (Rallan and Harland 2003). Because ultrasound imaging 
is a non invasive modality which is generally quicker, less expensive and more 
easily accessible than these other techniques and because measurements of skin 
thickness taken from ultrasound images have been shown to correlate well with in 
vivo confocal microscopy (Nouveau-Richard et al 2004) as well as the gold 
standard xeroradiography (Alexander and Miller 1979) it was selected as the 
method of choice for use in this study. 
Ultrasound has been used as an imaging modality for many years and the advent 
of high frequency (20MHz+) scanners now allows the outermost layers of the skin 
to be studied in some detail (Serup 1992, Gniadecka 1996, Altmeyer et al 1991). 
Interface measurements can be performed and images analysed by the 
application of mathematical transforms. The advantage over conventional lower 
frequency ultrasound is the greater definition that can be obtained for surface 
structures by positioning the focal zone to coincide with the superficial layers of the 
skin; this is achieved by placing a membrane behind the ultrasound window and 
filling the space between with water. 
A high frequency 20MHz ultrasound scanner interfaced to a PC (Dermascan C, 
Cortex Technology Denmark) was available for use in this study. The system 
contains an inherent measurement system based on A-scan (amplitude scan) 
presentation and allows distances between structures to be calculated by placing 
a cursor at each end of the relevant section of the image (figure 6b). However   60
measurements are only valid if the scanning plane intersects the skin surface at 
right angles (Collins 1996); the correct orientation has been achieved if the image 
shows the scanner membrane lying parallel to the skin surface (figure 6a). A stand 
was designed which would hold the scan head in the correct alignment and allow it 
to be raised and lowered to make contact with the skin surface (figure 7).  
Thickness measurements 
The first interface visualised on an ultrasound image of skin relates to the echo 
created between contact jelly and the outer surface of the stratum corneum (SC).  
The first bright echogenic band (figure 8) represents the entire epidermis 
extending from the skin surface to the papillae adjacent to the basement 
membrane (Nouveau-Richard et al 2004); it is not possible to distinguish between 
the layers of dead corneocytes and the living keratinocytes below. Beneath this 
the papillary dermis is identified as a lower echogenic band extending into the 
reticular dermis, which is thicker and more highly echogenic due to increases and 
orientation of the fibrous bundles which predominantly lie parallel to the skin 
surface and therefore provide maximum reflection (Querleux et al 1988).  
An A-scan is a line graph representing the amplitude of the signals derived from a 
single line of grey scale values contained within an image. A-scans derived from 
different images can be compared providing that the image acquisition settings, 
most importantly the time gain compensation, remain unchanged. In order to 
obtain the grey scale values the signals must be digitised allowing each pixel to be 
allocated a value between 0 and 256. Values around 0 represent low levels of 
returning echoes, such areas are perceived as dark grey and black and termed 
hypoechoic, examples would be fluid filled spaces and water interfaces. High level 
echoes reach maximum at 256 when virtually all the incident beam is reflected 
backwards. These are perceived as bright (hyperechoic) areas, examples include 
the SC and fibrous bundles within the skin. Most tissues contain a mixture of 
components with high and low reflective qualities whose density and arrangement 
affect their interaction with the ultrasound beam and therefore produce a variety of 
imaging patterns.  
The Dermascan C software digitises pixel values and presents a line selected from 
an image as an A-scan superimposed upon the image so that the amplitude 
values can be related to the visual components. Measurements can then be 
obtained by manipulating the cursors so that they intercept the entry and exit   61
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The Dermascan C software digitises pixel values and presents a line selected from an 
image as an A-scan superimposed upon the image so that the amplitude values can be 
related to the visual components. Measurements can then be obtained by manipulating 
the cursors so that they intercept the entry and exit points of selected regions of interest. 
To measure the thickness of the epidermis (area A) the vertical measurement cursors are 
positioned at the interfaces (between arrows. Dermal measurements (area B) can be 
obtained by repositioning the cursors to include both the papillary and reticular dermis. 
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A -  Stand designed to hold ultrasound scan head in a horizontal position 
 
B  - Close up view of scan head and support mechanism 
 
C - Scan head positioned to capture a transverse image of skin from the right calf    63
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Figure 8 – Ultrasound appearances of the epidermis, papillary and 
reticular dermis and subcutaneous layers    64
points of selected regions of interest. To measure the thickness of the epidermis 
the vertical measurement cursors are positioned at the interfaces (between 
arrows) as demonstrated in figure 6b. The result is presented in an on screen 
results table. Dermal measurements can be obtained by repositioning the cursors 
to include both the papillary and reticular dermis (figure 6b). 
Validation of the Dermascan measurement system 
The measurement system was tested to confirm reliability over the expected range 
of epidermal and dermal thicknesses (0.5 – 4mms). Two items, a microdialysis 
tube and a drinking straw, were chosen to simulate well defined highly reflective 
structures such as the SC and fibrous bundles; the decreased reflectivity and less 
well defined borders of the dermal matrix was simulated by a length of soft twine. 
All objects were placed in a water bath and aligned with their long surfaces parallel 
to the transducer. The twine was suspended between upright supports and held 
firmly but without tension. The speed of ultrasound was adjusted to account for 
transmission in water (1480 m/s) and images were obtained in both longitudinal 
and transverse planes. System measurements were performed as described 
above and external diameter measurements recorded in both planes (figure 9). 
Comparisons were then made with the corresponding dimensions obtained by 
measuring the external diameters of all items using a micrometer. The results are 
compared in table 2. Results from the highly reflective microdialysis tube were 
identical. The micrometer measurements for the straw were slightly higher and this  
Table 2 – Comparison between Dermascan measurements  
and results obtained using a micrometer 
 
Item Scan  plane  Micrometer 
measurement 
Dermascan 
measurement 
Microdialysis tube  Transverse  0.6 mms  0.6 mms 
  Longitudinal  0.6 mms  0.6 mms 
Drinking straw  Transverse  3.65 mms  3.6 mms 
  Longitudinal  3.65 mms  3.6 mms 
Twine Transverse  0.35  mms  0.4mms 
  Longitudinal  0.35 mms  0.4 mms 
 
may be because the membrane and the long axis of the straw were not quite  
parallel. Micrometer measurements of the twine were slightly lower than system 
dimensions; this was most likely due to difficulties in placing the cursors because  
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Figure 9 – Validation of Ultrasound Measurements 
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the outline of the object was less sharp. Such errors are likely to occur when 
capturing and measuring skin images in vivo. In order to minimise these errors it 
was decided to record the average of three measurements obtained from different 
parts of the image.  
Image analysis 
Ultrasound image interpretation requires pattern recognition and depends on the 
experience of the operator to distinguish pathology from normal appearances. 
Image analysis is an extension of this concept but allows digitised data to be 
compared mathematically thus facilitating statistical analysis. Transformation  
programmes can also be used to identify subtle variations of patterns or texture 
not always obvious to the naked eye.  
The normal high frequency ultrasonic (HRUS) appearance of the various layers of 
human skin has already been described and is shown in figure 8. The literature 
suggests that various types of oedema can also be characterised with confidence. 
Histamine induced oedema, characterised as a band of low echogenic pixels in 
the papillary dermis, has been demonstrated by HRUS and verified by Magnetic 
Resonance Imaging (MRI) (Gniadecka and Quistorf 1996). Similarly bands 
associated with lipodermatosclerosis occur at the same depth while those 
attributable to chronic heart failure manifest in the deep dermis (Gniadecka 1996). 
Oedema is important in this study, its location, extent and persistence with respect 
to cellulitis need to be assessed. A technique for comparing areas of low 
echogenic pixels presented in an A-scan format was selected for this purpose. 
Coloured images used to obtain thickness measurements were transformed into 
greyscale equivalents, saved as lossless TIF files and transferred to a PC. A 
digitising programme (S.W.Computing 1999) was used to obtain numerical data 
for each image. A line through each image was chosen according to the following 
criteria: 
•  The skin surface was parallel to the ultrasound membrane 
•  The line chosen was separate from any appendages or artefacts (eg: hair 
follicles or acoustic shadowing from surface hairs) 
•  The SC was clearly defined and represented by at least 3 highly reflective 
values (256)   67
The selected data lines were graphed (Microsoft Excel) to produce A-scans. By 
comparing A-scans, differences between visits and between subjects, could be 
shown. High value pixels representing the SC (256) were used as a marker to 
align A-scans so that the skin depths for comparison could be correctly 
superimposed.  
3.1.2.4 Skin  blood  flow 
The skin microcirculation consists of a complex of arterioles, capillaries and 
venules, which collectively regulate tissue perfusion. One important function is to 
act as a vehicle to deliver large numbers of specialised blood cells to the tissues in 
response to episodes of infection and/or inflammation. Delivery must reflect the 
scale of the episode and endure for the length of the episode before shutting down 
at the appropriate time. If this mechanism is impaired, infective/inflammatory 
events may be prolonged or incompletely resolved and this could have 
implications for episodes of cellulitis. It was therefore decided to assess the 
functional effectiveness of the microcirculation as part of this study. 
Because skin blood flow is so complex it is difficult to measure all the various 
parameters by one technique. For instance erythema measurements depend on 
reflection by chromophores within the sample, which only partially reflect the 
haemoglobin content (Piérard 1998, Fullerton et al 1996). Likewise evaluation of 
transcutaneous partial pressure of oxygen (TCPO2) is an indirect assessment of 
vascular delivery (Khan and Newton 2003, Barnes et al 1991). Other modalities, 
capillaroscopy, videomicroscopy and spectrophotometry (Simonen et al 1997, 
Chul Eun 1995) demonstrate vascular distribution but fail to quantify the rate or 
volume of blood flow. The only comprehensive method for evaluating the 
microcirculation is to measure the uptake and clearance of radioactive isotopes  
(X
133 or Tc
99)
 that have been injected into the dermal vasculature (Sejrsen 1968). 
Progress is tracked with a gamma camera or scintillation counter and the 
clearance rate calculated from documented decay rates.  Although thorough, this 
process is not without risk, and only used after some deliberation. An alternative is 
the use of Laser flowmetry which has been shown to closely approximate 
microcirculatory blood flow when tested against a fluid model (Nilsson 1980); this 
technique has further advanced to produce perfusion images without skin contact 
making it ideal for use in the presence of infection. For these reasons it has been 
selected as the technique of choice for use in this study.   68
Laser flow measurement and imaging techniques are able to demonstrate 
vascular perfusion in skin by measuring the frequency shift obtained when laser 
light is deflected from moving particulate matter beneath the skin surface 
(Fullerton et al 2002, Harrison et al 1993, Stern 1975). The phenomenon is known 
as the Doppler effect (White 1982). The laser Doppler imager (LDI) employs a 
system of mirrors which direct the laser beam to a depth of between 0.3 and 0.6 
mms below the skin surface as the machine scans the region of interest in a raster 
pattern (figure 10). The signals received are converted to colour coded images 
representing vascular perfusion, which can then be analysed and compared.  
In this study images were used to assess microculatory blood flow within the skin 
of cellulitic legs during and post episode and to effect comparisons with 
contralateral legs as well as the normal legs of control subjects.  
 
Figure 10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Line Diagram of the Principle of the LDI Imager 
(Courtesy of Moor Instruments UK and Newcastle General Hospital)  
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3.1.2.5   Venous incompetence 
Abnormalities in venous function have been shown to be an important factor in the 
aetiology of diseases affecting the lower limbs (Wollina et al 2006, Khan and 
Newton 2003, del Mar Sāez et al 2001). Chronic venous insufficiency (CVI) is a 
key factor in a decline in skin health leading to conditions such as oedema and 
ulceration (Ryan 2002), but because progress to these conditions is often slow, 
changes in skin appearance such as lipodermatosclerosis frequently provide the 
first evidence of underlying disease. CVI has been cited as a risk factor for 
cellulitis (Roujeau et al 2004, Dupuy et al 1999); this finding was based on clinical 
appearance and the underlying causes were not investigated. The most common 
cause of CVI is damage to the venous valves, a condition known as venous 
incompetence whose sequelae include oedema and through this possible links 
with cellulitis that have already been explained. For these reasons, the testing of 
venous competence was included in this study and placed within this section.  
Venous incompetence can be assessed by direct pressure measurements (vein 
cannulation), changes in leg volume (plethysmography) or methods involving the 
Doppler shifting of laser light or ultrasound. Vein cannulation and volume 
plethysmography were unsuitable for this study as the former is invasive and the 
latter requires meticulous measurements taken over several hours.  
Laser Doppler flowmetry is a quick, easy, non invasive technique which has been 
validated against direct in vivo pressure measurements (Abromowitz 1979). Small 
probes are fixed to the skin surface and signals are obtained when laser light is 
shifted from moving blood cells according to the Doppler principle. The signals 
represent an arbitrary unit known as ‘flux’ relating to the velocity and cell volume 
within the sampled area (Braverman et al 1990), and can be used to assess 
changes in microcirculatory blood flow in response to exercise with reference to a 
baseline determined during the resting state. Following muscular exercise venous 
volume and pressure drop and it takes time for arterial inflow to refill the capillary 
bed. If venous valves are working well the time to return to baseline will be 
relatively long, if they are damaged backflow will quickly refill the capillary bed and 
shorted times will be recorded. Readings of >25 secs represent adequate venous 
function, readings below this figure are regarded as consistent with venous 
incompetence (Stücker et al  2005).  
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3.1.3   Immunological outcomes 
Cellulitis and dermatophytosis are both conditions that should evoke immune 
responses. The immune pathway during cellulitis is initiated as an innate response 
but latterly extends to involving the adaptive immune mechanism and is therefore 
cell mediated. Dermatophytes should be expelled by a delayed type 
hypersensitivity (DTH) response, which is an allergic reaction. 
This part of the study was designed to use haematological methods to plot the 
course of the immune response during and after the cellulitic event, observe its 
severity and duration, and identify unexpected variations in cell types and 
numbers. Evidence to support the presence of either a proinflammatory TH1 or 
antibody mediated TH2 cytokine environment was sought, together with indicators 
of exaggerated or unexpected responses. Presence of dermatophyte specific 
antibodies was included to corroborate evidence obtained by culture and 
microscopy. The spectrum of cytokines chosen to identify TH1 or TH2 responses 
could also assist in evaluating any immune effects likely to have been manipulated 
by fungal presence.  
Biopsy specimens taken at the cellulitic site were considered because they could 
provide histological information, evaluate cell types and numbers and also 
investigate the milieu at a local level. However, this method was considered to be 
unacceptable because of its invasive nature, the risk of infection, and poor 
tolerability by sick patients.  
The following alternative methods were therefore chosen: 
• Continuous assessment of blood profiles. Types and numbers of 
specialised cells circulating in peripheral blood were assessed with 
reference to levels of CRP, which was used as an indicator for the severity 
and time scale of the cell mediated response.  
•  Indirect analysis of T cell status by reference to cytokines present in 
peripheral blood. This was included to assess detection levels of cytokines 
associated with TH1 (inflammatory) and TH2 (antibody mediated) phenotype 
and also to evaluate the practicality of this method to differentiate between 
IH, DTH and anergic reactions in patients/controls where dermatophytosis 
had been demonstrated.    71
•  Measurements of levels of total serum IgE as an additional marker for 
antibody mediated (TH2) phenotype and as an indicator of possible allergy. 
•  Measurements of levels of serum specific IgE to Trichophyton Rubrum (TR) 
as an adjunct to the fungal investigations. (TR is the most frequently 
occurring dermatophyte grown from human feet, specific IgE to TR was 
therefore chosen because this dermatophyte was the most likely to be 
cultured). 
3.1.3.1 Blood  profiles 
Blood profiles taken serially through the course of an infective/inflammatory 
episode provide evidence of its severity and duration. CRP is an acute phase 
protein produced by the liver in response to increases of acute phase cytokines, 
predominantly IL-6. Levels of CRP are normally low (< 6mg/L) but rise steeply in 
infective/inflammatory episodes and may remain elevated for some considerable 
time. CRP values of > 500mg/L are typical in the acute phase, but the half life is 
short (approx 9 hours), so that levels plummet once the initiating stimulus has 
been removed (Gozzard 1986). Because the response curve of CRP in 
inflammation assumes the same shape as that of IL-6 a surrogate relationship has 
been proposed (Bataille 1992). Total white cell expansion during the episode 
follows a similar but less steep curve at the outset although contraction is slower 
and levels may still be falling when CRP has already returned to normal. 
Conversely, during the inflammatory response leucocytes traffic to the tissues and 
therefore numbers in the peripheral circulation fall.  Plotting numbers of these 
various cell groups in conjunction with CRP therefore provides a means by which 
to evaluate the severity and duration of an episode as well as assess variations 
from the sequence just described.  
3.1.3.2 Serum  cytokine profiles 
The number of the various types of T cell present in a sample can be measured 
accurately by a technique known as Flow Cytometry (Hill and Martin 2006).  With 
fluorescent tagging, the various protein modulators (cytokines) produced by each 
cell type, can also be determined by an extension of this technique known as 
Fluorescence Activated Cell Sorting (FACS). FACS analysis can determine TH 
status and identify the cytokines produced by these cells but does not provide an 
overall picture of the prevailing milieu in peripheral blood or suggest the stimulus   72
for the differential TH1 and TH2  phenotype. Cytokine production is complicated 
because many cells secrete the cytokines contributing to the milieu, which in turn 
influences the differentiation and proliferation of the participating cells. Cell 
cytokine secretion affects the cells themselves (autocrine effect), neighbouring 
cells (paracrine effect), all cells in a given tissue (endocrine effect) or adjacent 
cells by receptor activation (juxtacrine effect). One aim of this part of the study was 
to attempt to categorise the immune stimulus causing predisposition to the 
exaggerated inflammatory skin effects. Alternatives to the FACS technique were 
considered. 
Western blotting involves protein separation by gel electrophoresis and 
subsequent transfer to a membrane where it can be detected by antibodies 
(Kurien and Scofield 2006).  An alternative is the immunoassay test based on the 
formation of antibody-antigen complexes; the former being fixed or solid state and 
the latter contained within the supernatant undergoing analysis. When the 
antibody-antigen complex has been formed an enzyme is added which links and 
labels the antigen so that amounts can be quantified using a suitable detection 
technique such as radioisotope detection, spectrophotometry, fluorescence or 
luminescence (de Jegar and Rijkers 2006). Such tests are known as Enzyme -
Linked ImmunoSorbent Assays or (ELISAs) and measure the amount of specific 
biomarker(s) in the unit volume of supernatant under test by reference to a dose 
response curve obtained from a standard analyte solution. The method described 
is known as a 'sandwich' immunoassay but many other variations exist; one such 
is the enzyme-linked immunospot (ELISPOT), which allows the measurement of 
cytokines associated with a specific cell population (Cox et al 2006). 
With strict adherence to the protocol such tests are accurate and reproducible and 
able to accommodate a wide range of biological fluids including serum, urine and 
saliva. They are however purely quantitative, furthermore results may be attributed 
to a large amount of biomarker being released by a few cells or to a small 
contribution made by many. The most recent immunoassay technology has 
provided the ability to detect several different biomarkers from within a single 
sample allowing best use of small quantities of supernatant and drastically 
reducing costs. Meso Scale Discovery (MSD) has developed a sandwich 
immunoassay for the specific analysis of cytokines relating to TH1 and TH2 type 
cells. The solid state consists of 10 captured antibodies presented in a patterned    73
 
Table 3 – Some of the origins and effects of the cytokines/chemokines      
included in the TH1/TH2 MSD assay    
 
Cytokine  Production  - effect 
IL-2  Produced by TH1 cells amongst others, differentiates TH1 cells 
(autocrine effect), promotes T cell expansion 
IL-1β 
Produced by macrophages in epithelium (amongst others) in response 
to bacteria and toxins. First phase response induces fever with > CRP , 
promotes proliferation of TH2 cells 
IL-4  Produced by T cells and mast cells, differentiates TH2 cells, promotes 
TH2 cells and IgE, inhibits TH1 cells 
IL-5 
Produced by activated TH2 cells , stimulates B cell growth and Ig 
secretion, promotes generation of eosinophils. Associated with 
parasites. 
IL-10 
Produced by TH2 cells and macrophages (amongst others), inhibits 
cytokine synthesis by TH1 cells, Inhibits macrophage function, is  
inhibited by IFN-γ 
IL-12  Produced by B cells, monocytes and macrophages, Acts with IL-2 to 
produce IFN-γ, differentiates TH1 cells. 
IL-13 
Produced by activated TH2 cells, promotes isotype switching to IgE 
synthesis, prevents synthesis of IL-1α IL1- β IL-6 IL-8 and TNF-α in 
response to LPS. 
TNF-α 
Produced by macrophages, T cells and B cells and monocytes in 
response to bacteria and viruses, diverse roles including inflammation, 
activating neutrophils, fever and septic shock. 
IFN-γ  Produced by TH1 cells and NK cells, differentiates TH1 cells, inhibits 
TH2, activates macrophages inducing NO synthesis, TNF-α and IL-1. 
Chemokine  
IL-8  Produced by monocytes, lymphocytes, endothelial cells and 
keratinocytes, chemotactic for neutrophils,< IL-4 induced IgE. 
 
 
 
 
array at the bottom of each well; the detection antibody is labelled with a reagent 
that quantifies the results by electrochemiluminescence. The range of cytokines 
together with their possible origins and some of their effects are summarised in 
table 3. The technique was selected for preliminary testing in this study because of 
the range of cytokines offered. In addition it was cost effective, able to 
accommodate serum or plasma and also faster and easier than processing a 
conventional ELISA. The technology is currently in use by other groups within our 
hospital and the specialist hard and software is available on site.  Results are 
reported to compare well with conventional ELISA techniques although some of 
the cytokines included in the TH1 /TH2 kit have not previously been evaluated by 
Differentiates TH1 
cells 
Differentiates 
TH2 cells  Promotes TH2 cells or is produced by TH2 cells   74
our researchers and therefore the levels of detection in peripheral blood are 
unconfirmed. An important part of the preliminary testing was to generate this 
data.  
3.1.4   Stress factors  
The final aim of this study was to consider the role of stressors, other than 
dermatophytosis, that might predispose patients to attacks of cellulitis through 
changes in skin function and/or immune responses. Such stressors could arise 
from co-morbidities or other physiological, psychological or environmental factors. 
It was not possible to evaluate all of these categories but the following were 
considered to be the most relevant in this context:  
• Detailed  chronological  history of previous trauma, surgery, co-morbidities 
(including psychological disease) and genetic factors. 
•  Evaluation of levels of perceived psychological stress relating to the time 
period directly preceding the cellulitic attack. 
3.1.4.1   Patient history 
Patient history was obtained from the hospital or primary care notes together with 
patient interview, subsequent to written consent. A chronological order of events 
was compiled to create a framework allowing systematic searching for interrelated 
links between cellulitic episodes and other medical events. A six month follow up 
review was conducted to document further episodes and other relevant medical 
occurrences. 
3.1.4.2   Stress questionnaire 
Stress results when demand on the individual exceeds the available resources 
(Boone and Christensen 1997). Differences in outcome are known to exist 
between stress in its acute and chronic forms: the former may be beneficial 
particularly to the immune system by enhancing priming, testing and effecting 
mechanisms while the latter may produce opposite and deleterious effects 
(Malarkey et al 2001, Bartrop et al 1977).  In addition the genetic variation 
between proactive and reactive personality types may produce different coping 
strategies to the same disease process (Korte et al 2004).   
The diagnosis of stress may be assessed by either physiological measures, 
biochemical measures or by questionnaire (Noble 2002). The role of some of the 
physiological stressors have been discussed in the literature review and some of   75
their effects are investigated by the skin and immunological tests already 
described.  
The hypothalamic-pituatory-adrenal (HPA) axis governs the biochemical reaction 
in response to stress through the release of corticotrophin-releasing hormone 
(CRH). The effect of CRH on the adrenal cortex induces increased secretion of 
corticosteroid hormones that are distributed via the circulation and can be 
measured directly in blood or other body fluids such as saliva and urine 
(Shimomitsu and Odagiri 2001). Although appealing by the apparent simplicity 
such measurements are problematic since levels of these hormones are subject to 
circadian rhythms and variations in physiological status (Posener et al 1996, 
Yehuda et al 1995, Sandin and Chorot 1985). They require successive or 
continuous measurements to establish meaningful reference points by which to 
assess results (Noble 2002, Kelly and Hertzman 2001). Alternatively a specifically 
tailored stress questionnaire may be used, this has the added advantage of being 
quick and convenient.  
Stress questionnaires may relate to subjective evaluation of life events (Clements 
and Turpin 2000, Holmes and Rahe 1967) or measurement confined to acute 
stress (Sandin 1985). For the purpose of this study evaluation by the number and 
severity of stressors alone was unsuitable because it assumed a universal 
response to the same stimulus. In order to investigate whether stress may have an 
effect on cellulitic attacks a questionnaire was required that would relate to the 
time period preceding the onset of the episode and subsequent hospital 
admission. The Perceived Stress Scale designed by Cohen at al (1983) is 
currently in use for evaluating stress in many contexts, assesses individual stress 
responses without reference to particular life events and has been shown to match 
well with clinical findings (Noble 2002). The questionnaire (appendix 1) consists of 
14 questions relating to levels of perceived stress as experienced over the 
preceding 30 days and was chosen as it was felt to most closely represent the 
investigative parameters required from the study. Each question offers 5 options 
ranging from never (0) to very often (5). 7 of the questions are scored in a positive 
direction and 7 in the opposite or negative direction; positive and negative 
questions are randomly arranged. Scoring methods are defined in Cohen et al 
(1983 p 387). 
   76
 
Table  4 – Risk factors, associated tests and expected results 
 
Risk factor/test/investigation  Expected results 
Dermatophytosis 
Tests : Specimen collection, 
culture and microscopy Serum 
immunoglobulin to 
Trichophyton Rubrum (TR) 
Expected frequency of dermatophytosis in the patient 
group was higher than for controls (Roujeau et al 2004) 
however reported frequency within the general 
population is variable (between 30 and 70%). ID spaces 
were expected to produce more cultures than the foot 
sole (Björnsdóttir et al 2005). Presence of IgE specific to 
TR would confirm current or previous exposure. 
(Woodfolk and Platts-Mills 1998, Fitzpatrick 1994). 
Changes in skin water loss 
Test: Measurement of 
Transepidermal water loss 
(TEWL) 
Higher values of TEWL were expected in the patient 
group during the cellulitic event. Enduring high or 
abnormally low values post event in this group might 
have implications for skin vulnerability (Nilsson 1977). 
Changes in pH balance at the 
skin surface 
Test: Measurement of  
skin pH 
Skin pH measurement might be expected to be higher 
(more alkaline) in the patient group both during and post 
episode. This would be consistent with altered skin 
physiology and frequency of bacterial/fungal infection 
(McBride 1993) 
Oedema 
Tests: Leg circumference 
measurements + Ultrasound 
tissue measurements 
Compared to contralateral and control legs cellulitic legs 
were expected to be greater in circumference and 
display greater dermal thickness during the episode as a 
consequence of oedema. This physiology might be 
expected to endure post episode particularly in those 
with recurrence (Cox 2006).  
Changes in skin blood flow 
Test: Measurement of skin 
blood flow Laser Doppler 
Imager (LDI) 
 
Hot erythematous skin would be expected to display 
increases in skin blood flow relative to normal (Ryan 
2005) therefore higher values were expected in the 
patient group during the cellulitic event. Variations from 
the accepted normal values post event in this group 
would have implications for skin vulnerability. 
Venous incompetence 
Test: Photoplethysmography 
Laser Doppler flowmeter (LDF)
Venous incompetence is a ubiquitous physiology, 
however because of associations with oedema high 
frequencies were expected in patients with enduring 
oedema particularly recurrent cases (Mortimer 2000, 
Johnson 1996). 
Abnormal haematological 
response to 
inflammation/infection 
Test: Blood profiles 
> CRP, > WBC, > neutrophil  and < lymphocyte counts 
would be expected in patients during the cellulitic event. 
Deviation from this or failure to return to normal ranges 
post event could indicate immunological abnormalities. 
Exaggerated immune 
response 
Test: Serum cytokine profiles 
Allergic response 
Test: Serum (IgE) 
> levels of IL-12 would support a TH1 cytokine profile 
and acute inflammation. > levels of IL-4 would support a 
TH2 cytokine profile and DTH reaction. In the latter case 
> serum levels of IgE would also be expected. 
Previous episode 
Co-morbidity 
Previous surgery etc 
Investigation: Patient history 
No studies were identified that had systematically 
searched the patient history for predisposing factors 
although the literature suggests that previous episode 
may be a risk factor for future episodes (Cox 2006).  
Psychological stress 
Investigation: questionnaire 
High total scores from the stress questionnaire would 
indicate > levels of psychological stress (Cohen1983)   77
3.2   Expected results 
In order to fully investigate the risk factors associated with cellulitis of the lower 
limb it was necessary to conduct a diverse range of tests (see table 1) and the 
rationale for those chosen has been discussed in this section. In each case a 
considered outcome, which would lend support to the theory, was anticipated.  
The expected results are set out in table 4.    78
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4  MATERIALS AND METHODS 
 
4.1   List of materials used in this study 
Equipment: IN TRAY 
TM DM (Biomed Diagnostics, USA) 
SABOURAUD DEXTROSE AGAR (Fisher Scientific, UK) 
MSD Human TH1/TH2 Cytokine Assay (Meso Scale Discovery, USA) 
Cotton Blue stain 
Sellotape (Guilbert , UK) 
Large emery boards, blister pack 12 (Tesco Ltd, UK) 
Small emery boards, blister pack 10 (Murrays Key Creations, UK) 
Disposable tape measures (NHS logistics, UK) 
10mm green sticky dots (Guilbert, UK) 
 
 
4.2  Plan of investigation 
The study was designed to address the study aims stated in section. 2.4.1. 
As part of this it was necessary to assess the logistics of recruiting from an acute 
clinic and conducting tests within a research facility situated in a distant part of the 
hospital. Ethics approval was obtained allowing patients to be recruited from the 
Ambulatory Care Unit (ACU) and for the study to be conducted within the 
Wellcome Clinical Research Facility at Southampton General Hospital (SGH). 
Patient consent included venesection, access to hospital notes and blood results, 
photographic imaging of the affected site and letter to the GP. 
The ACU within SGH accepts GP referred patients with suspected cellulitis, 
assesses them and initiates their therapy. Its purpose is to provide patient 
management on an out patient basis whenever possible and it is therefore 
described as an OPAT (Out Patient Antibiotic Therapy) unit. Current treatment 
policy for cellulitis within the ACU at SGH is as follows: 
•  Simple cases (no previous history, no confounding co-morbidities and with 
pain management under control) - 3 days of intravenous (IV) antibiotic 
therapy (commencing on day of referral) followed by 7 days of oral therapy.   80
•  Complicated cases (those with confounding co-mobidities such as cancer, 
those who have been on antibiotic treatment for some time, or whose 
condition demands additional nursing care) – 4 to 5 days of IV antibiotics 
(commencing on day of referral) followed by 14 days of oral therapy.  
Objective measures include clinical evaluation, blood markers CRP (Isaacman and 
Burke 2002) and WBC (Sachs 1990) and the time to when the cellulitis fails to 
advance (Corwin et al 2005); thus monitored improvement informs the change 
from IV back to oral therapy.  
4.2.1   Participants 
Potential recruits were identified by the medical team and nursing staff within the 
ACU. Suitable candidates included those with clinically diagnosed cellulitis of the 
lower limb confined to one leg (including calf) which were unresolved in primary 
care.  
•  Cellulitis was defined as an area of erythematous skin, exuding heat, 
advancing in all or any direction and accompanied by swelling of the 
affected limb. Presence of fever and malaise and /or evidence of > white 
cell count and levels of CRP were also required. The differential diagnosis 
was determined by a member of the medical team and confirmation of this 
was sought by the chief investigator with reference to the clinical notes. 
The following exclusion criteria were used: 
•  Age < 16 years, cellulitis in both legs, presence of comorbidities likely to 
have dominant and overriding systemic effects (eg Rheumatoid Arthritis, 
Cancer), systemic antifungals within the last 4 weeks or application of 
topical antifungal medication within the last 7 days, patient unable to comply 
or give written consent. 
The definition of acute and recurrent cases was defined as follows: 
•  Acute cases were classified as those without recall or medical reference to 
a previous cellulitic event 
•  Recurrent cases were classified as those who had experienced a least one 
previous event displaying the same symptoms at a similar anatomical 
location. 
Healthy controls matched for age, sex and mobility were recruited by poster from 
the general staff and student populations of the University of Southampton and   81
Southampton University Hospitals NHS Trust. The following exclusion criteria were 
used: 
•  Age < 16 years, previous proven episodes of cellulitis, presence of 
comorbidities likely to have dominant and overriding systemic effects (eg 
Rheumatoid Arthritis, Cancer), systemic antifungals within the last 4 weeks, 
or application of topical antifungal medication within the last 7 days, person 
unable to comply or give written consent. 
4.2.2   Sample size 
It was necessary to recruit sufficient numbers to provide an indication of 
differences in the proposed test results between groups of patients and control 
subjects as well as between acute and recurrent cases within the patient group. It 
was difficult to calculate a sample size with confidence because two of the 
proposed tests, namely TEWL values for calf skin and levels of serum cytokines, 
did not have well confirmed normal ranges. Advice from a statistician was sought 
and it was decided that equal numbers of acute and recurrent cases should be 
recruited along with matched controls. A total of 60 individuals composed of 30 
patients n = 15 (acute) and n = 15 (recurrent) together with their respective 
matched controls was considered to be adequate to provide the preliminary data, 
as well as achievable within the available time frame. 
4.2.3  Recruitment and attendance 
Potential participants were approached by the chief investigator who explained the 
purpose of the study, the broad outline and purpose of the tests and the 
commitment required.  Participants who expressed interest were given an 
information sheet and allowed a period of 24 hours for consideration before written 
consent was obtained. 
Patients attended the Wellcome Clinical Research Facility on two occasions: 
Visit 1 – during the course of intravenous therapy, as soon after referral as 
permitted by OPAT treatment protocol and obtaining consent.  
Visit 2  – approximately 4 weeks after completion of the final course of oral 
antibiotics.  
OPAT treatment continues until the treatment criteria (beginning of section 4.2.) 
are fulfilled and patients are then discharged into the care of the GP who may 
prescribe additional courses of oral antibiotic treatment in cases where the skin 
appearances are assessed as not yet ‘normal’. For the purpose of this study a   82
period of four weeks following completion of the last antibiotic treatment was 
allowed between visits. No data was found which would provide guidance with this 
time interval, which was assumed to be adequate for two reasons: 
1 – The switch from IV to oral antibiotics is informed by near normal levels of 
inflammatory markers in peripheral blood indicating that systemic effects are 
reaching resolution. The time period between this switch and the second visit 
would therefore amount to at least six weeks. 
2 – Antibiotic treatment continues until visual skin appearances are considered to 
be normal which then allows a further four weeks to clear antibiotics from the 
system and for cellulitic skin regain its baseline physiological characteristics. 
The final appointment date was set after the relevant information had been 
obtained through discussion with the patient and the time interval for control 
participants was set to correspond with their respectively matched recruit. 
4.2.4 Data   
Data and samples relating to each patient and control were labelled with a unique 
code number known only to the chief investigator. All data was stored in 
compliance with the data protection act. 
4.2.5 The  protocol 
On each occasion the study was conducted according to a protocol; a flow 
diagram for investigations is presented in figure 11.  
The investigation for dermatophytosis and skin physiological tests were conducted 
with patients semi-recling on a bed with legs elevated and the back supported by 
pillows. The calves of both legs and the feet were exposed. The physiological tests 
required a period of acclimatisation and 20 mins was allowed; during this time 
those measurements that were not affected by the resting state were conducted 
(see figure 11). Skin physiological measurements were performed with the leg 
abducted, within an area of interest (AOI) 4 x 4 cms,  bounded by green sticky 
dots, on the medial aspect of each calf situated half way between the medial 
malleolus and the angle of the knee (figure 12 and figure 13) or at a closely related 
site within the area of erythema. In the patient group tests were conducted on the 
cellulitic leg and on the unaffected (contralateral) leg; matching legs ,either left or 
right , were chosen in the control group and referenced as either control or 
contralateral control respectively (see figure 12). Measurements of venous 
competence were performed with legs dependant (a full description is included in   83
the relevant section). All tests were conducted on intact skin to minimise the risk of 
infection.  
Digital photography and recording of anatomical landmarks were performed on 
each leg and at each visit in order to compare changes in appearance and to 
provide a permanent record of the anatomical location. A digital camera NIKON 
COOLPIX 4500 was used to record a digital image that included the foot, the area 
of interest and the leg up to the level of the knee line. Images were coded, 
transferred to a PC and stored as jpeg files.  
 
Figure 11 - Study Investigations 
 
Tests were conducted within the Wellcome Trust Clinical Research Facility on two 
occasions: 
Visit 1 – during the course of intravenous therapy, as soon after referral as permitted by 
OPAT treatment protocol and obtaining consent.  
Visit 2  – approximately 4 weeks after completion of the final course of oral antibiotics.  
The time interval for control participants was set to correspond with their respectively 
matched recruit. 
 
 
 
 
 
 
 
 
 
15 to 20 minutes was allowed for acclimatisation to the resting state, this was 
important for the physiological tests shown in the lower box. The following tests, 
which did not require acclimatisation, were conducted during this period: 
 
•  *Digital photography (photographic record) 
•  *Investigation for dermatophytosis 
•  *Venesection to obtain blood for the analysis of immunological outcomes  
•   Stress questionnaire  
 
Tests marked* were conducted at both visits. The questionnaire was 
presented and completed once, at the first visit. 
 
The following skin structure and physiology tests were conducted after the 
2 20 minute acclimatisation period. 
•  *Measurement of skin water loss       
•  *Measurement of skin blood flow       
•  *Measurement of skin pH         
•   Measurement of venous incompetence   
•  *Leg circumference measurements  
•  *Ultrasound skin images and tissue measurements  
 
Tests marked* were conducted at both visits. Measurement of venous 
incompetence was performed once, at the second visit.  
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Figure 12 – Area of investigation (AOI) for cellulitic and control legs 
 
 
 
 
 
 
 
Figure 13 – Cellulitic leg to show AOI bounded by green dots 
 
 
 
 
Cellulitic leg 
Contralateral leg 
Control cellulitic leg 
Control contralateral leg 
AOI  AOI 
PATIENTS  CONTROLS 
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4.3   Methods 
4.3.1   Investigation for Dermatophytosis 
4.3.1.1   Initial culture 
Skin samples were taken from each of the soles and the combined interdigital 
spaces of both right and left feet; the individual samples were cultured in four 
separate trays. The investigator wore disposable gloves, which were changed 
between obtaining samples from right and left feet.  
Soles - A sheet of coloured paper was positioned under each foot. The foot sole 
was abraded with a large emery board producing a fine dust, which was collected 
on the paper. The transparent window of the dermatophyte culture medium (DM) 
was peeled back and the protective covering removed, the collected sample was 
distributed evenly over the agar surface and the window resealed around the 
edges of the plate (figure 14).  
Interdigital spaces – A small emery board was used to abrade the skin between 
each of the toes in turn. The flat surface of the emery board was then pressed 
directly onto the surface of the agar plate. 
The plates were labelled with patient code, date and anatomical site and incubated 
in racks on trays at 25°C (figure 15). Humidity was maintained by adding a small 
amount of tap water to the tray. Incubation time was variable (between 1-6 weeks). 
Cultures were observed through the transparent window (figure 16) and serial 
images were recorded with a digital camera (NIKON COOLPIX 4500) to plot 
progress. Cultures were also observed microscopically at a magnification of  X 10. 
The depth of the tray limited the scope for obtaining higher magnification because 
the distance between tray and objective was too small; pictures on dissecting and 
inverted microscopes were poor because the incident light could only poorly 
penetrate the dense agar. In some cases it was necessary to produce slides to 
achieve the higher magnification required for positive identification.  
4.3.1.2 Microscopy 
Slides for microscopic examination were prepared as follows: 
1 - Between 1 and 2 drops of cotton blue dye were placed on a microscope slide 
2 - The transparent culture tray window was peeled back. 
3 -  A small piece of sellotape was cut and attached at one corner to the head of a 
pin.  
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Figure 14 – DM Tray with sample 
Figure 15 – Arrangement of DM Trays in the rack 
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Figure 16 
Trichophyton Rubrum (TR) growing on InTray DM 
 
 
 
 
 
 
 
 
Figure 17  
Sabouraud Dextrose Agar growing TR (white colonies) 
and penicillium  (black colonies) 
Note - penicillium appears to be inhibiting the growth of 
TR, this is particularly evident in one colony where the 
demarcation line between the two organisms can be 
clearly seen (arrows).   88
4 – The pin was lowered to allow the sticky side of the sellotape to be brought into 
contact with the surface of the colony.  
5 – Gentle finger pressure was applied through the sellotape to obtain the sample.  
6 - The sample was placed in contact with the cotton blue dye and the pin slid 
away allowing dye to be dispersed throughout the sample beneath the sellotape 
window.  
7 – Another drop of cotton blue was placed over the sample area on top of the 
sellotape window. 
8 – A cover slip was gently placed over the area of interest and pressed down to 
exclude the air and preserve the contents.  
Slides were observed at magnifications of X 10, X 20, X 40 and X 80. Images were 
recorded via the microscope by interfacing with the digital camera. 
4.3.1.3 Reculture 
Positive identification of fungi requires visualisation of both hyphae and spore 
receptacles (conidia) and it is important to observe the pattern of attachment 
between the conidia and the hyphal elements. Production of conidia is dependant 
upon the culture conditions and it was often necessary to change the growing 
medium to encourage development of the identifying factors. Sabouraud dextrose 
agar (figure 17) is available ready plated and is universally used in mycology 
laboratories. Culture plates have clear transparent lids and growing conditions are 
similar to those required for DM. Samples were transferred between mediums 
using a clean pin head. SAB cultures were then grown on at 25°C to produce new 
colonies. Progress was recorded by digital photography and slides produced by 
the previous method where appropriate. 
4.3.2  Investigation of skin structure and physiology 
4.3.2.1  Skin water loss 
A TEWAMETER 300 (Courage + Khazaka Electronic, Germany was used to 
measure the skin evaporative water loss (Pinnagoda et al 1990) within the area of 
interest on both legs. Calibration procedures were performed and the results 
recorded at regular intervals. For each session the equipment was switched on 
and allowed to stabilise for at least 1 hour prior to measurements taking place. 
Between readings the part of the cylinder used for skin contact was cleaned with 
an alcohol wipe and sufficient time was allowed for stabilization before the next 
reading took place.    89
The probe was applied to the skin of each leg, in the centre of the 4 x 4 square, 
and held in place while continuous measurements of evaporative water loss were 
recorded until the reading became stable (approx 60 secs). Simultaneous 
temperature and humidity values were also acquired and the results were stored 
as graphs onto an integrated portable PC. The final TEWL result was expressed 
as a single reading stated as g/hr/cm
2 recorded from the stable end of the curve.  
4.3.2.2 Skin  pH 
A SKIN pH METER 905 (Courage + Khazaka electronic, was used to measure the 
pH of skin (Parra and Paye 2003, Roberts et al 2002). Calibration and stabilisation 
were performed as described in the previous section. The tip of the pH probe was 
rinsed in sterile distilled water and the probe shaken so that the surface was just 
damp. The tip was then applied to the skin of the contralateral leg, in the centre of 
the area of interest, and held in place until the reading became stable (approx 60 
secs). The probe was disinfected and rinsed in sterile distilled water and shaken 
before being applied to the affected leg. Continuous pH values were recorded and 
stored as graphs onto an integrated portable PC. The final result for each leg was 
expressed as a single pH value recorded from the stable end of the curve.  
4.3.2.3 Oedema 
 Limb volume 
Circumferential leg measurements were taken in order to compare swelling 
between legs, between visits and between participants. A disposable tape 
measure was used and measurements were recorded at three levels: just below 
the knee, at mid calf level and at the ankle. In patients, the asymptomatic leg was 
measured first, in order to minimise the risk of infection spreading between legs.  
Skin structure and thickness 
A DERMASCAN C (Cortex Technology Denmark) 20 MHz ultrasound scanner was 
used to assess skin structure and measure the thickness of the epidermal and 
dermal layers (Serup 1992). The membrane was applied to the ultrasound window 
and secured with the water retaining sealing ring. Deionised water was injected 
into the transducer cavity to provide the stand off required to achieve focussed 
images within the skin. The transducer was positioned and secured on the 
scanning arm of the purpose-designed stand (section 3.1.2.3). The equipment was 
disinfected between scans by wiping the ultrasound window with an alcohol wipe 
and between sessions by removing and disposing of the water tight membrane   90
and disinfecting all other contact surfaces. The profile and level of the time gain 
compensation curve was preset and remained unchanged throughout the study. 
Each leg was abducted to present a parallel surface to the ultrasound beam. 
Ultrasound jelly was applied to the skin within the area of interest and the scan 
head lowered until even contact was made with the ultrasound window. Care was 
taken to apply firm but not excessive pressure (figure 7c). Images were obtained 
by successive frames and were considered to be satisfactory if the water 
membrane and skin surface were straight and parallel indicating that the scan/skin 
plane intersect approximated 90°. Images were captured in Dermascan format 
(dsc) and were labelled and recorded via a PC interface. Measurements were 
made using the inherent software measuring facility, which had previously been 
validated (3.1.2.3). Images were also saved as lossless greyscale TIF files for 
further image analysis. (Details of skin measurements and A-scan image analytical 
technique have been described in section 3.1.2.3) 
4.3.2.4 Skin  blood  flow 
A LASER DOPPLER IMAGER LDI-2 (Moor Instruments Ltd, UK.) was used to 
assess blood flow in the microcirculation of the skin (Fullerton et al 2002, Harrison 
et al 1993, Stern 1975). Calibration procedures were performed and the results 
recorded at regular intervals. 
The scan head was positioned above the skin at a distance of 30 cms and 
centrally aligned to the area of interest. Images were obtained from each leg as 
the beam scanned the tissue surface in a raster pattern (figure 10). Colour coded 
images were obtained which represented vascular perfusion patterns within the 
region highlighted by the marker dots picked out by the scanner. The images were 
labelled and transferred to an integrated portable PC prior to analysis.  
 The dedicated LDI software was used to perform the following analysis on the LDI 
images: 
An area of interest (AOI) was selected within the boundary of the green dots.  
AOI: Area = 2.41 cm
2 (total pixels enclosed within AOI = 2809). 
The mean flux value for the pixels within each AOI was recorded and the results 
compared by statistical analysis. 
4.3.2.5 Venous  incompetence 
A LASER DOPPLER FLOWMETER DRT4 (Moor Instruments Ltd, UK) was used 
to assess venous refilling time in the lower extremity (Stǖcker et al 2005,   91
Abromawitz et al 1979). Calibration procedures were performed and the results 
recorded at regular intervals. The technique is non invasive but requires the 
sensors to come into contact with the skin so between tests the adhesive contact 
covering the sensors was removed and the sensors cleaned with an alcohol wipe. 
Subjects were asked to sit upright on the edge of the bed with legs dependant and 
the laser Doppler probes were positioned on the medial aspect of each calf half 
way between the medial malleolus and the angle of the knee and secured with 
designated double sided sticky O rings (figure 18).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Both laser Doppler channels were switched on to allow simultaneous monitoring of 
right and left legs. Patients were asked to remain still for a period of 2-3 minutes to 
establish a base line measurement and then asked to perform 10 vigorous 
sequential dorsiflexions and plantarflexions of the foot, followed by immediate and 
complete relaxation of the foot. Continuous traces of ‘flux’ were recorded and 
transposed as txt files, which could be opened and graphed in an EXCEL 
spreadsheet. The point at which exercise ceased was recorded on the graph and 
Figure 18  
Measurement of venous refilling time (VRT) 
Legs were dependant and the electrodes were positioned on the 
medial aspect of each calf   92
the time taken to return to the base line reading calculated. Times of < 25 secs 
were considered consistent with venous incompetence (Stǖcker et al 2005). 
Skin quality, the presence of oedema and the discomfort experienced by the 
patients made this test unsuitable to use during the initial cellulitic episode. For 
these reasons and also because venous incompetence is a chronic condition and 
unlikely to fluctuate, a single evaluation conducted at the second session, was 
performed. 
4.3.3   Immunological Outcomes 
Routine blood investigations are performed on patients attending the ACU on 
alternate days and surveillance of the blood markers is used to monitor the course 
of cellulitic episodes. CRP, WBC, neutrophil, basophil and monocyte counts are 
always requested. In the acute stage levels of CRP are frequently in excess of 
500
+mg/L and white blood cell counts, particularly those of neutrophils, are 
expected to be high. Decreasing CRP, WBC and neutrophil levels are signs that 
the acute phase is resolving and this information is an important part of the clinical 
evaluation and determines further management.  
Results of routine blood analyses for patients were accessible with consent and 
retrieved via the hospital computerised E-Quest system. At the second visit  
samples were collected from patients within the Wellcome Clinical Research 
Facility so that all routine tests could be repeated and control participants donated 
blood at both visits to provide the full range of comparisons. A dedicated nurse 
performed the venesection at each occasion and samples were coded for identity. 
Initial analyses, follow up tests and tests from control subjects were conducted 
within the Haematology Department at SGH according to their standard protocol. 
Follow up reports and those from controls were sent to the chief investigator. 
4.3.3.1 Blood  profiles 
Research samples were taken from patients in conjunction with the routine 
collection on the first available occasion after obtaining written consent and again 
at the follow up visit. The extra blood required for these tests was also taken from 
controls on both occasions. Samples were collected in red topped blood bottles 
(no additives) for serum and purple topped bottles (EDTA added) for plasma. 
Samples were spun, pipetted into 500 µL aliquots, labelled and stored at -20°C.  
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Analysis of IgE  
A serum sample from each patient and each volunteer was used to determine IgE 
levels at each visit. As an adjunct to the fungal investigations levels of IgE to 
Trichophyton Rubrum (TR) from each visit were also assessed. TR was chosen as 
it is regarded to be the most frequently occurring dermatophyte to be found on 
human feet and therefore the most likely to present circulating antibodies. 
All IgE tests were conducted within the Immunology Department at SGH where 
results were determined according to hospital protocol by enzyme-linked 
immunosorbant assay (ELISA). 500µL of serum was required for each separate 
test and frozen aliquots were stored until sufficient numbers were obtained to carry 
out a complete batch. All reports were sent to the chief investigator. 
TH1 /TH2 cytokine analysis 
A 96 well multi array MSD Human TH1/TH2 Cytokine Assay was used (Meso 
Scale Discovery, USA). 40 wells were available for use in this study permitting 
analysis of plasma for five patients and five controls, from both initial and follow up 
visits, to be performed in duplicate. This number was considered to be sufficient to 
provide data on cytokine detection levels in peripheral blood and also evaluate the 
suitability of the method as a means of assessing the milieu and comparing levels 
of proinflammatory cytokines against leukocyte numbers as described in 4.3.3. 
The solid state consists of 10 captured antibodies relating to the following 
cytokines (IFN-γ, IL-1β, IL-2, IL-4, IL-5, IL-8, IL-10, IL-12, IL-13, TNF-α) these are 
presented in a patterned array and correspond to the numbers as shown in figure 
19. Samples were allocated to the plate as shown in figure 20. The numbers and 
pattern arrangement are fixed to create links with the software, plate packaging 
and data files permitting traceability of the data throughout the system. Details of 
reagent preparation and the protocol are set out in table 5.  
Levels of each cytokine were determined by referencing the seven point standard 
curve, (derived from the average of duplicate samples), and ranging from 0-2500 
pg/ml. The software calculates results and presents them as a series of detailed 
tables. The following raw data can also be accessed  
•  individual readings for each cytokine in each well 
•  accuracy of pipetting expressed as a coefficient of variation 
•   full calibration data  
•  levels of cytokine below the limit of detection for the assay     94
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  1 2 3 4 5 6 7 8 9 10  11  12 
A  2500pg/mL S1  S1  S9  S9  S17 S17 S25 S25 S33 S33 
B  625pg/mL  S2  S2  S10 S10 S18 S18 S26 S26 S34 S34 
C  156pg/mL  S3  S3  S11 S11 S19 S19 S27 S27 S35 S35 
D  39pg/mL  S4  S4  S12 S12 S20 S20 S28 S28 S36 S36 
E  9.8pg/ml  S5  S5  S13 S13 S21 S21 S29 S29 S37 S37 
F  2.4pg/mL  S6  S6  S14 S14 S22 S22 S30 S30 S38 S38 
G  0.6pg/mL  S7  S7  S15 S15 S23 S23 S31 S31 S39 S39 
H  0pg/mL  S8  S8  S16 S16 S24 S24 S32 S32 S40 S40 
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Figure 19 
Spot numbers and position of related  
cytokines at the base of each well 
 
Figure 20 
Example of set up for 96 well MSD plate 
Columns 1 – 2 contain the standard curve dilutions in duplicate 
Columns 3 –12 contain duplicate samples in adjacent columns   95
 
Table 5 – MSD reagent preparation and protocol 
 
Step Method 
A standard curve was generated between the ranges 
of 0.6pg/mL and 2500pg/mL 
1 
Calibration curve 
 
 
 
1µg/mL of stock solution was added to 990uL of 
Human Serum Cytokine (HSC) Assay Diluent. This 
high calibrator was used to prepare the standard curve 
following a 1:4 dilution series as follows: 
2500pg/mL         50µL of combined high calibrator was 
added to 150µL of HSC assay 
diluent 
625 pg/mL            50µL of 2500pg/mL calibrator was 
added to 150µL of HSC assay 
diluent   
156 pg/mL            50µL of 625pg/mL calibrator was 
added to 150µL of HSC assay 
diluent   
 
0 pg/mL            150µL of HSC assay diluent   
 
2  Detection Antibody 
Solution 
60µL of the Stock Detection Antibody Mix was diluted 
into 2.94mL of HSC Antibody Diluent 
3  Read buffer 
 
12.5mL of Read Buffer was added to 25mL of 
deionised water 
4 
Addition of Human 
Serum Cytokine 
Assay Diluent 
25µL of Human Serum Cytokine Assay Diluent was 
dispensed by pipette into the bottom of each well. The 
plate was sealed and incubated while being shaken 
(300-1000rpm) for 30 mins at room temperature 
5  Addition of Sample 
or Calibrator 
25µL of each calibrator or sample solution was 
pipetted into a separate well of the MSD plate 
(duplicate samples were pipetted into adjacent wells 
figure 18). The plate was sealed and incubated while 
being shaken (300-1000rpm) for 2 hours at room 
temperature  
6 Wash  The plate was washed 3 times with a solution of PBS 
containing 0.05% Tween-20.  
7 
Addition of 
Detection Antibody 
Solution 
25µL of the Detection Antibody Solution (step 2) was 
pipetted into each well of the MSD plate. The plate 
was sealed and incubated while being shaken (300-
1000rpm) for 2 hours at room temperature 
8 Wash  The plate was washed 3 times with a solution of PBS 
containing 0.05% Tween-20.  
9 Read 
150µL of of the Read Buffer (step 3) was pipetted into 
each well of the MSD plate.The plate was then 
analysed on the SECTOR PR 
TM Reader. 
Quantification of cytokines present in each sample is 
derived from the levels of light measured from the 
tracer during electrochemicoluminescence with 
reference to the 7 point standard curve.  
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4.3 4   Stress  factors 
4.3.4.1 Medical  History 
This data was obtained verbally from the patient and from detailed searches of the 
medical history after obtaining consent. Information regarding causes of present 
episode, details of previous episodes, co-morbidities and medication were 
required for inclusion/exclusion criteria and for grouping. Clinical assessment with 
regard to fungal foot infection was documented and assessed in conjunction with 
observations from a foot inspection carried out as part of the study. Previous 
history was noted and evidence to support the presence of the risk factors 
identified in the literature or as previously discussed (chapter 2) was sought 
together with other medical events with possible relationship to the cellulitic 
attacks. For each patient and control the evidence was compiled in chronological 
order and tabulated to allow systematic searching. The categories chosen are 
listed in table 6.  For each category scores of 0 were recorded if no supporting 
evidence was found and scores of 1 were recorded for positive evidence. Hospital 
records were recalled after a period of six months for update and review. 
4.3.4.2 Stress  questionnaire 
Participants were asked to complete a stress questionnaire (Cohen et al 1983) 
appendix 1. The choice of questionnaire has been reviewed in section 3.1.4.2. 
Participants were asked to respond to each question by ticking one of 5 options 
ranging from never (0) to very often (5). The questionnaire was presented only on 
the first occasion since it was intended to relate to events directly preceding the 
cellulitic episode. 
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Table 6 - Medical history  
 
 
Previous history of skin or mucosal infections assumed to be caused by bacteria 
Recurrent skin rashes (not cellulitis) 
Previous history of Athletes foot 
Previous history of any fungal infection 
Presence of fissures on feet 
Powdery skin on the foot sole 
Dry skin on legs 
Previous abdominal surgery/ injury, trauma, surgery to cellulitic leg 
Previous injury /trauma/surgery to cellulitic or contralateral leg 
Previous abdominal surgery/ injury, trauma, surgery to cellulitic or contralateral leg 
Persistent oedema (post study) in cellulitic leg 
History of thrombophlebitis 
Prescription antibiotics ++ (recall/record of numerous courses of antibiotic 
treatment in association with recurrent infections) 
Asthma 
Allergies including asthma 
Overweight 
History of cancer 
Diabetes 
 
 
Previous history was noted and evidence to support the presence of the risk factors 
identified in the literature was sought together with other medical events with possible 
relationship to the cellulitic attacks. For each patient and control the evidence was 
compiled in chronological order and tabulated to allow systematic searching. The 
categories chosen are shown in the table above. For each category scores of 0 were 
recorded if no supporting evidence was found and scores of 1 were recorded for positive 
evidence. Hospital records were recalled after a period of six months for update and 
review. 
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5 STUDY  RESULTS 
 
5.1 Recruitment 
 
Patient recruitment began at the end of October 2006 and finished in mid August 
2007. During this time thirty five patients were identified who matched the inclusion 
criteria (see section 4.2) and fifteen patients declined when approached with 
details of the study. When the recruitment of control participants was complete a 
total of thirty two individuals had taken part (recruitment details are shown in figure 
21). Twelve patients and matched controls completed both visits, five patients 
completed the first visit but later refused a second appointment, one patient 
completed all tests but venesection had to be abandoned on both occasions, two 
patients donated blood samples but were unable to take part in other tests.  
 
Figure 21 - Numbers of patients and controls recruited to the study 
 
Patients identified as suitable by medical/nursing staff (N = 35) 
 
 
Agreed to take part (N = 20)  Refused (N =15)     
 
 
Participated at visit 1 (N = 20)   
Refused second visit (N = 5) 
    Incomplete  tests  (N  =  2)   
      
Participated at both visits (N = 13)   
Incomplete tests (N = 1) 
 
 
 
Participated in the final analysis : 
Patients (N = 12) + volunteer controls (N = 12) 
 
    
 
5.1.1 Participants 
The twelve completed pairs consisted of 8 males and 4 females, age range 24-77 
years. (Mean 55.6 ± 14.2). All patients were clinically diagnosed as suffering from 
cellulitis. Five were classified as a first episode and seven as recurrences. Patient 
3 (P3) classed as recurrent, had been taking oral antibiotic treatment prescribed   100
by the GP for several months. Table 7 shows the age distribution of the twelve 
pairs together with frequencies for sex, acute and recurrent episodes and whether 
the right or left leg was affected.  
 
Patient /control  Age (years)  Sex M/F  Cellulitic leg  Acute/Recurrent 
P1/C1 55/54  F  Left Acute 
P2/C2 50/50  M  Right  Acute 
P3/C3 61/60  F  Right  Recurrent 
P4/C4 46/46  M  Right  Recurrent 
P5/C5 24/25  M  Right  Recurrent 
P6/C6 66/66  M  Left Recurrent 
P7/C7 77/75  M  Left Recurrent 
P8/C8 62/61  F  Left Recurrent 
P9/C9 61/60  M  Left Acute 
P10/C10 61/60  M  Left  Recurrent 
P11/C11 38/38  M  Left  Acute 
P12/C12 66/67  F Left  Acute 
 
Age   Sex  Right/Left   Acute/recurrent 
20-30 = 1 = 8.3% 
30-40 = 1 = 8.3% 
40-50 = 1 = 8.3% 
M = 8 
= 66.6% 
Right = 4 
= 33.3% 
Acute = 5 
= 42% 
50-60 = 2 = 16.6% 
60-70 = 6 = 50% 
Distribution by  
70-80 = 1 = 8.3% 
F = 4 
= 33.3% 
Left = 8 
= 66.6% 
Recurrent = 7 
= 58% 
 
Table 7 – Patient/control characteristics and distribution by age, sex,  
status (acute/recurrent) and leg affected by cellulitis (right/left).  
 
 
5.2 Statistics 
This was a case controlled study designed to make comparisons between cellulitic 
and normal legs, acute and recurrent cases and patients and controls. Within 
patient comparisons were made between the affected (cellulitic leg) and the 
unaffected (contralateral leg) and patient control comparisons were made between 
the cellulitic leg and the control cellulitic leg (matched by left or right) see figure 12. 
Where appropriate comparisons were also made between the patient contralateral 
leg and the control contralateral leg (eg: numbers of dermatophytes cultured). 
Differences between these comparisons at visit 1 and visit 2 were important to 
establish whether results from cellulitic patients returned to near normal values 
post episode. For this reason only the twelve matched pairs have been included in 
the analysis although occasional reference is made to those patients who only 
attended for a first visit. Even with few matched pairs a large amount of data was   101
generated. A statistician reviewed this data and the following statistical tests were 
selected to conduct the analysis: 
•  Normally distributed data from related samples describing continuous 
variables (eg. measurements of pH) - paired t-test (PT) 
•  Skewed data describing continuous variables from related samples 
Wilcoxon Signed Ranks Test (WSR) 
•  Normally distributed data describing discrete variables from related samples 
(eg. stress questionnaire) Wilcoxon Signed Ranks Test (WSR) 
•  Binary (nominal) data from related samples (eg. patient history) - Chi-
squared (McNemar)  
•  Data from unrelated samples and data sets of unequal length (eg. 
Comparison between acute /recurrent cases – Mann-Whitney U (MWU) 
The probability value (P value) for significance was set at 5% (P = 0.05) 
Dot plots were constructed to demonstrate the distribution of each data set before 
deciding on the appropriate test. In some sections these dot plots are presented in 
the text in others they are referenced and appear as part of the appendix. The 
significance tests for results of each modality have been compiled into a table 
showing the number of results, the P value and the chosen test. In each table (1) 
and (2) indicate whether the results were obtained at visit 1 or at visit 2 and the 
number of results tested either patient or control is shown as N. The last three 
columns show the test used, the degrees of freedom and the P values obtained. 
Where appropriate the mean value, standard deviation (SD) and minimum to 
maximum values of the data together with the 95% Confidence Interval (95% CI) 
of the mean are also shown.  
These tables appear either in the text or in the appendix. Dot plots were 
constructed in Minitab 15, statistical data was generated in SPSS 15. Graphs were 
produced in Minitab 15 and Microsoft Excel 2000.  
5.3   Results by category 
The results are presented by the same categories as set out in the methodology: 
Results of culture and microscopy and IgE tests for Trichophyton Rubrum 
Results relating to skin structure and physiology 
Results of immunological tests 
Results relating to additional stress factors   102
5.3.1   Results of culture, microscopy and IgE tests for Trichophyton Rubrum 
The InTray Dermatophyte Medium chosen was convenient and low risk for health 
and safety; however it was not specific for Dermatophyte growth as moulds, 
bacteria and yeasts also grew and produced similar colour changes. 
Morphological observation and microscopic examination were always required for 
positive identification and it was sometimes necessary to subculture onto SAB. 4 
weeks was the average time to obtain a confident positive identification of species 
using DTM and microscopy, plus a further 2-3 weeks if recultures onto SAB were 
required. The primary objective was to identify dermatophytes but during this 
process it was necessary to identify other microorganisms in order to exclude the 
rarer dermatophyte forms. These other organisms were categorised as either 
opportunists, bacteria or yeasts. Opportunists or opportunistic dermatomycoses, 
include penicillium, paecilomyces, aspergillas, scopulariopsis, cladosporium and 
alternaria. Most of these could only be positively identified by microscopy and 
some examples are shown in figure 22. Some colonies of yeasts and bacteria (eg 
Rhodotorula and Pseudomonas (figure 23) were easily identified by culture alone. 
Because of the diversity of organisms grown, once dermatophytes had been 
excluded, only the most obvious from the other categories were positively 
identified. 
5.3.1.1. Culture  results 
Both patients and controls produced more cultures from the foot sole than from the 
ID spaces and larger and more diverse categories of organisms were obtained 
from the feet of control subjects. Table 8 shows the number of patients and 
controls who grew dermatophytes, opportunists, bacteria and yeasts from either 
site or either foot during the course of the study. Wilcoxon Signed Ranks Test 
(WSR) was performed on this data but no significance was found between 
categories. Three individuals, patient 7 (P7), patient 12 (P12) and Control 1 (C1) 
cultured no organisms although adequate amounts of skin scales were 
demonstrated on the DM surface. Distributions of the numbers of the four different 
categories of microorganisms grown at the various sites is shown in appendix 2-9. 
Dermatophytes 
The only patient included on the analysis who grew Dermatophytes was P11, 
Trichophyton Interdigitale (TI) was grown from both foot soles at the first visit and 
Trichophyton Rubrum (TR) was grown from the sole of the cellulitic (left) foot at   103
visit 2. The microscopic appearances of TR and TI are quite distinct and shown in 
figure 24. No other patients grew dermatophytes on either foot or at either visit 
 
Dermatophytes Opportunists  Bacteria    Yeasts 
Number of 
Patients  1 9  5  4 
Number of 
Controls  6 11  4  3 
 
Table 8 - Numbers of patients and controls who grew  
colonies of dermatophytes, opportunists, bacteria and yeasts.  
 
although 3 of the patients who were unable to attend for follow up grew 
dermatophytes (TI in one case and TR in the other two).  
Dermatophytes were grown from 6 (50%) of the control group. Trichophyton 
Rubrum was grown from four individuals (C2, C6, C9 and C10) and Trichophyton 
Interdigitale was grown from two (C3 and C11). C2 and C6 grew dermatophytes 
from both feet at both visits, C3, C6, C9 and C10 produced one colony from one 
foot on either occasion. 
WSR was performed on the data to look for evidence of statistical significance 
between the cellulitic and the contralateral feet of patients and between 
corresponding feet of the matched controls at both visits. The data between acute 
and recurrent groups (acute  = 5, recurrent = 7) was analysed using the Mann-
Whitney U test because the data was unrelated and the data sets unequal. The 
results are presented in table 9 and show that no significance was found for any of 
the statistical testing carried out on the dermatophyte data.  
Opportunists 
Large numbers of opportunistic dermatomycoses (section 2.2) were cultured from 
the feet of both patients and controls. In total for both visits patients grew more 
colonies (P= 20, C = 17) than controls on the first occasion and also (P = 23, C = 
21) at the second visit but these results did not reach significance (Chi8). The 
most frequently occurring opportunist was Penicillium (patients = 7 = 58%, controls 
= 7 = 58%) and its closely related variant Aspergillas (P = 2 = 17%). Cladosporium 
Werneckii (Tinea Nigra) was identified in four patients (25%) and in five (42%) of 
controls (P2, P3, P5, P9, C3, C6, C7, C8 and C10). Other opportunists identified 
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Figure 22 – Opportunistic Dermatomycoses 
Microscopic appearance x 60 
 
Aspergillas Nigilans 
Penicillium 
Alternaria 
Scopulariopsis 
Cladosporium (Tinea Nigra)   105
 
Figure 23  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Morphological appearance Rhodotorula (yeast) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Morphological appearance Pseudomonas (bacteria) 
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Figure 24 
 
 
 
 
 
 
 
 
 
Microscopic appearance of Trichophyton Rubrum  x 60– conidia are club 
shaped and attached to hyphae by stalks (arrows) 
Microscopic appearance of Trichophyton Interdigitale  x 60 – conidia are 
round and form clumps. A distinguishing feature is the presence of coiled 
spirals (arrows).   107
 
 
were Acromium (P = 2, C = 1), Alternaria (C = 1), Exophiala (P = 1), Geomyces (P 
= 1), Scopulariopsis (P = 2) see figure 22. The statistical testing described in the  
previous section was repeated using this data, no significance was found and the 
results are shown in appendix 10.  
 
Table 9 - Significance tests for results of Dermatophyte cultures 
 
 
N = 12 
 
Min-Max 
 
 
N = 12 
 
Min-Max  Test 
 
P 
value 
 
Cell foot (1)   0 - 1  Contra foot (1)  0 - 1  WSR  1.0 
           
Cell foot (1)   0 - 1  Control foot (1)   0 - 1  WSR  0.188 
           
Cell foot (1)   0 - 1  Cell foot (2)  0 - 1  WSR  1.0 
           
Cell foot (2)  0 - 1  Contra foot (2)  0 - 0  WSR  1.0 
           
Cell foot (2)  0 - 1  Control foot (2)  0 - 1  WSR  0.625 
           
Contra foot (1)  0 - 1  Contra control foot (1)  0 - 2  WSR  0.500 
           
Contra foot (1)   0 - 1  Contra foot (2)  0 - 0  WSR  1.0 
           
Contra foot (2)  0 - 0  Contra control foot (2)  0 - 1  WSR  0.500 
           
Control foot (1)  0 - 2  Control foot (2)   0 - 1  WSR  0.500 
 
      
 
 
 
 
 
 
Table 9 shows the results of statistical testing for the results of the 
dermatophyte cultures.The first row shows the test results for cultures  
grown from cellulitic feet and contralateral feet. (1) and (2) indicate  
whether the results were obtained at visit 1 or at visit 2. N = the number 
 of results tested (in this case a full data set of 12). The minimum and 
maximum (min-max) numbers of cultures obtained on an individual basis 
are recorded. The last two columns show the test used and the P values 
obtained. 
 
Bacteria 
Unidentified colonies of bacteria were grown from six participants (P1, P10, C5, 
C6, C7 and C11). Pseudomonas (figure 23) was positively identified from the foot 
soles of both feet in one patient (P6) and was grown on both occasions. No 
significance was found for this data and the results are shown in appendix 11. 
 
N = numbers compared (column 1 and column 3) 
(1)  =  visit 1    (2)  =  visit 2 
 
WSR = Wilcoxon Signed Ranks Test (exact 2 tailed test) 
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 Yeasts 
Unidentified yeasts were cultured from four participants (P1, P11, C3 and C7). The 
yeast Rhodotorula (figure 23) was positively identified in two cases (P8 and C6) 
and Trico Beigelli in one (P10).  No significance was found for this data and the 
results of the statistical tests are shown in appendix 12.  
5.3.1.2  Results for specific IgE to Trichophyton Rubrum (TR). 
The results of this immunological test have been included in this section because 
they relate directly to the identification of dermatophytosis.  
Serum levels of antibody (IgE) to TR are reported as negative = 0  (< 35 kUA/L), 
low = 1 (0.4 – 0.7 kUA/L), moderate = 2 (0.7 – 3.5 kUA/L), high = 3 (3.5 – 17.5 
kUA/L), and very high = 4 (17.5 - >100kUA/L) and values between 0 and 4 are 
commonly used to reflect the immunological status at the time of testing. Amongst 
the matched pairs, three patients (25%) (P2, P5 and P11), and three controls 
(25%) (C2, C6 and C9), recorded detectable levels of IgE to TR. All three control 
subjects and P11 produced TR on culture but although P2 and P5 produced other 
microorganisms including the opportunist Tinea Nigra neither produced TR from 
samples taken during the study. No antibodies to TR were recorded from C3 and 
C11 who both cultured TI, but this was as expected. One control C10, with an 
intermittent history of athletes foot, produced a culture with macroscopic 
appearances of TR but no antibodies were reported. Microscopy was equivocal 
and the culture may have been TI or another dermatophyte.  
WSR was used to compare test results between patient and controls and between 
visits; MWU was performed between acute and recurrent cases but no statistical 
differences were found between any groups. Levels of IgE between the patient 
and control groups at both visits are shown in figure 25 and the statistical results 
and raw data appear in appendix 13 and 14.   
5.3.2  Results relating to skin structure and physiology 
Measurements of skin water loss, skin pH, skin blood flow and skin thickness were 
attempted on all participants at both sites and at both visits in order to establish 
normal values and to assess any changes, transient or permanent, that might 
affect skin physiology in the cellulitic legs. 
5.3.2.1  Skin water loss   109
The Tewameter was easy to operate and well received by patients. There was no 
difficulty in obtaining measurements on normal or cellulitic skin. However it was 
difficult to calibrate and several attempts had to be made each time before 
acceptable calibration results were obtained. This may be because the Tewamater 
references a closed volume during calibration; in operation the cylinder is open to 
the air and the study readings were obtained according to the recommended 
instructions; in a draught free room, within the stated temperature and humidity 
values and after a suitable period had been allowed for acclimatisation to take 
place. 
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Results were obtained from all twelve pairs of participants at both visits. 
Measurements were initially higher and remained higher in cellulitic legs as 
compared to the contralateral legs and controls (figure 26).  In the cellulitic legs the 
range at the first visit was 2.5 – 17.2 and at the second visit 6.1 – 20 g/hr/cm
2 
respectively. The data were compared using paired T test or WSR depending on 
distribution (section 5.2). Raw data and distribution plots are set out in Appendix 
15 and 16 and the results shown in table 10. 
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P2, TR 
–  
P11, TR
+ 
P5, TR 
- 
Figure 25 - Graph to show serum levels of IgE toTrichophyton 
Rubrum. Patients and controls (n = 12) visits1 and  2. 
Patient (P11) and controls (C2, C6 and C9) who cultured TR are 
shown as TR
+. Patients P2 and P5 who did not culture TR are 
shown as TR 
-   110
TEWL readings were found to be significantly higher in the cellulitic legs than in 
contralateral legs or control legs at visit two, P = 0.003 and 0.04 respectively. 
Comparisons between cellulitic legs, contralateral legs and control legs were close 
to but did not achieve significance at visit one see table 10. No significance was 
found between acute and recurrent cases on either occasion.  
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Figure 26 - Graph to show TEWL results (gm/hr/cm
2) for cellulitic legs  
visit 1 (cell 1), cellulitic legs visit 2 (cell 2), contralateral legs visit 1(contra 
1), contralateral legs visit 2 (contra 2) and control legs at both visits (N = 
12). TEWL readings were found to be significantly higher in the cellulitic 
legs than in contralateral legs or control legs at visit two, P = 0.003 and 
 0.04 respectively.  
 
Normal ranges established from the twelve controls were between 1.2 and 10.0 
g/hm
2. C2. C3, C4, C6, C7, C8, and C9 all recorded one or more readings below 
the lower limit of normal as defined by Nilsson (1977) who documented 6-11 
g/hr/cm
2  as
 the normal range for TEWL measurements recorded  from the legs.
 
However, except for one control, results were comparably low for both right and 
left legs on each separate occasion. The contralateral legs in the patient group 
presented similar ranges ; 2.8 – 8.1 g/hr/cm
2  at visit 1 and 1.5 to 7.6 g/hr/cm
2  at 
visit 2. These findings suggest that the results obtained were reliable and that the 
accepted lower end of normal might need to be revised.    111
It was anticipated that TEWL readings would be higher in the cellulitic legs during 
the episode due to increased blood flow and skin temperature at the site of 
infection. Comparisons with control and contralateral legs did not quite achieve 
significance at visit 1 but this may have been because the numbers were small. 
The significance found at the second visit is interesting as it suggests changes in 
physiology. P1, P2, P8 and P10 all showed increases in the rate of TEWL at visit 
two as compared to visit one but these results were within the normal range. P3 
however, produced a considerable increase from 7.9 – 20 g/hr/cm
2 and this is 
interesting as this patient had been on antibiotic therapy for several months and  
 
Table 10 - Significance tests for results of Transepidermal Water Loss  
 
N = 12 
 
Mean 
(SD) 
Min-Max 
 
N = 12 
Mean 
(SD) 
Min-Max 
 
95% mean CI  
      (A - B) 
 
Test  DF 
 
P  
value 
 
Cell legs (1)   2.5 – 17.2  Contra legs (1)  2.8 – 8.1   WSR    0.065 
               
Cell legs (1)   2.5 – 17.2  Control 
 legs (1)   1.4 – 10.0    WSR    0.092 
               
Cell legs (1)   2.5 – 17.2  Cell legs (2)  6.1 – 20.0    WSR    0.583 
               
Cell legs (2)  6.1 – 20.0  Contra legs (2)  1.5 – 7.6   WSR    0.003 
              
Cell legs (2)  6.1 – 20.0  Control 
 legs (2)  1.2 – 9.1   WSR    0.04 
               
A = Contra 
legs (1) 
4.96 
(1.81) 
2.8 – 8.1 
B = Contra  
control legs (1) 
4.9 
(2.33) 
1.4 – 9.0 
-1.185 –1.918  PT  11  0.613 
               
Contra legs (1)  2.8 – 8.1  Contra legs (2)  1.5 – 7.6    WSR    0.232 
               
Contra legs (2)  1.5 – 7.6  Contra  
control legs (2)  2.5 – 9.4    WSR    0.807 
               
A = Control 
legs (1) 
5.6 
(2.39) 
1.4 – 10.0 
B = Control 
legs (2) 
5.8 
(2.41) 
1.2 – 9.1 
-1.465 –0.773  PT  11  0.529 
A = Control 
legs (1) 
5.6 
(2.39) 
1.4 – 10.0 
B = Control 
legs (2) 
5.8 
(2.41) 
1.2 – 9.1 
-1.465 –0.773  PT  11  0.529 
 
 
 
 
 
 
 
was clinically the least representative of cellulitis with respect to skin 
characteristics.  With the exception of P5 all other patients recorded readi 
 
N = numbers compared (column 1 and column 3) 
(1)  =  visit 1    (2)  =  visit 2 
 
CI = confidence interval ( A = parameter column 1, B = compared parameter column 3)  
PT = Paired T-test 
WSR = Wilcoxon Signed Ranks Test (exact 2 tailed test) 
DF = degrees of freedom 
      
   = significant (P = 0.05)  = P value close to 0.05  112
was clinically the least representative of cellulitis with respect to skin 
characteristics. With the exception of P5 all other patients recorded readings 
within the normal range on both occasions. Readings for P5 were 17.2 – 12.3 
g/hr/cm
2 at visit 1 and 2 respectively
. 
 This patient had substantial longstanding  
oedema in the cellulitic leg and a history of frequent recurrence. Because 
increases in skin water content are likely to disturb the rate at which water leaves 
the skin this result is not unexpected. 
5.3.2.2 Skin  pH 
pH measurements were performed at the centre of the area of interest of the 
cellulitic legs, contralateral legs and control legs at both visits. Calibrations were 
within range on each occasion and results were obtained from all twelve pairs of 
participants at both visits.  
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Figure 27 - Graph to show pH results for cellulitic legs visit 1 (cell 1), 
cellulitic legs visit 2 (cell 2), contralateral legs visit 1(contra 1),  
contralateral legs visit 2 (contra 2) and control legs at both visits  
(N = 12).   (mean and 95% confidence intervals are shown).  
No significant differences were found between the groups  
 
The reported pH range for normal unoccluded human skin varies from 3 - 6.5 
(Matousek and Campbell 2002). Noble (1968) demonstrated the mean pH value 
     = mean.  Bars show 95% confidence interval (CI)   113
for calf skin of the legs to be 5.5. In this study the range of pH values in cellulitic 
legs at visit one was 5.6 – 6.6 (mean 5.6 ± 0.68) and within the limits generally  
accepted as normal. At visit two the highest values for cellulitic legs extended into 
the alkaline range; a similar pattern was obtained for contralateral, control and 
contralateral control legs at both visits (figure 27). Three out of twelve (25%) of  
patients (P3, P8 and P7 all recorded pH values above 6.5 in one or both legs at 
one or both visits. Six out of twelve 50% of controls (C1, C3, C5, C7, C10 and 
C11) also produced these high values.  
 
Table 11 - Significance tests for pH results 
 
N = 12 
 
Mean 
(SD) 
Min-Max 
 
N = 12 
Mean 
(SD) 
Min-Max 
 
95% mean CI 
(A - B) 
 
Test DF 
 
P 
value 
 
A = Cell  
legs (1)  
5.642 
(0.68) 
4.6 – 6.6 
B =  
Contra legs (1) 
5.325 
(0.84) 
4.2 – 6.9 
-0.124 – 0.758  PT  11  0.142 
             
A = Cell 
legs (1)  
5.642 
(0.68) 
4.6 – 6.6 
B =  
Control legs 
(1)  
5.883 
(0.60) 
4.8 – 7.1 
-0.790 – 0.306  PT  11  0.370 
             
A = Cell 
legs (1)  
5.642 
(0.68) 
4.6 – 6.6 
B =  
Cell legs (2) 
5.692 
(0.69) 
4.4 – 7.1 
-0.516 – 0.416  PT  11  0.818 
             
A = Cell  
legs (2) 
5.692 
(0.69) 
4.4 – 7.1 
B =  
Contra legs (2) 
5.817 
(0.66) 
5.1 – 7.4 
-0.429 – 0.179  PT  11  0.385 
             
A =  
Cell legs (2) 
5.692 
(0.69) 
4.4 – 7.1 
B =  
Control legs 
(2) 
6.117 
(0.61) 
5.0 – 7.0 
-0.982 – 0.132  PT  11  0.128 
             
A = Contra 
legs (1) 
5.325 
(0.84) 
4.2 – 6.9 
B = Contra 
control legs (1) 
6.033 
(0.72) 
4.6 – 7.2 
-1.376 – 0.041  PT  11  0.039 
             
Contra legs 
(1)   4.2 – 6.9  Contra legs (2)  5.1 – 7.4    WSR    0.095 
             
Contra legs 
(2)  5.1 – 7.4  Contra 
control legs (2)  5.2 – 6.8    WSR    0.241 
             
A = Control 
legs (1) 
5.883 
(0.61) 
4.8 – 7.1 
B =  
Control legs 
(2)  
6.117 
(0.61) 
5.0 – 7.0 
-0.574 – 0.108  PT  11  0.160 
 
 
 
 
 
N = numbers compared (column 1 and column 3) 
(1)  =  visit 1    (2)  =  visit 2 
 
CI = confidence interval ( A = parameter column 1, B = compared parameter column 3)  
PT = Paired T-test 
WSR = Wilcoxon Signed Ranks Test (exact 2 tailed test) 
DF = degrees of freedom 
      
= significant (P = 0.05)   114
The data were compared using PT or WSR. Descriptive statistics and significance 
results are set out in table 11. (Raw data and distribution plots are shown in 
appendices 17 and 18).  
For differences between right and left legs within visit variability was less than 
between visit variability for both patients and controls. There was no statistically 
significant difference between the values for the cellulitic legs during the cellulitic 
episode and the follow up visit or between the cellulitic legs and the contralateral 
or control legs on either occasion or between acute and recurrent cases. However 
a statistically significant difference was found between contralateral legs and 
contralateral control legs at visit 1 (p = 0.04). This is likely due to the unusual 
distribution of values from the contralateral legs giving a cluster of values just 
above 6 and because of the low numbers of participants. 
Although no statistical significance was found between the groups the overall pH 
values were higher than expected, there are many possible explanations and 
these will be discussed in the next chapter. 
5.3.2.3 Oedema 
This section contains the results of the leg circumference measurements, the skin 
thickness measurements and the ultrasound image analysis. These tests were  
performed to assess the oedema in the cellulitic leg in order to understand where it 
was located, whether it was acute or chronic and whether the skin structure 
appeared changed. 
Leg circumference measurements 
Circumferential limb measurements were used to compare swelling between legs, 
between visits and between groups. Measurements were recorded for the lower 
leg and taken just below the knee, at mid calf level and at the ankle. Data was 
obtained from eleven pairs of patients and controls . (P10 was heavily bandaged 
on the first occasion so measurements were not performed). 
The data obtained was normally distributed throughout (see appendices 19 - 21) 
and paired t tests were used for statistical analysis.  
Significant differences were found between patients and controls for both legs at 
the ankle and mid calf sites and on both occasions (appendices 22-23). 
Measurements at these sites were consistently higher in the patient group. The 
mean value for the cellulitic legs at the ankle was 29.5 ± 5.4 cms at visit 1(V1) and 
28.2 ± 4.5 cms at visit 2 (V2) and for the mid calf  40.1 ± 7.2 cms (V1) and  40.3 ±   115
7.7 cms (V2). Mean values for the control cellulitic legs at the ankle were 22.2 ± 
0.9 cms (V1) and 22.1 ± 0.8 cms (V2), and at the mid calf 33.2  ± 2.7 (V1), 33.6 ± 
0.9 (V2). Significance was also found between these two groups at the upper calf 
level (see table 12). These findings are most likely the result of differences in body 
profile between patients and controls and occurred because the control group had 
thinner calves. 
Within the patient group no significant differences were found for ankle or mid calf 
measurements taken from the cellulitic legs at either visit at any site, or between 
measurements taken from the cellulitic legs and contralateral legs at either visit. 
However circumferential measurements of the cellulitic upper calf were 
significantly higher (p = 0.013) than at the same site on the contralateral leg but 
only at the first visit (figure 28 and table 12). The raw data in appendix 24 shows  
that in  four patients (P3, P6, P7 and P12) the upper calf circumference in the 
cellulitic leg was greater at the second visit and increases were also found in the 
contralateral leg in seven patients (P2, P3, P5, P6, P7, P9 and P11) also at visit 2. 
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Figure  28 - Graph to show results for circumferential measurements  
(cms) taken at the upper calf. Cellulitic legs visit 1 (cell 1), cellulitic legs visit 2 
(cell 2), contralateral legs visit 1(contra 1), contralateral legs visit 2 (contra 2) 
and control legs at both visits (N = 11). Circumferential measurements of the 
cellulitic upper calf were significantly higher (p = 0.013) than at the same site 
on the contralateral leg but only at the first visit.  
     = mean.  Bars show 95% confidence interval (CI)   116
 
 
Table 12 - Significance tests for leg measurements (cms) taken at upper calf level  
 
 
N = 11 
 
Mean 
(SD) 
Min-Max 
 
N = 11 
Mean 
(SD) 
Min-Max 
 
95% mean CI 
(A - B) 
 
Test  DF 
 
P 
value 
 
A = Cell 
legs (1)  
42.5 
(5.9) 
32 - 52 
B = Contra 
legs (1) 
39.1 
(4.6) 
29 – 45.5 
0.89 – 5.83  PT  10  0.013 
              
A = Cell 
legs (1)  
42.5 
(5.9) 
32 - 52 
B = Control 
legs (1)  
37.0 
(1.9) 
33 - 40 
1.47 – 9.44  PT  10  0.012 
              
A = Cell 
legs (1)  
42.5 
(5.9) 
32 - 52 
B = Cell 
legs (2) 
41.4 
(5.9) 
30 - 48 
-1.134 – 3.225  PT  10  0.310 
              
A = Cell 
legs (2) 
41.4 
(5.9) 
30 - 48 
B = Contra 
legs (2) 
39.9 
(5.0) 
29.5 - 47 
-1.134 – 3.225  PT  10  0.310 
              
A = Cell 
legs (2) 
41.4 
(5.9) 
30 - 48 
B = Control 
legs (2) 
37.2 
(1.8) 
34.5 - 40 
0.31 – 8.23  PT  10  0.037 
               
A = 
Contra 
legs (1) 
39.1 
(4.6) 
29 – 45.5 
B = Contra 
control legs (1) 
37.5 
(2.0) 
35 – 41.5 
-1.63 – 4.90  PT  10  0.290 
               
A = 
Contra 
legs (1)  
39.1 
(4.6) 
29 – 45.5 
B = Contra 
legs (2) 
39.9 
(5.0) 
29.5 - 47 
-1.819 – 0.181  PT  10  0.098 
               
A = 
Contra 
legs (2) 
39.9 
(5.0) 
29.5 - 47 
B = Contra 
control legs (2) 
37.5 
(1.8) 
34.5 - 41 
-0.96 – 5.87  PT  10  0.140 
               
A = 
Control 
legs (1) 
37.0 
(1.9) 
33 - 40 
B = Control 
legs (2)  
37.2 
(1.8) 
34.5 - 40 
-0.739 – 0.466  PT  10  0.625 
 
 
 
 
 
 
 
 
 
 
 
N = numbers compared (column 1 and column 3) 
(1)  =  visit 1    (2)  =  visit 2 
 
CI = confidence interval ( A = parameter column 1, B = compared parameter column 3)  
PT = Paired T-test 
DF = degrees of freedom 
      
 
 
 
 
 
 = significant (P = 0.05)   117
During the episode the legs were elevated to encourage a reduction in oedema; 
this would be marginally effective in the cellulitic leg but more effective in its 
counterpart. Following the episode increased dependency would encourage 
swelling in both legs and this is the likely cause of the significance between legs in 
the patient group.  
Ultrasound 
Ultrasound imaging was attempted on ten pairs of patients and controls (two pairs 
were not imaged because the equipment was unavailable). Image capture was 
conducted according to the protocol set out in 4.3.2.4, aiming to achieve the 
correct orientation between the scanner membrane and the skin surface in order 
to produce reliable measurements (see figures 6a and 7c).  
It was difficult to obtain good ultrasound images on many of the participants. Some 
were unable to abduct their legs sufficiently to allow the scan to be conducted at 
the correct angle and some were unable to tolerate skin pressure. For these 
reasons there are gaps in the data (appendix 26) and only seven pairs produced 
images suitable for measuring and data analysis (P1, P2, P3, P5, P8, P10, P11 
and matched controls). It was not possible to evaluate the extent of the dermis in 
P11 at visit one because of the diffuse oedema and poor images; comparisons for 
area B are therefore limited to six. The distances between the A-scan interfaces 
relating to the epidermis (area A) and the dermis (area B) were measured at three 
levels on each image and the average calculated (see section 3.1.2.3).  
•  Area A (epidermis) 
The data were compared using paired t test or WSR according to the distribution 
(see appendix 27). No statistical differences were found between patients and 
controls or between cellulitic or normal legs at either visit. (appendix 28). 
•  Area B (dermis) 
The data was all normally distributed and tested by paired t test (appendix 29) the 
results are shown in figure 29 and table 13. Dermal measurements were 
significantly greater in the cellulitic legs as compared to the cellulitic control legs at 
the first visit (p = 0.029). Comparison of the cellulitic legs between visits, and the 
cellulitic legs and contralateral legs at both visit 1 and visit 2 were almost 
significant (p = 0.071, p = 0.081 and p = 0.087 respectively).   118
The numbers entered into the analysis were low but the findings are consistent 
with those in the previous section and suggest that leg swelling in the cellulitic legs 
is persistent and that the difference may be partly or totally due to increases in 
thickness in the dermis. Figure 30 shows the images taken from the cellulitic leg of 
P8. In figure 30a the arrows indicate low echogenic pixels consistent with the 
presence of fluid (oedema) in the papillary dermis. In figure 30b the oedema can 
be seen to have reduced. It may be that the fluid remains within the papillary 
dermis, that it disperses deeper into the dermal tissue or that it resolves. In order 
to more fully investigate this some data was selected for image analysis. 
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Figure 29 
Graph to show ultrasound measurement results (area b dermis) for cellulitic legs 
visit 1 (cell 1), cellulitic legs visit 2 (cell 2), contralateral legs visit 1(contra 1), 
contralateral legs visit 2 (contra 2) and control legs at both visits (N = 6).       
Dermal measurements were significantly greater in the cellulitic legs as compared 
to the cellulitic control legs at the first visit (p = 0.029). Comparison of the cellulitic 
legs between visits, and the cellulitic legs and contralateral legs at both visit 1 and 
visit 2 were almost significant (p = 0.071, p = 0.081 and p = 0.087 respectively). 
 
 
 
 
 
 
     = mean.  Bars show 95% confidence interval (CI)   119
 
 
 
Table 13 - Significance tests for ultrasound measurements (area b) mms 
 
 
N = 6 
 
Mean 
(SD) 
Min-Max 
 
N = 6 
Mean 
(SD) 
Min-Max 
 
 
95% mean CI 
(A - B) 
 
Test  DF 
 
P 
value 
 
A = Cell 
legs (1) 
 
2.20 
(0.58) 
1.36 – 3.09 
B = Contra 
legs (1) 
 
1.58 
(0.36) 
1.27 – 2.20 
-0.076 – 1.313  PT  5  0.071 
              
A = Cell 
legs (1) 
 
2.20 
(0.58) 
1.36 – 3.09 
B = Control 
legs (1) 
 
1.53 
(0.13) 
1.39 – 1.70 
0.104 – 1.239  PT  5  0.029 
               
A = Cell 
legs (1) 
 
2.20 
(0.58) 
1.36 – 3.09 
B = Cell 
legs (2) 
 
1.87 
(0.34) 
1.29 – 2.31 
-0.060 – 0.733  PT  5  0.081 
               
A = Cell 
legs (2) 
 
1.87 
(0.34) 
1.29 – 2.31 
B = Contra 
egs (2) 
 
1.63 
(0.38) 
1.21 – 2.22 
-0.119 – 0.592  PT  5  0.148 
               
A = Cell 
legs (2) 
 
1.87 
(0.34) 
1.29 – 2.31 
B = Control 
legs (2) 
 
1.56 
(0.19) 
1.26 – 1.76 
-0.065 – 0.678  PT  5  0.087 
               
A = Contra 
legs (1) 
 
1.58 
(0.36) 
1.27 – 2.20 
B = Contra 
control legs 
(1) 
 
1.68 
(0.19) 
1.46 – 2.04 
-0.482 – 0.282  PT  5  0.531 
               
A = Contra 
legs (1) 
 
1.58 
(0.36) 
1.27 – 2.20 
B = Contra 
legs (2) 
 
1.63 
(0.38) 
1.21 – 2.22 
-0.109 – 0.019  PT  5  0.135 
               
A = Contra 
legs (2) 
 
1.63 
(0.38) 
1.21 – 2.22 
B = Contra 
control legs 
(2) 
 
1.62 
(0.23) 
1.37 – 2.01 
 
-0.036 – 0.367  PT  5  0.973 
               
A = 
Control 
legs (1) 
 
1.53 
(0.13) 
1.39 – 1.70 
B = Control 
legs (2) 
 
1.56 
(0.19) 
1.26 – 1.76 
-0.174 – 0.117  PT  5  0.638 
 
 
 
 
 
 
 
 
 
 
 
 
N = numbers compared (column 1 and column 3) 
(1)  =  visit 1    (2)  =  visit 2 
 
CI = confidence interval ( A = parameter column 1, B = compared parameter column 3)  
PT = Paired T-test 
DF = degrees of freedom 
      
 
 
 
 
 = significant (P = 0.05)  = P value close to 0.05  120
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Oedema 
reduced at the 
second visit 
Figure 30a - Acute dermal oedema during the 
cellulitic episode (20MHz ultrasound scan) 
Figure 30b - Repeat scan of the same area 6 
weeks post episode. 
Low echogenic 
pixels (arrows) 
indicate oedema 
in the upper 
papillary dermis   121
 
Figure 31 - Images taken from the cellulitic leg of P5 at visit 1 and visit 2 and A-
scans derived from the data lines P1 and P2 
 
      
          
Greyscale image from visit 1. The A-scan is derived from line P1 and aligned with  
data from image 3 (Line P2) using the border of the SC as a guide (arrow) 
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Cellulitic leg visit 1
Cellulitic leg visit 2
 
A-scan graphs of lines P1 and P2 matched at the SC border (arrow). The grey 
scale values deep to the SC are predominantly low (note some higher values from  
1     produced by an area of high reflectivity within the dermis). 
 
 
 
 
Greyscale image from visit 2. The A- scan is derived from line P2 and aligned with  
data from image 1 (Line P1) using the border of the SC as a guide (arrow). 
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Figure 32 - Images taken from the control cellulitic leg of C5 at visit 1 and visit 2 
and A-scans derived from the data lines C1 and C2 
 
 
 
Greyscale image from visit 1. The A-scan is derived from line C1 and aligned with 
data from image 3 (Line C2) using the border of the SC as a guide (arrow) 
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Control cellulitic leg visit 1
Control cellulitic leg visit 2
A-scan graphs of lines C1 and C2 matched at the SC border (arrow). In both 
images the region deep to the SC contains much more structure. The grey scale 
values are higher than those in figure 31. 
 
 
 
 
Greyscale image from visit 2. The A-scan is derived from line C2 and aligned with 
data from image 1 (Line C1) using the border of the SC as a guide (arrow). 
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Image analysis 
The image analysis was performed as described in section 3.1.2.3 (Image 
Analysis). The colour images were also saved in a lossless grey scale format.  
Figure 31 shows images taken from the cellulitic leg of P5 at visit 1 and visit 2. A 
line of pixels was selected from each image (lines P1 and P2) and the data was 
digitised and graphed to produce A-scans. Graphs from both visits were matched 
together using the high values from the SC to position the skin entry points (figure 
31). The corresponding images and graphs from the matched control C5 are 
shown in figure 32. P5 had long standing oedema which may have increased 
during the cellulitic episode but there is no obvious fluid collection in the papillary 
dermis as seen in figure 30. C5 shows structural differences in the strata deep to 
the SC and this is consistent with a fibrous content and reflected in the higher 
values obtained in the graphs. The lack of structure and the predominance of low 
echogenic pixels shown in images and A- scans from P5 suggest a higher fluid 
concentration and textural differences.  
The results obtained from this part of the study lend support for the role of oedema  
in cellulitic episodes . A-scans are useful but are unable to quantify the nature of 
the textural differences that can be observed. More advanced analytical 
techniques need to be applied to images en block in order to advance the 
understanding and relate more exactly to the physiology. 
5.3.2.4   Skin blood flow 
Laser Doppler Imaging (LDI) was performed to compare changes in skin blood 
flow between cellulitic legs, contralateral legs and controls at both visits. This test 
was well tolerated by patients and controls because no skin contact was required. 
Only one patient (P7) had difficulty in remaining still during the scan, his 
involuntary movements are reflected in the results and will be discussed later.  
 The LDI software was used to calculate the mean flux value for the pixels within 
each ROI (see section 4.3.2.5). All twelve pairs were entered into the statistical 
analysis for cellulitic legs, contralateral legs and control legs, the data were evenly 
distributed and paired t tests were performed. Two data sets were missing for 
contralateral control legs and WSR tests were used because the numbers were 
uneven.  
Mean flux values for the cellulitic legs were 371 ± 149 during the cellulitic episode 
and 176 ± 103 at the second visit. Values for the contralateral legs were 134 ± 39   124
(visit 1) and 173 ± 47 (visit 2). Values for control legs were 152 ± 36 (visit 1) and 
149 ± 41 (visit 2). These results are presented in figure 33 and table14, raw data 
and distribution plots are shown in appendix 30 and 31. 
Results from the cellulitic legs were significantly higher at visit 1 than at visit 2 (p = 
0.0001) and also significantly higher than controls or contralateral legs at the first 
visit  (p = 0.0001) in both cases. No other significance was found between acute 
and recurrent cases at either visit. These findings show that microcirculatory blood 
flow increased during the cellulitic episode and this is assumed to be in 
conjunction with the immune response. Decreased mean values at the second 
visit suggest that blood flow had by then returned to normal levels. However the  
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Figure 33 
Graph to show results for LDI flux  for cellulitic legs visit 1 (cell 1), cellulitic 
legs visit 2 (cell 2), contralateral legs visit 1(contra 1), contralateral legs 
visit 2 (contra 2) and control legs at both visits (N = 12).    
Paired t tests were used to compare data (mean and 95% confidence 
intervals are shown. 
Results from the cellulitic legs were significantly higher at visit 1 than at 
visit 2 (p = 0.0001).  Results from the cellulitic legs were also significantly 
higher than controls or contralateral legs at visit 1 (p = 0.0001) in both 
cases. 
 
     = mean.  Bars show 95% confidence interval (CI)   125
raw data shows some very low mean flux values in the patient group (P4 and P5) 
where textural differences, thought to be related to chronic oedema, had also been 
demonstrated. Although in these patients blood flow was shown to increase during 
the cellulitic episode the increase in relation to normal resting flow for that 
individual was unknown. 
 
Table 14 - Significance tests for results of mean flux Laser Doppler Imager (LDI) 
 
 
   N = 12 
* N = 10 
 
Mean 
(SD) 
Min-Max 
 
N = 12 
*N = 10 
Mean 
(SD) 
Min-Max 
 
95% mean CI 
(A - B) 
 
Test  DF 
 
P 
value 
 
A = Cell 
legs (1)  
371.0 
(149.0) 
138 - 567 
B = Contra 
legs (1) 
134.4 
(48.1) 
45 - 240 
144 – 329.5  PT  11  0.0001 
              
A = Cell 
legs (1)  
371.0 
(149.0) 
138 - 567 
B = Control 
legs (1)  
152.2 
(36.2) 
93.0 - 214 
128.6 – 309.1  PT  11  0.0001 
              
A = Cell 
legs (1)  
371.0 
(149.0) 
138 - 567 
B = Cell 
legs (2) 
176.4 
(103.1) 
21 - 436 
106.6 – 282.6  PT  11  0.0001 
               
A = Cell 
legs (2) 
176.4 
(103.1) 
21 - 436 
B = Contra 
legs (2) 
153.8 
(78.7) 
16.0 – 280 
-19.3 - 64.6  PT  11  0.259 
               
A = Cell 
legs (2) 
176.4 
(103.1) 
21 - 436 
B = Control 
legs (2) 
149.4 
(41.2) 
109 - 230 
-56.1 – 110.1  PT  11  0.489 
               
Contra 
legs (1) 
 
45 - 240 
*Contra 
control legs (1) 
 
101 - 224    WSR    0.386 
               
A = Contra 
legs (1)  
134.4 
(48.1) 
45.0 – 240 
B = Contra 
legs (2) 
153.8 
(78.7) 
16.0 – 280 
-51.8 – 12.8  PT  11  0.211 
               
Contra 
legs (2)  16.0 – 280  *Contra 
control legs (2) 
115 - 246    WSR    0.754 
               
A = Control 
legs (1) 
152.2 
(36.2) 
93.0 - 214 
B = Control 
legs (2)  
149.4 
(41.2) 
109 - 230 
-26.6 – 32.1  PT  11  0.841 
 
      
 
 
 
 
 
 
N = numbers compared (column 1 and column 3) 
(1)  =  visit 1    (2)  =  visit 2 
 
CI = confidence interval ( A = parameter column 1, B = compared parameter column 3)  
PT = Paired T-test 
WSR = Wilcoxon Signed Ranks Test (exact 2 tailed test) 
DF = degrees of freedom 
      
 
 
 
 = significant (P = 0.05)   126
Parameters for normal resting flow 
In order to establish a set of parameters for normal resting flow the control images 
were compared with respect to the distribution of the histogram of flux values 
together with the mean, standard deviation and maximum flux values for the pixels 
within the AOI. A criterion representing normal was devised (value 2 in table 15). 
Using this as a reference AOIs with higher or lower overall flux values could then 
be defined (values 1 and 3). The higher values were further subdivided into high 
(value 3) and very high (value 4). The appearance of LDI images relating to these 
categories is shown in figure 34. Each AOI was then assigned to a value of 1, 2, 3 
or 4 (see table 15). The results are shown in figure 35 and the raw data in 
appendix 32. 
 
Value  Relative flux   Criteria 
    1  Low   80% of pixels < 75 relative flux units (RFU), 
mean = < 50 RFU, Max = < 250 RFU 
2 Normal  80% of pixels < 250 RFU, mean = > 50 <240 
RFU 
3 High  80% 0f pixels > 200 RFU, mean = > 240 < 440 
RFU 
4 Very  high  Absence of pixels below 100 RFU, 80% of 
pixels > 400 RFU, mean = > 440 RFU 
 
Table 15 – Criteria for categorising resting flow by reference to mean/  
maximum flux values and histogram distribution. 
 
All controls showed resting blood results within category 2 for each leg on both 
occasions. All patients except three (P4, P7 and P8) exhibited a resting blood flow  
consistent with category 3 or category 4 during the cellulitic episode and normal 
values on the follow up visit. (P4) showed normal values (category 2) in the 
cellulitic leg at visit 1 and low (category 1) values in this leg at the second visit 
while in the contralateral leg category 1 values were recorded at both visits. By 
external appearance both legs were oedematous on both occasions and the 
ultrasound images revealed structural changes thought to be associated with 
oedema. Low flow in the microcirculation of both legs is clearly a permanent 
feature; despite this flow levels increased during the episode but only attained 
normal resting levels. (P8) displayed normal pallor in the calf skin of the affected 
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0             Perfusion Units            1000 
A B 
C  D 
Figure 34 - LDI perfusion scans: skin of medial calf with participant in resting 
mode after 15 mins acclimatisation. Scan area (marked by black dots) and 
selected AOI (white box). 
A = low perfusion 
B = normal resting perfusion 
C = high perfusion 
D = very high perfusion (dots were not applied as this patient was unable to 
tolerate any contact) 
(For classification criteria see table 15)   128
 
 
 
Figure 35 - Graph to show results for resting flow after categorisation 
according to table 15. 
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Cellulitic legs visit 1 (cell 1), cellulitic legs visit 2 (cell 2), contralateral legs 
visit 1(contra 1), contralateral legs visit 2 (contra 2) and control legs at both 
visits (N = 12).        
All controls showed resting blood results within category 2 for each leg on 
both occasions. All patients except three (P4, P7 and P8) exhibited a resting 
blood flow consistent with category 3 or category 4 during the cellulitic 
episode and normal values on the follow up visit.  
 
 
leg at the first visit. Six days had elapsed since the onset of the episode and 
although the skin had been red initially and the leg swollen there was a rapid 
response to treatment and swelling was thereafter confined to the foot. Resting 
relative flux measurements were found to be normal in both legs on both 
occasions. (P7) produced scores of 3 for both legs for both occasions. This patient 
was unable to remain still for the period of the scan and the flux patterns obtained 
were consistent with the presence of mild physical activity. It was impossible to 
estimate the contribution made by inflammation in the cellulitic leg although a 
consistent score of 3 on both legs suggests that it was low. 
   129
 
5.3.2.5   Assessment of venous incompetence 
This assessment took place at the second visit and participants performed the 
exercise according to the protocol (see section 4.3.2.6). The data obtained was 
graphed in Microsoft  EXCEL to produce a trace of the exercise routine (figure 36) 
and the time taken for the trace to return to baseline values (venous refilling time) 
was calculated. Times in excess of 25 secs were scored as competent and those 
less than 25 secs were scored as incompetent. Two patients were unable to 
comply with the calf exercise; P4 had oedema in the cellulitic leg and a dropped 
foot on the contralateral side, P6 was diabetic with neuropathy in both feet and 
was unable to coordinate his movements.  
Statistical analysis was performed on the actual venous refilling times for the ten 
pairs of patients and controls (raw data is shown in appendix 33); this produced an 
uneven distribution and WSR tests were used (appendix 34). The raw data was 
also scored as competent and incompetent (competent  = 1, incompetent  =  2) 
this data is shown in appendix 35. 
Incompetence was found to be statistically higher in the cellulitic legs as compared 
to the control cellulitic legs or the contralateral legs (P = 0.016 and 0.047) 
respectively (Table 16). Seven patients (70% of those tested) were found to be 
incompetent in the cellulitic leg (P3, P7, P8, P9, P10, P11 and P12) and six of 
these were also incompetent in the contralateral leg. The remaining patients (P1, 
P2 and P5) were found to be competent in both legs, although P5 recorded a 
much lower level of flux on exercise in the cellulitic leg, which was oedematous 
and had also been found to have a high rate of TEWL and textural skin changes. 
However he was young (24), otherwise physically fit and able to perform the test 
with ease.  
Three members of the control group (30% of matched controls) were found to 
have incompetence. (C4 and C7) were incompetent in one leg and (C3) was 
incompetent in both. 
These findings show a high rate of incompetence in the patient group involving 
both legs in most cases. In four cases incompetence was coincident with 
increases in leg circumference (P3, P7, P11 and P12) suggesting the link with 
oedema and altered skin physiology.  
   130
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Figure 36a – LDF traces to show venous competence in both legs 
Figure 36b – LDF traces to show venous incompetence in both legs   131
 
Table 16 - Significance tests for venous refilling times (secs) 
 
 
N = 10 
 
 
Min-Max 
 
N = 10 
 
Mean 
 
Test 
 
P 
value 
 
Cellulitic leg  5 - 30  Contralateral leg  5 - 30  WSR  0.469 
          
Cellulitic leg  5 - 30  Control leg  18 - 30  WSR  0.016 
          
Contralateral leg  5 - 30  Control 
contralateral leg  12 - 30  WSR  0.047 
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Figure 37  
Graph to show venous refilling times for cellulitic legs (Cell leg), 
contralateral legs (Contra leg), control legs and contralateral control legs 
 (N = 10). Values > 25 secs are classed as competent, values < 25 secs 
are classed as incompetent. 
Incompetence was found to be statistically higher in the cellulitic legs as 
compared to the control cellulitic legs or the contralateral legs (P = 0.016 
and 0.047).  
 
 
Values above this level are classed as competent 
 
N = numbers compared (column 1 and column 3) 
 
WSR = Wilcoxon Signed Ranks Test (exact 2 tailed test) 
      
 
= significant (P = 0.05)  132
5.3.3   Immunological Outcomes 
5.3.3.1   Routine blood results 
Full blood count  (FBC) and CRP results for patients were obtained for alternate 
days throughout attendance at the ACU. All tests were repeated at the second visit 
and results were received, together with those for the controls, directly from the 
haematology department at SGH. Data sets were compared at two time points: 
For patients, at the start of hospital treatment and at the follow up visit 
For controls the results from the two consecutive visits.  
The time interval between visits was matched between pairs to adjust for different 
lengths of antibiotic treatment. Statistical analysis was conducted for levels of 
CRP, numbers of white blood cells, neutrophils and lymphocytes and comparisons 
made between patients and controls as well as between visits (raw data are 
presented in appendix 36 and 37, distributions are shown in appendix 38 and 39). 
Levels of CRP for patients were statistically higher at visit 1 than at visit 2 (p = 
0.001) and also statistically higher than controls between visits (p = 0.001). White 
cell count was also statistically higher in the patients between visits and between 
patients and controls at visit 1 (p = 0.015 and p = 0.011) respectively (see 
appendix 40). Lymphocyte levels only showed significance between visits in the 
patient group (p = 0.034) see table 17a. These results reflect the expected 
immune response to inflammation. Neutrophil counts were statistically higher in 
the patient group between visits (p = 0.016) and patient counts were also 
significantly higher than controls at the second visit (p = 0.022) and this was 
unexpected see table 17b. The mean value in the patient group was 4.31 ± 1.35 
and in the control group 3.13 ± 0.73. Although these results all lie within the 
accepted range 2 -7.5 (10^9/L) the trend in the patient group is interesting and 
may be important.  
Profiles of cell counts and CRP levels were constructed in order to examine the 
relevance of these findings. Examples are shown in figures 38a and 38b. 38a 
represents an acute case and plots the expected haematological response from 
day 1- day 25 of IV antibiotic therapy. High levels of CRP fall rapidly as the 
episode becomes controlled signalling a decline in first the neutrophil count and 
then the white cell count while lymphocyte levels gradually return to normal.  
For most patients little data exists for the first few days of the episode when 
treatment is carried out in primary care. Figure 38b (P8) shows a limited blood   133
 
 
Table 17a 
Significance tests for Lymphocytes (10^9/L) 
 
N = 12 
 
Mean 
(SD) 
Min-Max 
 
N = 12 
Mean 
(SD) 
Min-Max 
 
95% mean CI 
(A - B) 
 
Test  DF 
 
P 
value 
 
A =  
Patients (1)  
1.433 
(0.693) 
0.6 – 3.3 
B =  
Patients (2) 
1.733 
(0.667) 
0.6 – 3.0 
-0.574 - 0.026  PT  11  0.034 
              
A =  
Controls (1)  
1.642 
(0.452) 
0.9 – 2.5 
B =  
Controls (2)  
1.675 
(0.494) 
1.0 – 2.6 
-0.187 – 0.121  PT  11  0.643 
              
A =  
Patients  (1)  
1.433 
(0.693) 
0.6 – 3.3 
B =  
Controls (1) 
1.642 
(0.452) 
0.9 – 2.5 
-0.759 – 0.342  PT  11  0.422 
              
A =  
Patients (2) 
1.733 
(0.667) 
0.6 – 3.0 
B =  
Controls (2) 
1.675 
(0.494) 
1.0 – 2.6 
-0.458 – 0.575  PT  11  0.808 
 
Table 17b 
Significance tests for Neutrophils (10^9/L) 
 
N = 12 
 
Mean 
(SD) 
Min-Max 
 
N = 12 
Mean 
(SD) 
Min-Max 
 
95% mean CI 
(A - B) 
 
Test  DF 
 
P 
value 
 
A =  
Patients (1)  
6.54 
(3.175) 
1.9 - 12 
B =  
Patients (2) 
4.31 
(1.357) 
1.9 – 6.9 
0.494 – 3.972  PT  11  0.016 
              
A =  
Controls (1)  
3.233 
(0.611) 
2.4 – 4.3 
B =  
Controls (2)  
3.133 
(0.73) 
2.3 – 4.3 
-0.268 – 0.468  PT  11  0.562 
              
A =  
Patients  (1)  
6.54 
(3.175) 
1.9 - 12 
B =  
Controls (1) 
3.233 
(0.611) 
2.4 – 4.3 
1.259 – 5.357  PT  11  0.005 
              
A =  
Patients (2) 
4.31 
(1.357) 
1.9 – 6.9 
B =  
Controls (2) 
3.133 
(0.73) 
2.3 – 4.3 
0.209 – 2.141  PT  11  0.022 
 
 
 
 
 
 
 
 
 
 
 
 
N = numbers compared (column 1 and column 3) 
(1)  =  visit 1    (2)  =  visit 2 
 
CI = confidence interval ( A = parameter column 1, B = compared parameter column 3)  
PT = Paired T-test 
DF = degrees of freedom 
      
 
= significant (P = 0.05)  134
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38a - Blood profile acute episode day 1 – day 25 of IV antibiotics 
38b - Blood profile of (P8) Day 1-9 of IV antibiotics and follow up visit day 47 
Figure 38 – Blood profiles    135
profile starting at day 5 of the episode and suggests that both the white cell count 
and the neutrophil count remained low throughout the episode and failed to reach 
normal limits even by the time of the second visit. Other patients show individual 
variations from the normal blood cell and serum protein ranges, (P7) and (P12) 
exhibit enduring lymphopenia and (P6) shows a high final value for CRP and was 
found to culture pseudomonas at the second visit. P6 and P12 were both suffering 
from diabetes. 
Although the numbers are small some interesting results have emerged in 
particular the difference in neutrophil counts between patients and controls at the 
second visit. These findings may be important and need to be considered in 
association with the immunology results. The data between acute and recurrent 
groups was analysed using the MWU but no significance was found. 
5.3.3.2   Cytokine results  
Cytokine assays were carried out on duplicate plasma samples from five pairs of 
patients and controls (P1/C1, P2/C2, P5/C5, P6/C6 and P7/C7) according to the 
protocol set out in 4.3.3.3. This was a preliminary experiment to ascertain 
detection levels for the ten cytokines predictive of TH1 and TH2 response (see 
table 3) and to ascertain possible links with the routine blood profiles already 
described. 
Detectable levels of all 10 cytokines were found (see table 18).  
  INF-γ IL-1β  IL-2 IL-4 IL-5 IL-8 IL-10  IL-12  IL-13  TNF-α 
Max  17.40 0.60 3.02 5.69 448.7 3.90  1559.0 4625.0 1213.0 7.09 
Min  0.379 0.03 0.05 0.105 0.03 0.008 0.106 0.082 0.262 0.041 
 
Table  18– Maximum and minimum values of detected cytokines (pg/mL)  
in plasma. Patients and matched controls (n = 5).  
 
The standard curves for all cytokines produced good correlation throughout the 
range. The coefficient of variation (C of V) for pipetting into each well did not 
exceed 16%, and most were below 10%. The mean values of adjacent samples 
were calculated and the results for the five pairs of patients and controls are 
shown in appendix 41. 
Because one patient (P2) produced very high results for some cytokines some 
distributions were abnormal (appendix 42– 46) and WSR tests were used to 
compare data. For normal distributions paired t tests were performed. Statistical   136
analysis was not performed between acute and recurrent cases because the 
numbers were too low. 
No significant differences was found between the data at p = 0.05. However 
results between patients and controls at visit 1 for levels of IL-12 and IL-8 were 
close to significance (P = 0.063) see table 19 and 20 and appendix 47 – 50. This 
would suggest a pro inflammatory pattern consistent with the cellulitic episode.  
 
Table 19 - Significance tests for serum IL-8 results (pg/ml) 
 
N = 5  Min - Max  N = 5  Min - Max  Test  P 
 value 
Patients (1)   1.05  -3.9  Patients (2)  0.43 – 2.19  WSR  0.313 
           
Controls (1)   0.35 – 0.81  Controls (2)   0.31 – 3.27  WSR  0.188 
           
Patients  (1)   1.05  -3.9  Controls (1)  0.35 – 0.81  WSR  0.063 
           
Patients (2)  0.43 – 2.19  Controls (2)  0.31 – 3.27  WSR  0.625 
 
Table  20 - Significance tests for serum IL-12p70 results (pg/ml) 
 
N = 5  Min - Max  N = 5  Min - Max  Test  P 
 value 
Patients (1)   0 - 3511  Patients (2)  0 - 4625  WSR  0.188 
           
Controls (1)   0 – 1.160  Controls (2)   0 – 1.380  WSR  0.625 
           
Patients  (1)   0 - 3511  Controls (1)  0 – 1.160  WSR  0.063 
           
Patients (2)  0 - 4625  Controls (2)  0 – 1.380  WSR  0.125 
 
 
 
 
 
 
P2 shows elevated levels of all ten cytokines at both visits.  IL-10, IL-12 and IL-13 
are exceptionally high and most of the results were higher at the second visit. 
Following antibiotic treatment this patient developed a diffuse skin rash with fluid 
filled vesicles covering his face, trunk, arms, face, head and ears. The medical 
history described an 'id' reaction thought to be secondary to a systemic fungal 
infection possibly caused by scopulariopsis (a dermatomycosis grown from both 
feet in this study). Swabs taken from the ears grew SA. The routine blood profile 
was unremarkable but levels of IgE were high (474iu/Ml at visit 1 and 373iu/mL at 
visit 2), moderate levels of IgE to TR were recorded but no dermatophytes were 
grown. Elevated levels of IgE, IL-4 and IL-5 would support a systemic fungal 
 
N = numbers compared (column 1 and column 3) 
(1)  =  visit 1    (2)  =  visit 2 
 
WSR = Wilcoxon Signed Ranks Test (exact 2 tailed test) 
      
 
= P value close to 0.05   137
infection while the high levels of pro inflammatory cytokines particularly IL-12 
would suggest a superantigen response to SA. The patient was treated with 
systemic antifungals and topical antifungal cream. There was no recurrence within 
six months.  
The MSD ELISA was able to detect high and low levels of all ten cytokines from 
the samples of peripheral plasma tested in this study. Unfortunately the number of 
samples tested was low so no definite comparisons can be made although the 
results for P2 are in accordance with the clinical evidence. Raised levels of IL-12 
and IL-8 in the patient group confirm a proinflammatory response and might reach 
significance if the samples from all twelve pairs were tested. The higher numbers 
of neutrophils recorded in the routine blood results suggest that increased levels of 
IL-8 should be seen particularly at the second visit, this is not evident from the 
existing data but may be because the numbers are low. These results suggest a 
definite role for the TH1/TH2 ELISA and a need to complete the analysis in order to 
better understand the data. 
5.3.3.3 IgE  results 
Serum samples to be tested for levels of IgE were processed by ELISA in batches 
of 16 within the Immunology Department at SGH. Results for the twelve pairs are 
presented in figure 39 and appendix 51. Values were higher in the patient group at 
both visits and the distribution was uneven (appendix 52) therefore WSR was used 
for the statistical analysis and the results are shown in appendix 53. 
No statistical differences were found between the patient and control groups at 
either visit. No statistical differences were found between acute and recurrent 
patient groups. 
Levels of serum IgE vary within the population and the range is wide. The cut off 
for normal value is generally taken as 81 iu/mL but 1 standard deviation only 
includes 60% of normals (Ownby 1998). Furthermore a condition known as hyper 
IgE syndrome exists where individuals consistently display IgE levels in excess of 
1000 iu/mL sometimes with no other apparent abnormality (Desai et al 1996, 
Hochreutener et al 1991). Five patients and four controls produced elevated levels 
of serum IgE (P2, P5, P6, P7 and P11,C4, C5, C6 and C9). Although two patients 
(P2) and (P5) showed concomitant raised levels of IgE to TR others (P6) and (P7) 
did not. Similarly, in the control group raised levels in (C2, C5, C6 and C9) were 
accompanied by elevated levels of IgE to TR in only two (C6 and C9).   138
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Figure 39  
Graph to show IgE levels in peripheral blood. Patients and controls  
(N = 12) visits 1 and 2. 
No statistical differences were found between the patient and control 
groups at either visit 
 
If we consider the various possible allergic responses (immediate, delayed and 
anergy) interpretation of these results as a set may be unhelpful. It may more 
informative to review the cases separately and with reference to the results of 
other individualised tests.  
5.3.4 Stress Investigations 
5.3.4.1 Medical  history 
Details of medical history were obtained verbally from participants and also from 
the medical records and categories for data analysis were selected (see section 
4.2.3.4 and table 6). For each variable scores of 0 (absent) or 1 (present) were 
recorded for each patient and matched control and McNemar’s test was performed 
on the paired binary data sets. Comparison between acute and recurrent cases 
was made using MWU because of the small and unequal numbers in each group.  
In eight categories results were statistically higher in the patient group as 
compared with the control group (see table 21). No statistical differences were 
found in any category between acute and recurrent cases (data not shown).    139
The patient group recorded a much greater number of previous bacterial infections 
(p= 0.008) and recurrent skin rashes, which were not attributed to cellultiis (p = 
0.016) they also recorded a greater prescription of antibiotics throughout their 
medical history aside from those prescribed for cellulitis (p = 0.031). Patients were 
found to have more allergies (food, drugs, contact sensitivities) than the control 
group (p = 0.008) when asthma was not included; asthma alone was not 
significant. Many more patients recorded fissuring on the feet and this was 
significant (p = 0.016); previous history of athletes foot, other fungal infections or 
powdery skin on the foot were however insignificant.  History of surgery, trauma or 
injury to the cellulitic leg as opposed to the control cellulitic leg did not reach 
significance between the groups (p = 0.125) however when history of 
abdominal surgery was added the result was significantly higher in the patient 
group (p = 0.031) and became greater (p = 0.008) when surgery, trauma or injury 
to the contralateral leg was also included. Oedema, defined as persistent leg 
swelling perceived by the patients or as documented in the medical history and 
occurring after the cellulitic episode used in this study, was recorded in nine (75%) 
out of twelve patients but not in controls. The significance for this was p = 0.002. 
Thrombophlebitis, cancer, diabetes or being overweight did not achieve 
significance in this study; previously Cox (2006) and Naguib et al (2004) have 
found associations between cellulitis and both diabetes and cancer, in 
retrospective studies but with much larger numbers.  
5.3.4.2  Results of the stress questionnaire 
All participants completed the stress questionnaire at the first visit. Many also 
reported specific incidents or ongoing stress at that time although this was not 
confined to the patient group. The design of the questionnaire requires that 
responses should be rapid in order to gain the first impression of the participant 
without in depth analysis and therefore capture their perception without reserve. 
The subtlety is achieved by slight differences between the questions and by 
interspersing positive and negative concepts. The suggested time allowance to 
answer the fourteen questions was approximately 5 minutes and participants were 
urged to keep within this limit. Despite this most participants took much longer and 
consequently many expressed problems with in depth interpretation of the 
questions, commenting that many were ambiguous or repetitive.  
The scoring for each line is shown in appendix 1. The minimum obtainable score   140
Table 21 - Significance tests for medical history (Patients and Controls) 
 
Scores of  0 or 1 were recorded for each of the categories for each patient and matched control 
0 = negative response or no evidence in medical history 
1 = positive response or evidence in medical history 
McNemar’s test was performed between patients (N = 12) and controls (N = 12) for each variable. 
 
Variable 
Number and % of 
patients in which 
variable was present 
Number and % of 
controls in which 
variable was 
present 
P 
value 
History of skin or mucosal infections 
assumed to be caused by bacteria  9/12 =  (75%)  1/12 =  (8%)  0.008 
      
Recurrent skin rashes (not cellulitis)  8/12 =  (66%)  0/12 =  (0%)  0.008 
      
Allergies including asthma  11/12 =  (92%)  4/12 =  (33%)  0.008 
      
Presence of fissures on feet  7/12 =  (58%)  0/12 =  (0%)  0.016 
      
Previous abdominal surgery/ injury, 
trauma, surgery to cellulitic leg  9/12 =  (75%)  3/12 =  (25%)  0.031 
      
Previous abdominal surgery/ injury, 
trauma, surgery to cellulitic or 
contralateral leg 
11/12 =  (92%)  3/12 =  (25%)  0.008 
      
Persistent oedema (post study) in 
cellulitic leg  10/12 =  (83%)  0/12 =  (0%)  0.002 
      
Prescription antibiotics ++  7/12 =  (58%)  1/12 =  (8%)  0.031 
      
Previous history of Athletes foot  8/12 =  (66%)  8/12 =  (66%)  1.0 
      
Previous history of any fungal 
infection  9/12 =  (75%)  8/12 =  (66%)  1.0 
       
Powdery skin on the foot sole  5/12 =  (42%)  1/12 =  (8%)  0.125 
       
Dry skin on legs  5/12 =  (42%)  0/12 =  (0%)  0.063 
       
Previous injury /trauma/surgery to 
cellulitic or contralateral leg  7/12 =  (58%)  2/12 =  (16)  0.125 
       
History of thrombophlebitis  3/12 =  (25%)  1/12 =  (8%)  0.500 
       
Asthma  2/12 =  (16%)  2/12 =  (16%)  1.0 
       
Overweight  5/12 =  (42%)  1/12 =  (8%)  0.125 
       
History of cancer  2/12 =  (16%)  2/12 =  (16%)  1.0 
       
Diabetes  2/12 =  (16%)  0/12 =  (0%)  0.5 
 
   = significant (P = 0.05)  = P value close to 0.05  141
was 0 and the maximum 56. The results were discrete data and WSR was used 
for analysis. 
Min – Max values for the patients were 10 - 41 points and for the control group 11 
– 27 points and the raw data is shown in appendix 54.  Figure 40 shows the 
recorded scores relating to the two groups. Patient scores were statistically higher 
than those for controls (p = 0.052) see table 22, but no difference was found 
between the results for acute as opposed to recurrent cases (data not shown). 
Ten patients (83%) recorded higher scores than their matched controls. P11 was 
the only patient to record a lower score (10 points as compared to 23 points from 
the matched control). The oldest pair, aged between 70 and 80 years, were equal 
with the lowest scores (11 points each), apart from this no age related scoring 
patterns were found between the groups. The results are difficult to interpret 
because of the difficulties already mentioned. But these difficulties were 
experienced by most of the participants and the data may therefore be sound. 
Although the concept of stress evaluation by this means fits well with this study the 
choice of questionnaire needs to be reconsidered since the one selected proves to 
have been a lot less 'user friendly' than expected. 
 
Table 22 - Significance test for the stress questionnaire 
 
N = 12  Min - Max  N = 12  Min - Max  Test  P 
value 
Patient scores  10 - 41  Control scores  11 - 27  WSR  0.052 
 
 
 
 
 
 
 
 
5.4 Summary  of  results 
 
It was difficult to recruit patients into this study and the expected numbers (30 
patients divided equally into acute and recurrent cases) was not realised. In the 
event 12 patients (five acute and seven recurrent) completed both visits and were 
successfully matched with controls. Even with few matched pairs a large amount 
of data was generated, thirteen different tests or investigations were carried out 
and ten of these required data collection from both visits.  
 
N = numbers compared (column 1 and column 3) 
 
WSR = Wilcoxon Signed Ranks Test (exact 2 tailed test) 
      
 
= significant (P = 0.05)   142
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Figure 40 
Graph to show results of scoring from the stress questionnaire (N = 12)  
Patient scores were statistically higher than those for controls (p = 0.52) 
see table 22. The oldest matched pair, aged between 70 and 80 years, 
produced the lowest scores (11 points each), apart from this no age 
related scoring patterns were found between the groups.  
 
 
The results presented in this section have been subdivided into four sections, 
investigation for microorganisms (particularly dermatophytes), skin structure/ 
physiological tests, immunological outcomes and stress factors. A summary of 
these results is presented in table 23 and their implications will be discussed in the 
next chapter. 
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Table 23 – Summary of results 
 
Risk factor 
test/investigation  Results 
Dermatophytosis 
Tests :Specimen 
collection, culture and 
microscopy Serum 
immunoglobulin to 
Trichophyton Rubrum  
The frequency of dermatophytosis and superficial 
dermatomycoses was lower in the patient group than the 
control group. No significance was found between the 
matched groups for any of the cultured organisms. Overall 
the study population produced more cultures from the foot 
sole than the ID spaces. Presence of IgE specific to TR 
was demonstrated in all subjects who cultured TR and 
also in 2 patients who did not thus providing proof of 
previous exposure. 
Changes in skin water 
loss 
Test: Measurement of 
Transepidermal water 
loss (TEWL) 
 Both patients and controls produced some TEWL 
readings that were lower than the expected normal. No 
significant differences were demonstrated between 
patients and controls at visit 1 but TEWL was found to be 
significantly higher in the cellulitic legs as compared to 
contralateral legs and control legs at visit 2.  
Changes in pH balance 
at the skin surface 
Test: Measurement of  
skin pH 
A statistically significant difference was found between 
contralateral legs and contralateral control legs at visit 1, 
likely due to the unusual distribution of values from the 
contralateral legs and the low sample size. No other 
statistically significant differences were demonstrated 
between groups at either visit. 
Oedema 
Tests: Leg 
circumference 
measurements + 
Ultrasound tissue 
measurements 
Circumference measurements taken at the ankle and mid 
calf were significantly higher in patients as compared to 
controls on both occasions. Dermal measurements were 
significantly greater in the cellulitic legs as compared to 
the cellulitic control legs at visit 1. Comparison of the 
cellulitic legs between visits, and the cellulitic legs and 
contralateral legs at both visits almost reached 
significance but numbers tested were low. 
Image analysis supports the presence of dermal oedema 
in cellulitic legs and suggests a ‘unique’ fluid retention 
pattern in those with chronic oedema. 
Changes in skin blood 
flow 
Test: Measurement of 
skin blood flow Laser 
Doppler Imager (LDI) 
 
Mean flux values from the cellulitic legs were significantly 
higher at visit 1 than at visit 2 and also significantly higher 
than controls or contralateral legs at the first visit. Values 
returned to within normal ranges for all except two patients 
at visit 2. These patients produced lower than average 
scores on both occasions consistent with their enduring 
oedema. 
Venous incompetence 
Test: 
Photoplethysmography 
Laser Doppler 
flowmeter (LDF) 
Venous incompetence was found to be statistically higher 
in the cellulitic legs as compared to the control cellulitic 
legs or the contralateral legs. In four patients (66%) 
incompetence was coincident with increases in leg 
circumference suggesting the link with oedema and 
altered skin physiology.  
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Table 23 continued 
 
Risk factor 
test/investigation  Results 
Abnormal 
haematological 
response to 
inflammation/infection 
Test: Blood profiles 
Levels of CRP and WBC for patients were statistically 
higher at visit 1 than at visit 2 and also statistically higher 
than controls between visits. WBC was also statistically 
higher between patients and controls at visit 1. 
Lymphocyte and neutrophil levels were significant 
between visits in the patient group. These results reflect 
the expected immune response to inflammation. 
Unexpectedly, neutrophil counts for patients were found to 
be significantly higher than controls at the second visit.  
Exaggerated immune 
response 
Test: Serum cytokine 
profiles 
 
 
Allergic response 
Test: Serum (IgE) 
5 paired samples were tested for cytokine data and 
detectable levels of all10 cytokines were obtained. No 
significant differences were found between the data 
however results between patients and controls for levels of 
IL-12 and IL-8 at visit 1 were close to significance 
suggesting a pro inflammatory pattern consistent with the 
cellulitic episode.  
 
Values of serum IgE were higher in the patient group at 
both visits but no statistical differences were found 
between the patient and control groups at either visit.  
 
Results from one patient showed > levels of IgE, IlL4 and 
IL-5 and > levels of pro inflammatory cytokines particularly 
IL-12. 
 
Previous episode 
Co-morbidity 
Previous surgery etc 
Investigation: Patient 
history 
The patient group recorded higher frequencies of the 
following as compared to controls 
•  previous bacterial infections and recurrent skin 
rashes 
•  prescription of antibiotics throughout their medical 
history 
•  allergies (food, drugs, contact sensitivities) 
•  fissuring on the feet (significant) 
•  history of surgery/trauma or injury to the cellulitic 
leg/abdominal surgery (significant) 
• oedema  (significant) 
 
Psychological stress 
Investigation: Stress 
questionnaire 
The total scores for the patient group were statistically 
higher than for the control group. 
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6 DISCUSSION 
 
There are two major problems affecting the management of patients with cellulitis. 
The first is the lack of proof concerning the nature of the infective organisms and 
the second is an uncertainty that exists in many cases relating to the mechanism 
by which the assumed causal pathogens access the skin.  There is no doubt that 
new evidence concerning either of these would consolidate the treatment and 
advance the future management. In recent years several studies have attempted 
to address the former but the enigma surrounding the inability to culture the causal 
pathogens remains. The latter problem has received more attention and has 
mainly been directed towards the investigation of predisposing factors assuming 
that cellulitic skin is either more vulnerable to pathogens or that portals of entry 
must be created in order to provide assess to the skin. The proposed effector 
mechanisms include dermatophytosis, portals of entry on the feet, venous 
incompetence and its sequelae cutaneous oedema as well as other universally 
accepted risk factors such as obesity and diabetes (Cox 2006, Björnsdóttir et al 
2005,  Ryan 2005, Roujeau 2004, Clark et al 2003, Dupuy et al 1999, Harrison et 
al 1993). Although these causal factors are constantly put forward none of them 
seems to have been investigated in detail, for instance oedema has been defined 
only as persistent leg swelling and dermatophytosis has often been assumed by 
findings of toe web intertrigo but without reference to culture or microscopy. 
Moreover they are all ubiquitous which raises the need to establish their true 
relationship with episodes of cellulitis.  
Under normal conditions commensal flora and pathogens breeching the skin 
remain confined to the affected area and are dealt with by localised immune skin 
residents. Visual evidence, such as pain and swelling, together with 
haematological markers, indicate that the expected infective/inflammatory 
response is in progress  and after an accepted time course the event subsides 
without recourse to intervention. Cellulitic events appear to differ in some aspects 
and previous studies highlight the following unexplained deviations:  
•  Swabs/aspiration from the infected site rarely produce positive cultures 
(Karakas et al 2002, Sachs 1991)   147
•  Although extensive areas of skin are involved the number of organisms 
obtained from positive cultures is often very low (Shelley 1995) 
•  A portal of entry is not always identified (Choo 2004, Bernard et al 1989) 
•  Although blood markers provide proof of systemic inflammation the skin 
infection is usually confined to one anatomical site (Stryjewski et al 2007) 
•  Recurrences predominantly occur at the same site (Badour and Bisno 
1984) 
•  Some episodes require many courses of antibiotic therapy to achieve 
resolution (Stulberg 2002) 
•  The time lapse between recurrent episodes is variable; can be days, 
weeks, months or years (Karakas et al 2002, Badour and Bisno 1984) 
Observations that the paucity of cultured organisms bears no relationship to the 
extent of skin involvement, that few patients have identifiable portals of entry and 
that recurrence often occurs at the previous site with unpredictable time lapses 
between events, have become the subject of much speculation and lack of 
conclusive proof for the accepted risk factors permit conjecture for alternative 
mechanisms. Implications for a prime role for immune involvement is appealing; 
concomitant with this is the inference that skin physiological defects such as 
oedema may be an effect rather than a cause. Despite this, no previous studies 
have investigated the relationship between cellulitis and the immune response, 
and this is surprising when associations between immunology and other clinical 
areas such as fungal disease and stress related skin conditions have been 
investigated in some detail and continue to provoke interest. However before any 
relationships can be established it is important to precisely define the features of 
individual factors in order to make meaningful advances upon the existing 
knowledge.  
The risk factors fall into three main categories; stress factors (including 
microorganisms), skin physiology and immune responses (see figure 4). 
This pilot study was designed to re-examine more precisely the accepted risk 
factors, contribute additional information regarding immunological outcomes and 
assess the possible relationships between these factors. The ultimate aim was to 
pursue areas worthy of further investigation in a subsequent larger scale study. As   148
part of this it was also necessary to evaluate the suitability, reliability and feasibility 
of the chosen investigations within an ambulatory care setting.  
Aside from issues of debilitation, this work is clinically important because the rate 
of recurrence amongst cellulitis patients is high and the extensive prescription of 
antibiotic treatment appears to be the only available mainstay. It is now well known 
that the continuous usage of antibiotic treatment impairs the effectiveness of future 
courses (Del Mar 2007, Goossens 2005) and may also contribute to the current 
high rate of nosocomial infections; moreover patients are now well informed and 
most would prefer to choose alternative treatments which carry less long term risk, 
if these are effective. If such treatments could be found the benefit to both patients 
and NHS resource would be great.  
6.1 The  study 
A case controlled study was selected and an ambulatory care setting chosen in 
order to access a study population providing a relatively straightforward 
comparison between patients with cellulitis and matched controls by creating 
groups with minimal other medical complications. Previous prospective case 
controlled studies have involved hospitalised patients with controls matched for 
age and sex selected from the in patient population undergoing treatment for 
various acute conditions. Southampton General Hospital provides the facility for 
ambulatory care available to those who are fit enough to travel and have the 
necessary home support. These patients tend to have less comorbidity and when 
matched with healthy control subjects provide a more straightforward comparison 
than patients hospitalised for other illnesses. In this study mobility along with age 
and sex was included in the matching because physical activity was considered 
important in relation to venous incompetence and oedema, and also because 
mobile patients and healthy controls were more likely to encounter a mixture of 
indoor and outdoor environmental conditions than those whose movements were 
restricted by disability.  
It was important that the initial patient visit be repeated at a future date in order to 
compare results and establish a patient baseline for comparison with controls. The 
nature of cellulitic disease suggests that some normal physiological or 
immunological factors may be absent or impaired and that this predisposes certain 
individuals to attacks. Whether this would be a prerequisite or a consequence is 
one of the questions yet to be answered, unfortunately in such cases previous   149
baseline information is unavailable so subsequent or serial investigation is the only 
choice. 
One aim of the pilot study was to assess the logistics of recruiting patients from an 
acute ambulatory unit and concurrently conduct a study in a research facility in a 
separate part of the hospital; as anticipated it proved to be quite difficult to 
coordinate patient treatment and study requirements. Patients recruited to the 
Ambulatory Care Unit (ACU) are mobile and attend from home each day. 
Preliminary assessment and haematological results are required to inform the 
intravenous antibiotic treatment, which may take 2-3 hours. The clinic can be very 
busy as new referrals are accepted on the day and fitted in amongst previous 
bookings. Because of limited bed/cubicle space and fixed levels of staffing waiting 
times are often long and the study protocol added an extra 1–1½  hours to time 
spent at the hospital; many patients were experiencing fever and pain and felt 
unable to cope with the protocol or with the extra time required. Many were willing 
but could not guarantee a second visit often because of family commitments or 
because self employment meant loss of earnings for a subsequent visit. Some 
who consented were lost because it was not possible to use the Wellcome 
Research Facility at weekends or on bank holidays, this meant that patients on 
short courses of IV therapy (3 days) who were recruited on Fridays and consented 
at the weekend, were discharged with oral therapy before a preliminary visit could 
be undertaken. 
From the investigators point of view coordination between the units was 
problematic. The research facility is situated some distance from the treatment unit 
and requires to be prebooked, in addition the time needed to set up and test the 
equipment is around 45 mins. On many occasions rooms were booked and 
equipment set up in anticipation of patients who subsequently failed to arrive. 
Return visits and appointments for controls were however easier to organise as 
these could be prebooked well in advance with some flexibility to fit in with the 
requirements of the participants and research unit alike. 
It was therefore difficult to recruit patients into this study and the numbers who 
succeeded in completing both visits were low, producing only twelve pairs by the 
end of the time period set aside for recruitment. These numbers would have been 
larger but data obtained from a single visit was not included in the analysis, neither 
were single visits matched with controls because interpretation of results was very   150
dependant on comparisons obtained between visits one and two. For instance 
TEWL values recorded from cellulitic legs would be expected to decrease 
significantly between visits because of decreased blood flow and heat dissipation, 
they would also be expected to be significantly higher than controls at visit one for 
the same reason. Because they should essentially be normal at visit two no 
differences should be seen with comparison between any group at that time. A 
finding of significant differences between patients and controls would therefore be 
more important in relation the second visit.  
The value of the physiological and immunological evidence depends on the 
establishment of baseline reference points for which it is important to have at least 
two measurements, this is required to aid in deciding whether a result is normal 
and also detect changes in the measurement system. This would apply to all 
physiological and immunological tests conducted in this study, where comparison 
between results from two points is minimal although serial recordings taken over 
time would be more advantageous. 
Although only twelve matched pairs completed both visits there were many 
comparisons and a large amount of data was generated. It was hoped to recruit 
equal numbers of acute and recurrent cases but this was not the case and when 
recruitment ended only five acute and seven recurrent cases had taken part. No 
statistical differences were demonstrated between these groups possibly as a 
result of the small numbers. Most acute patients felt too ill to cope with study 
protocol in addition to treatment although many expressed interest. In contrast 
recurrent cases were much more willing to take part although many had to be 
refused because they did not meet the inclusion criteria often because of 
comorbidities such as rheumatoid arthritis or because both legs were affected. 
However a large proportion of patients expressed a willingness to assist with the 
study offering commitment to tests such as venesection that could be conducted 
within the ACU while treatment was ongoing. In order to recruit sufficient numbers 
into a subsequent study it would be necessary to consider tailoring the protocol to 
more closely fit this patient requirement. It is accepted that this study covered 
many aspects and included many tests all of which have added to the knowledge 
base, but there is no evidence to support the logistics of proceeding with the 
project in its present form. A more targeted approach will be adopted to explore   151
specific areas identified as important in this study. In the event some tests will be 
excluded and the reasons for this will be discussed in context. 
6.2 Dermatophytosis 
Dermatophytes were only cultured from one patient (8%) in this study as 
compared with six (50%) from the control group. It is possible that the culture 
method was inadequate but when present, dermatophytes grew strongly and were 
very evident within several days. The collection method was vigorous and large 
quantities of skin scales were collected as demonstrated by microscopy and it 
seems unlikely that dermatophytes growing in the upper layers of the SC were 
missed on both occasions. However the study population consisted of more men 
than women and the group of matched controls happened to contain a high 
proportion of ex servicemen, a group known to produce an increased frequency of 
athlete’s foot. These findings demonstrate differences from the studies presented 
in the literature. Dermatophytosis was found to be a strong risk factor in studies 
conducted by Dupuy et al (1999) but only assumed by the presence of toe web 
intertrigo. Roujeau et al (2004) in a study of 243 patients and 267 controls used 
culture and microscopy to demonstrate dermatophytes in 42% of patients as 
compared with 24% of controls. Björnsdóttir et al (2005) in a similar but smaller 
study (100 patients and 200 controls) cultured both fungi and bacteria from the toe 
webs but concluded that the presence of dermatophytes only became significant 
when bacteria were excluded from the analysis. From the study by Dupuy the 
frequency of dermatophytosis cannot be calculated and from the remaining studies 
differences exist because of the tests performed and the analytical techniques 
used. In all these studies the controls were recruited from amongst a hospitalised 
patient population, the only information given is that their medical conditions were 
acute. No details of medication are supplied so it is impossible to know if these 
conditions could somehow affect the numbers of dermatophytes confirmed by 
culture. Day (1996) has shown that the presence of bacteria on the skin can in 
some cases drive fungi deeper into the skin where they may be inaccessible to the 
methods used to obtain culture samples and this could have happened in the 
previous studies. It is an unlikely cause in this study because the condition is 
accompanied by maceration and malodour and neither this or toe web intertrigo 
was identified on either patients or controls.    152
There is a commonly held misconception that dermatophytes gain access to the 
feet via the toe web skin. However this is not the case, as the initial infestation 
invariably affects the footsole, possibly as a result of the lack of sweat glands on 
the medial plantar aspect (Miller 1959) thought to encourage a more alkaline 
environment. Invariably spread extends to toe web skin where ideal conditions of 
humidity assist proliferation. Cracks and fissures assist bacteria and fungi alike but 
both result from thickened skin, which ceases to be supple so although the 
mechanical implications are obvious the immune response may also be affected. If 
skin is thick it is more difficult for toxic agents to penetrate below the surface and 
consequently they may evade detection by the immune system, which requires to 
remain primed in order to provide the best defence. Hard skin was found on the 
heels of most patients and on some controls and the presence of fissures on heels 
and foot soles were found to be significantly higher in patients than in controls. 
Thickened skin may therefore be more the important finding than lack of fungi on 
the feet and it may be that overall better foot care would be a suitable method of 
prevention.  
The presence of cultured Trichophyton Rubrum (TR) was confirmed by serum 
levels of IgE to Trichophyton Rubrum (TR) in all cases where TR was grown and 
additionally in two patients where it was not. The latter finding is proof of exposure 
to TR at some time in the past since this particular fungus was not cultured during 
the study. One of these negative results was patient (P2) with elevated cytokine 
results and the other (P5) who grew the superficial dermatomycosis Tinea Nigra, 
from the sole of his cellulitic foot on both occasions in great quantity. Increased 
levels of IgE to TR suggest an immunological mechanism for its control but 
previous studies have shown that individuals are in some cases able to produce 
varying immunological responses to the same fungal species after infection on 
subsequent occasions (Woodfolk 1998, Svejgaard 1985) and that such diverse 
responses could have implications for the immunological control of other infective 
organisms (Woodfolk 1998, Svejgaard 1985, Walters (1974). Therefore although  
dermatophytes per se may not be responsible for cellulitic events their infestation 
whether past or present may contribute to immune disruption such as decreased 
lymphocyte trafficking, lymphoproliferation and differentiation Maleszka (2001). 
Aside from this the results obtained from this study indicate that IgE detection is a 
reliable method of confirming exposure to fungal disease although as a stand   153
alone it would be unable to discriminate between past or present infective 
episodes. In order to produce a comprehensive assessment, IgE status would 
need to be determined for all of the various dermatophyte strains. 
Some participants grew a large number of different types of microorganism from a 
single sample. It was interesting to note that penicillium was frequently included 
and in several cases colonies grew up beside dermatophytes. In this association 
there appeared to be a mutual inhibition of the growth patterns so that when the 
organisms touched both colonies ceased to expand (figure 17). Penicillium is a 
ubiquitous organism and this finding demonstrates that natural flora have a limiting 
effect upon other microorganisms including dermatophytes. The ongoing 
prescription of antibiotic therapy has the potential to negate this relationship and 
this may be important for the study where a significantly higher lifetime use of 
antibiotic therapy was shown in the patient group.  
6.3 Prophylaxis 
Healthy skin is colonised by an indigenous population of commensal bacteria who 
assist in control over transient pathological species by numerical dominance, 
secretion of bacteriocins and maintaining the immune system in a constantly 
primed state (Holland 1993, Scheffel 1979). Concomitant with this 
the intercellular epidermal matrix contains natural antimicrobial peptides known as 
cathelidicins and β-defensins which have been shown to confer a degree of 
natural prophylaxis against bacteria and fungi (Nizet 2007, Nizet et al 2001, 
Ricketts at al 1951) and an additional antibiotic peptide has also been identified in 
sweat (Schittek at al 2001). These combined effects help to decrease the risk of 
infection and maintain the immune system in a constantly primed state (Holland 
1993, Scheffel 1979). 
Preliminary results from the PATCH study (Dermatology Clinical Trials Network 
ONLINE) suggest that the prophylactic use of antibiotics reduces the number of 
recurrent cellulitic attacks but at a cost. Sprunt (1971) showed that high doses of 
antibiotic upset the balance of the natural flora present upon surface skin, 
facilitating the opportunistic overgrowth of pathogenic forms, and thereby offering 
the potential for dominance in one species such as SA which has a propensity for 
superantigen activity. Three patients in this study P2, P7 and P12 failed to produce 
any cultured organisms from either foot or at either visit; interestingly these 
participants also recorded a high lifetime exposure to prescription antibiotics.   154
However this study did not set out to culture bacteria and those that grew are only 
the small sample who managed to survive antibacterial agents present in the 
culture medium which was primarily developed for fungal identification. A useful 
addition to a future study would therefore be to produce cultures from foot 
scrapings for both bacteria and fungi. The protocol would only need slight 
adaptation and the data, particularly in respect of commensal bacterial forms and 
superantigen activity, would greatly advance the understanding. 
The PATCH study has problems with recruitment. As patients become aware of 
the consequences of prolonged antibiotic usage most decide in favour of 
alternative treatments and try to implement their own selfcare. Many podiatrists 
assume the presence of athlete’s foot and prescribe antifungal treatment without 
culture. Many patients assume the same and treat themselves with over the 
counter medication and this management has been reported to reduce the number 
of recurrences. There was one such patient in this study whose data was not 
paired because of difficulties with venesection at either visit. This patient had 
suffered several recurrent attacks and was displaying classic signs of chronic 
oedema. Trichophyton Interdigitale was cultured from the foot sole of the cellultic 
foot on both occasions; the patient was informed and the GP made aware. 
Consequently antifungal treatment was applied and the patient had remained 
episode free at last contact (twelve months after the second visit). This patient, like 
many others, expressed concern that no identifiable portal of entry could be 
identified in the area of the calf recurrently affected. In such cases health care 
workers naturally turn their attention to the feet but patients do not always reason 
in this way and it is often found that the feet have previously been ignored. 
Attention to such issues as hard skin and toe web intertrigo are provided in 
dedicated foot clinics available to those who suffer from diabetes where 
neuropathy and vascular perfusion issues make them high risk for foot disease 
and ulceration. Podiatrist care also offers such intervention but unless this is free 
few assess the benefit as worthy of the cost. Two diabetic patients took part in the 
study one (P12) previously mentioned, was receiving foot care and cultured 
nothing from the feet on either occasion. The other was not attending a foot clinic 
and cultured virulent pseudomonas from both feet which persisted at the second 
visit. This patient was prescribed two additional courses of antibiotic therapy by the 
GP because the skin condition continued to exhibit signs of cellulitis. At visit two   155
CPR levels were above normal at 14 and the neutrophil count remained high; 
following this the GP was contacted. It may be that the IV and oral antibiosis 
administered throughout this episode was inappropriate to deal with this infection 
or that immune dysfunction allowed it to rekindle when the systemic effects were 
withdrawn, in either case knowledge of the offending organism would have 
informed the intervention and influenced the further management.   
There is no doubt that application of topical antifungal emollients appear to be of 
benefit to those who suffer from fungal foot disease but podiatrist opinion suggests 
that the benefits may be negated by continuous usage and current advice 
suggests intermittent breaks of several weeks between courses. The logic is that 
small amounts of fungi are necessary to keep the immune system primed. An 
alternative method of control may be to inhibit fungal growth by using a natural 
biological preparation the rationale for this has been derived from the literature and 
the methodology is being considered.  
With regard to prophylaxis, it may be the awareness of feet and shoes, rather than 
medication, that serves to enhance foot hygiene and implement an element of 
control in cases of recurrent cellulitis. The mechanism concerning fungal foot 
disease and its association with cellulitis is still not understood but the prevention 
may be simpler. Foot care is cheaper than antibiotics and advice costs even less. 
6.4 Skin  physiology 
Physiological skin testing produced some interesting results and showed 
significance in some areas. Because of the observed erythema and concomitant 
radiated heat it was expected that skin blood flow would be increased during the 
episode and that values of evaporative water loss would be high and these 
expectations were confirmed. All cases recorded a decline in resting 
microcirculatory blood flow by the second visit, which was normal by comparison 
with results from control subjects.  It would appear that an adequate mechanism 
for the delivery of the immune response was demonstrated. Two patients P4 and 
P5 had gross oedema. Despite this P5   produced the expected responses at both 
visits. P4 displayed much lower perfusion levels overall and the response at the 
second visit was well below normal. This patient had oedema in both legs and was 
much older, the contralateral foot was dropped and the range of movement limited. 
The reason for the low results can only be speculated but the persistent low 
perfusion in this case is a likely sequel to oedema.    156
The microcirculatory blood measurements have produced the expected results 
and no additional information has been obtained therefore it would be 
unnecessary to include this test in any future study.  
In his original thesis concerning evaporative water loss through the epidermis 
Nilsson (1971) showed a correlation between water loss and temperature. These 
findings were confirmed by this study but although the cellulitic skin produced 
higher values than contralateral legs or controls at visit one the results did not 
achieve the expected significance. However at visit two patient data for cellulitic 
legs produced a significantly higher value for TEWL when comparison was made 
to contralateral and control legs. This latter finding in P1, P2, P8 and P10, 
although within the normal range, might indicate altered physiology. P3 however, 
produced a considerable increase from 7.9 – 20 g/hr/cm
2 and this is interesting as 
this patient was clinically the least representative of cellulitis with respect to skin 
characteristics. In addition some readings that were well below the accepted 
normal were obtained in both patient and control groups and it may be that the 
lower end of normal needs to be revised. However the performance of the 
Tewameter was a cause for concern throughout the study as it was consistently 
difficult to obtain valid calibrations thus undermining the confidence that should be 
commanded by a reliable scientific test. The data obtained with respect to TEWL 
are unremarkable with respect to cellulitis although they may have relevance to 
oedema. For this reason and on the grounds of reliability it has been decided to 
exclude TEWL measurements from any further investigations. 
Variations in skin pH values have been shown to have relevance for the balance of 
the microflora at the skin surface (McBride 1993) and elevated pH readings within 
the acidic range were expected in relation to fungal/bacterial cultures within the 
study population. The data obtained showed that pH readings for the lower leg 
reached levels of 6.5 and above in some patients and also some controls but there 
were no significant differences between the patient and control groups and no 
association was found within groups between pH values and numbers of cultured 
organisms. However pH values are difficult to interpret because even transient 
changes have dramatic effects on the results. Soaps, creams and emollients 
applied to the skin may have long lasting effects, however if such creams are 
constantly applied the readings obtained reflect the ongoing value for the 
individual and must be noted and this information may be a useful addition to the   157
patient history. Although pH values on calf skin do not appear to be increased, 
values recorded from the plantar aspect of the foot may be more important (see 
dermatophyte section) and these would be included as part of future studies.   
6.5 Oedema 
No significant differences were found for circumferential measurements of the 
cellulitic legs between visits. Significant differences were shown between cellulitic 
and contralateral legs at visit one but differences were less at visit two and 
significance was not found. Persistent swelling remains a feature in those who 
have suffered from cellulitis and this is confirmed by patients who report that legs 
never return to ‘normal size’. The expected difference between legs at the return 
visit was not found and this is probably due to increased dependency after return 
to normal daily life.  
The epidermal thickness did not appear to change between episodes although 
seven out of the twelve patients reported skin peeling following the cessation of 
antibiotic treatment and imaging appearances indicated that the skin was 
stretched. Peeling is considered to be part of the innate (inherited) mechanism for 
clearing pathogens including fungal organisms from the epidermis (Milstone 2004) 
and is an expected feature of infections such as scalded skin syndrome.  Badour 
and Bisno (1984) comment on this in some cases of patients recovering from 
episodes of cellulitis and the mechanism may have implications for closure of the 
episode and/or future immunity. This finding deserves attention in a future study 
where the timing and nature of the event would need more careful investigation. 
In the inflammatory state fluid content between skin layers is greatly increased due 
to an influx of water and plasma proteins, which exit the small blood vessels and 
pool in the extravascular space. In this study dermal thickness measurements 
were significantly greater in the cellulitic legs as compared to the cellulitic control 
legs at the first visit and the findings nearly reached significance at visit two. High 
levels of venous incompetence were also found in the patient group and the links 
between this and dependant leg swelling are well known (Ryan 2005). Ultrasound 
dermal thickness measurements confirm the theory that leg swelling is the 
consequence of increased depth of tissue in the dermis but characterisation of this 
tissue is important. Figure 30a shows that acute oedema manifests as fluid 
collection in the papillary dermis just beneath the SC. Post episode the 
appearances (30b) suggest that this case has almost completely resolved leaving   158
small and reduced pockets of fluid interspersed throughout this layer which would 
be consistent with the normal daily rise and fall in fluid levels resulting from 
circadian processes (Gniedieka 1994). Despite this, the patient who provided this 
image, reported swelling in excess of normal in this leg with subsequent increases 
after each three cellulitic attacks. This patient was middle aged, without 
comorbidities, and reasonably fit but there were no apparent structural changes in 
the dermis although incompetence was demonstrated in this leg. In contrast, P5 
with gross oedema, demonstrated no incompetence but displayed a dermal image 
almost completely devoid of structure (figure 31). Although the latter patient was 
younger he had experienced many more attacks and the originating factor was 
almost certainly an injury sustained during a sporting event with subsequent 
oedema originating as a consequence of trauma. Previous injury upon the 
ipsilateral side was found be significantly higher in the patient population and 
appears to be the most likely initiating event, whether by tissue damage or residual 
infection retained at the site of insult. Cox (2006) maintains that oedema is a 
predisposing factor for cellulitis; this new evidence suggests that it is not an initial 
cause but a deleterious sequel of the initiating event, which deteriorates with time. 
Oedema may provide consequences that facilitate future episodes and create a 
self perpetuating series of events. Consistent oedema may have a role in 
persistent low level inflammation, the trapping of left over antigen within the tissue 
or masking the presence of infective organisms from immune system surveillance 
and the wide variation in time scales between attacks may be associated with the 
time taken for the oedema to manifest. It is known that with age oedema impedes 
the circulation and promotes the risk of ulceration and that such oedema displays 
fluid pockets interspersed with islands of tissue. The chronic oedema that has 
been demonstrated in this study appears to have a different form and it may be 
possible to characterise it more precisely than with the quantification of low 
echogenic pixels chosen for the image analysis in this study; the application of 
mathematical transforms may provide this information. 
 The ultrasound imaging techniques developed in this study have been shown to 
be feasible, valid and reliable but time and precision are required to obtain images 
of suitable quality. In this study imaging was the final test because application of 
contact jel was expected to affect results of the other physiological tests, it was 
difficult to obtain the perfect views required for confident analysis because patients   159
were beginning to tire; consequently the number of good quality images was small. 
Because of these limitations it seems appropriate that further studies should 
address oedema as a separate issue. 
6.6  Immunology and stress factors 
Patient history revealed significantly higher values for allergy including asthma, 
recurrent skin rashes and bacterial infections excluding cellulitis. This finding may 
be suggestive of immune problems and the finding of significantly higher 
neutrophil counts and elevated levels of IL-8 (chemotactic agent for neutrophils) in 
the patient group at visit one supports this theory although the numbers for the 
latter test are too small to make positive conclusions. 
The construction of blood profiles (figure 38) was useful to plot the course of the 
various cell types during the episode and highlight individual differences between 
patients. In addition it has revealed a limitation for this study. When cellulitis is 
uncontrolled a maintained increase in CRP is observed (figure 38a), while falling 
levels signal that response is underway. Because patients were recruited at 
varying stages of the cellulitic episode/antibiotic treatment, levels of CRP were in 
some cases already falling and this affects the understanding of the cytokine 
analysis. In order to effect meaningful comparisons only patients displaying the 
initial high levels of CRP as well as subsequent results should be included so that 
levels of cytokines can be matched at the appropriate stages. 
The cytokine analysis as a whole appears promising; detection levels were good 
and in accordance with those expected from the patient with the systemic fungal 
infection. The markers which support this diagnosis (IL-4 and IL-5) were elevated 
with respect to the other samples and although normal values of these cytokines 
are unknown there is some confidence that others displaying an IH reaction could 
be identified. In this case IgE was only of benefit to corroborate the evidence 
because levels in serum can be very high without any particular inference.  
Evaluation of psychological stress using the stress questionnaire was the most 
problematic because of the difficulties with interpretation experienced by many 
participants. Patients reported higher levels of stress and the results just reached 
significance. This area of research is particularly important and many studies are 
investigating relationships between psychological stress, immune function and 
skin disease. The effects of stress hormones, cortisol in particular, are just 
beginning to be understood (Nakano 2004, Dhabhar 2003, Nakano 2002,   160
O’Sullivan 1998). The results obtained from this study suggest a possible 
association between psychological stress and cellulitis but the subject is too 
complex for assessment by questionnaire alone. This area requires the attention 
of an independent study combining qualitative methods with quantitative 
investigation through immunological pathways. Scientists at Southampton General 
Hospital have developed such quantitative methods, which are currently being 
used to examine brain function with respect to skin challenges, but presently only 
in animal models. A future objective will be to devise a methodology for use in 
collaboration at a later date. 
6.7 Limitations/benefits 
Lack of recruitment proved to be a major limitation in this study; even so the study 
aims have been met except in the comparison between acute and recurrent 
patients and in the cytokine analysis. The paucity of acute/recurrent data does not 
allow meaningful comparisons between the groups and no clear indications have 
emerged; this aim will therefore need to be carried forward into all aspects of the 
future work. The cytokine analysis was hampered by lack of funds, it is an 
important component of the study and requires to be completed in advance of 
further studies. However a limitation has been identified (see previous section) and 
this must be considered in the interpretation of results.  
The following addition limitations have also been identified: 
•  The TEWL equipment was found to be unreliable with respect to calibration, 
this is a crucial aspect of the validation procedure and the results obtained 
have been reviewed with caution.  
•  The Dermascan protocol was exacting and arduous and imaging had to be 
abandoned in some cases, however recruitment into a standalone study 
should permit the time and attention required to obtain the information 
needed for additional analysis. 
•  The stress questionnaire proved less user friendly than anticipated 
although results suggest that this aspect of the study may have important 
consequences for cellulitic events. A purpose designed version will be 
devised for use in future investigations. 
The large amount of data generated by this study has been reviewed in great 
detail and this may not have been the case if the expected recruitment numbers   161
had been realised. Aspects such as blood profiling and updates of patient history 
could not have been pursued in such depth. As a consequence additional 
information has been acquired which will assist in the planning of subsequent 
work. 
6.8 Summary 
The major difficulty was recruitment and this impacted on all parts of the study 
particularly the comparison between acute and recurrent cases. At the end of the 
study only twelve matched pairs of patients and controls had completed both 
visits. Sufficient numbers of patients fulfilling the entry criteria were identified but 
some patients refused because they were unwell, short of time or unwilling to 
attend for tests in the research facility situated some distance from the treatment 
clinic. Despite this the study aims have been met except in the comparison 
between acute and recurrent patients and in the cytokine analysis. Some logistical 
and technical difficulties were discovered and will be addressed. 
From the tests conducted the major findings were: 
•  Fewer dermatophytes were grown from the feet of patients as compared 
with matched controls and this finding was also consistent for opportunistic 
dermatomycoses, bacteria and yeasts. Where TR was cultured the findings 
were confirmed by specific IgE to TR in all cases.  
•  Physiological tests for microcirculatory blood flow, transepidermal water 
loss and pH produced results expected from cellulitic skin.  
•  Differences in epidermal thickness did not reach significance between 
patients and controls but dermal thickness, venous incompetence and 
observed leg swelling were all found to be greater in the patient group and 
this is consistent with enduring oedema. Ultrasound images of the 
oedematous legs revealed dermal patterns whose appearance differs from 
the presentation of classic oedema.  
•  Ipsilateral injuries, allergies, history of other bacterial infections and 
excessive life prescription of antibiotics were found to be significant in the 
patient group as compared to matched controls. 
•  The cytokines tested were detected throughout a wide range. Levels of IL-
12 and IL-8 almost reached significance in the patient group but the   162
numbers compared were low. Blood profiling showed evidence of increased 
neutrophil count post episode in the patient group.  
•  The stress questionnaire produced problems with interpretation. Despite 
this scores were significantly higher in the patient group.  
6.9 Conclusion 
In this preliminary investigation into the risk factors associated with cellulitis of the 
lower limb a large number and diversity of tests were required in order to evaluate 
the existing knowledge base. It was hoped to contribute clear indications for more 
focussed studies and, although numbers were small, this has been achieved. 
Fungi, bacteria, immunology, patient history and foot care together with oedema 
assessment and stress investigations have been identified as areas worthy of 
further investigation and powered studies are now required to increase our 
understanding of this debilitating condition. 
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7 FUTURE  WORK 
The pilot study has generated large quantities of data, which would be difficult to 
manage in a larger study. For this reason and also because of the difficulties 
experienced with recruitment it has been decided to divide the future work into the 
following three focus areas: 
Fungi/bacteria/immunology/history and foot care 
These studies will be conducted within the ACU in conjunction with treatment 
protocol and this approach is expected to increase recruitment rates. Tests will 
include fungal/bacterial cultures, blood profiles and cytokine analysis, investigation 
into the frequency and timing of episodes of skin peeling, pH of the feet, patient 
history and foot care issues.  
Oedema assessment 
These studies will be conducted within the Wellcome Clinical Research Facility 
and will target recurrent cases. Serial ultrasound skin images will be collected and 
investigated by image analytical transforms. 
Stress investigations 
These studies will be carried out in conjunction with other groups who are currently 
researching in this area. Tests will include evaluation of stress by biochemical 
methods and purpose designed questionnaire. 
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 never almost 
never 
sometimes fairly 
often 
very 
often 
 1 
In the last month, how often have you 
been upset because of something that 
happened unexpectedly? 
0 1  2  3  4 
 2 
In the last month, how often have you 
felt that you were unable to control the 
important things in your life? 
0 1  2  3  4 
 3 
In the last month, how often have you 
felt nervous and ‘stressed’ ?  0 1  2  3  4 
 4 
In the last month, how often have you 
dealt successfully with irritating life 
hassles? 
4 3  2  1  0 
 5 
In the last month, how often have you 
felt that you were effectively coping 
with the important changes that were 
occurring in your life? 
4 3  2  1  0 
 6 
In the last month, how often have you 
felt confident about your ability to 
handle your personal problems? 
4 3  2  1  0 
 7 
In the last month, how often have you 
felt that things were going your way?  4 3  2  1  0 
 8 
In the last month, how often have you 
felt that you could not cope with all the 
things that you had to do? 
0 1  2  3  4 
 9 
In the last month, how often have you 
been able to control irritations in your 
life? 
4 3  2  1  0 
10 
In the last month, how often have you 
felt that you were on top of things?  4 3  2  1  0 
11 
In the last month, how often have you 
been angered because of things that 
happened that were outside of your 
control? 
0 1  2  3  4 
12 
In the last month, how often have you 
found yourself thinking about things 
that you have to accomplish? 
0 1  2  3  4 
13 
In the last month, how often have you 
been able to control the way you 
spend your time? 
4 3  2  1  0 
14 
In the last month, how often have you 
felt that difficulties were piling up so 
high that you could not overcome 
them? 
0 1  2  3  4 
 
 
Appendix 1  
 
Questionnaire of Perceived Stress 
Ref: Cohen , S., Kamarck, T., Mermelstein, R. (1983)  
A global measure of perceived stress, 
Journal of Health and Social Behavior pp 385-396.  167
Appendix 2 
 
Dot plots to show distribution of dermatophytes, opportunists, bacteria and yeasts 
cultured from the foot sole of the cellulitic foot  (n = 12) 
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Appendix 3 
 
Dot plots to show distribution of dermatophytes, opportunists, bacteria and yeasts 
cultured from the interdigital spaces of the cellulitic foot (n = 12) 
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Appendix 4 
 
Dot plots to show distribution of dermatophytes, opportunists, bacteria and yeasts 
cultured from the foot sole of the contralateral foot (n = 12) 
 
 
2 1 0
Dermatophytes visit 1
 
2 1 0
Dermatophytes visit 2
 
      
      
2 1 0
Opportunisits visit 1
 
2 1 0
Opportunists visit 2
  
        
    
2 1 0
Bacteria visit 1
 
2 1 0
Bacteria visit 2
  
 
      
2 1 0
Yeasts visit 1
 
2 1 0
Yeasts visit 2
 
 
 
 
   170
Appendix 5 
 
Dot plots to show distribution of dermatophytes, opportunists, bacteria and yeasts 
cultured from the interdigital spaces of the contralateral  foot (n = 12) 
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Appendix 6 
 
Dot plots to show distribution of dermatophytes, opportunists, bacteria and yeasts 
cultured from the foot sole of the control foot (n = 12) 
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Appendix 7 
 
Dot plots to show distribution of dermatophytes, opportunists, bacteria and yeasts 
cultured from the interdigital spaces of the control foot (n = 12) 
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Appendix 8 
 
Dot plots to show distribution of dermatophytes, opportunists, bacteria and yeasts 
cultured from the foot sole of the contralateral control foot (n = 12) 
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Appendix 9 
 
Dot plots to show distribution of dermatophytes, opportunists, bacteria and yeasts 
cultured from the interdigital spaces of the contralateral  control foot (n = 12) 
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 Appendix  10 
 
Significance tests for results of Opportunist cultures 
 
 
N = 12  Min - Max  N = 12  Min-max  Test  P 
value 
Cell foot (1)   0 –6  Contra foot (1)  0 – 4  WSR  0.656 
           
Cell foot (1)   0 –6  Control foot (1)   0 - 2  WSR  0.586 
           
Cell foot (1)   0 –6  Cell foot (2)  0 – 5  WSR  0.250 
           
Cell foot (2)  0 – 5  Contra foot (2)  0 - 1  WSR  0.754 
           
Cell foot (2)  0 – 5  Control foot (2)  0 - 3  WSR  0.797 
           
Contra foot (1)  0 – 4  Contra control foot (1)  0 - 3  WSR  1.0 
           
Contra foot (1)   0 – 4  Contra foot (2)  0 - 1  WSR  1.0 
           
Contra foot (2)  0 - 1  Contra control foot (2)  0 - 4  WSR  1.0 
           
Control foot (1)  0 - 2  Control foot (2)   0 - 3  WSR  0.250 
 
      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N = numbers compared (column 1 and column 3) 
(1)  =  visit 1    (2)  =  visit 2 
 
WSR = Wilcoxon Signed Ranks Test (exact 2 tailed test) 
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Appendix 11 
 
Significance tests for results of Bacterial cultures 
 
 
N = 12  Min-Max  N = 12  Min-Max  Test  P 
value 
Cell foot (1)   0 – 1  Contra foot (1)  0 – 1  WSR  1.0 
           
Cell foot (1)   0 – 1  Control foot (1)   0 - 1  WSR  1.0 
           
Cell foot (1)   0 – 1  Cell foot (2)  0 – 1  WSR  1.0 
           
Cell foot (2)  0 – 1  Contra foot (2)  0 - 2  WSR  1.0 
           
Cell foot (2)  0 – 1  Control foot (2)  0 - 1  WSR  1.0 
           
Contra foot (1)  0 – 1  Contra control foot 
(1)  0 - 1  WSR  1.0 
           
Contra foot (1)   0 – 1  Contra foot (2)  0 - 2  WSR  1.0 
           
Contra foot (2)  0 - 2  Contra control foot 
(2)  0 - 1  WSR  1.0 
           
Control foot 
(1)  0 - 1  Control foot (2)   0 - 1  WSR  0.750 
 
      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N = numbers compared (column 1 and column 3) 
(1)  =  visit 1    (2)  =  visit 2 
 
WSR = Wilcoxon Signed Ranks Test (exact 2 tailed test) 
      
   177
Appendix 12 
 
Significance tests for results of Yeast cultures 
 
 
N = 12  Min-Max  N = 12  Min-Max  Test  P 
value 
Cell foot (1)   0 - 1  Contra foot (1)  0 - 1  WSR  1.0 
           
Cell foot (1)   0 - 1  Control foot (1)   0 - 3  WSR  1.0 
           
Cell foot (1)   0 - 1  Cell foot (2)  0 - 1  WSR  1.0 
           
Cell foot (2)  0 - 1  Contra foot (2)  0 - 1  WSR  1.0 
           
Cell foot (2)  0 - 1  Control foot (2)  0 - 1  WSR  1.0 
           
Contra foot (1)  0 - 1  Contra control foot 
(1)  0 - 1  WSR  1.0 
           
Contra foot (1)   0 - 1  Contra foot (2)  0 - 1  WSR  1.0 
           
Contra foot (2)  0 - 1  Contra control foot 
(2)  0 - 0  WSR  1.0 
           
Control foot (1)  0- 3  Control foot (2)   0 - 1  WSR  0.750 
 
      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N = numbers compared (column 1 and column 3) 
(1)  =  visit 1    (2)  =  visit 2 
 
WSR = Wilcoxon Signed Ranks Test (exact 2 tailed test) 
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Appendix 13 
 
Significance tests for IgE to Trichophyton Rubrum results 
 
 
N = 12  Min-Max  N = 12  Min-Max  Test  P 
value 
A =  
Patients (1)   0 – 1.46  B =  
Patients (2)  0 – 1.14  WSR  0.500 
         
A =  
Controls (1)   0 – 17.30  B =  
Controls (2)   0 – 20.6  WSR  1.0 
         
A =  
Patients  (1)   0 – 1.46  B =  
Controls (1)  0 – 17.30  WSR  1.0 
         
A =  
Patients (2)  0 – 1.14  B =  
Controls (2)  0 – 20.6  WSR  1.0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N = numbers compared (column 1 and column 3) 
(1)  =  visit 1    (2)  =  visit 2 
 
WSR = Wilcoxon Signed Ranks Test (exact 2 tailed test) 
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Appendix 14   
 
Patient/Volunteer Serum levels of IgE to 
Trichophyton Rubrum (kUA/L) 
 
Patients Controls 
  P1 C1 
Visit 1  0 0 
Visit 2  0 0 
  P2 C2 
Visit 1  1.46 1.72 
Visit 2  0.85 1.05 
  P3 C3 
Visit 1  0 0 
Visit 2  0 0 
  P4 C4 
Visit 1  0 0 
Visit 2  0 0 
  P5 C5 
Visit 1  0.81 0 
Visit 2  0.44 0 
  P6 C6 
Visit 1  0 0.42 
Visit 2  0 0.36 
  P7 C7 
Visit 1  0 0 
Visit 2  0 0 
  P8 C8 
Visit 1  0 0 
Visit 2  0 0 
  P9 C9 
Visit 1  0 17.3 
Visit 2  0 20.6 
  P10 C10 
Visit 1  0 0 
Visit 2  0 0 
  P11 C11 
Visit 1  1.0 0 
Visit 2  1.14 0 
  P12 C12 
Visit 1  0 0 
Visit 2  0 0 
 
Clinical relevance of result 
0 = undetectable, 0.4 - 0.7 = low level 
0.7 – 3.5 = moderate, 3.7 – 17.5 = high 
17.5 - > 100 = very high 
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Patient/Volunteer TEWL Scores g/hm
2 
 
 
 Cellulitic Leg   Matched Control  Contralateral Leg  Matched Control 
  P1 C1  P1  C1 
Visit 1  2.5  7.1 2.8 6.6 
Visit 2  6.4  7.6 4.6 5.9 
  P2 C2  P2  C2 
Visit 1  4.3  3.1 6.2 2.6 
Visit 2  7.1  6.0 5.5 9.4 
  P3 C3  P3  C3 
Visit 1  7.9  4.9 3.5 6.0 
Visit 2  20.0  3.8 4.8 3.5 
  P4 C4  P4  C4 
Visit 1  13.6  5.0 6.3 5.3 
Visit 2  8.7  1.2 6.0 2.5 
  P5 C5  P5  C5 
Visit 1  17.2  8.5 8.1 6.8 
Visit 2  12.3  6.2 7.0 7.2 
  P6 C6  P6  C6 
Visit 1  7.0  5.4 3.0 2.7 
Visit 2  6.6  9.0 1.5 5.5 
  P7 C7  P7  C7 
Visit 1  8.3  1.4 5.5 1.4 
Visit 2  8.0  2.6 4.8 3.1 
  P8 C8  P8  C8 
Visit 1  4.0  4.4 3.5 2.5 
Visit 2  7.8  4.7 6.0 5.7 
  P9 C9  P9  C9 
Visit 1  8.9  4.0 3.3 3.6 
Visit 2  10.0  5.9 6.0 3.5 
  P10 C10  P10  C10 
Visit 1  4.0 10.0  4.0  9.0 
Visit 2  8.2  9.1 7.5 3.7 
  P11 C11  P11  C11 
Visit 1  10.0  7.4 6.4 6.6 
Visit 2  6.1  6.5 4.5 7.1 
  P12 C12  P12  C12 
Visit 1  8.2  6.5 6.4 6.5 
Visit 2  9.2  7.4 7.6 8.5 
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Appendix 16 
 
Dot plots to show distribution of data for Transepidermal water loss (TEWL) 
(n = 12) 
 
 
18 15 12 9 6 3
Cellulitic legs visit 1
 
18 15 12 9 6 3
Cellulitic legs visit 2
 
 
  
18 15 12 9 6 3
Contralateral legs visit 1
 
18 15 12 9 6 3
Contralateral legs visit 2
 
       
 
18 15 12 9 6 3
Control legs visit 1
 
18 15 12 9 6 3
Control  legs visit 2
 
  
 
18 15 12 9 6 3
Contralateral control legs visit 1
 
18 15 12 9 6 3
Contralateral control legs visit 2
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Patient /Volunteer pH scores 
 
    Cellulitic Leg   Matched Control  Contralateral Leg  Matched Control
   P1 C1  P1  C1 
Visit 1  5.8  6.0  5.5  6.5 
Visit 2  5.2  6.4  5.1  6.7 
   P2 C2  P2  C2 
Visit 1  6.5  4.8  4.6  4.6 
Visit 2  5.4  5.0  5.9  5.2 
   P3 C3  P3  C3 
Visit 1  6.6  6.5  6.9  6.6 
Visit 2  5.6  7.0  5.8  6.7 
   P4 C4  P4  C4 
Visit 1  5.6  5.3  4.2  5.2 
Visit 2  5.5  6.2  5.8  6.2 
   P5 C5  P5  C5 
Visit 1  6.2  6.2  5.9  6.2 
Visit 2  6.3  6.7  5.6  6.8 
   P6 C6  P6  C6 
Visit 1  5.0  5.6  4.7  6.3 
Visit 2  5.9  6.0  5.7  6.0 
   P7 C7  P7  C7 
Visit 1  5.5  6.2  5.4  6.2 
Visit 2  6.5  6.6  6.8  6.6 
   P8 C8  P8  C8 
Visit 1  6.4  6.0  6.3  5.7 
Visit 2  7.1  5.7  7.4  6.0 
   P9 C9  P9  C9 
Visit 1  4.6  5.3  4.5  5.2 
Visit 2  4.4  5.3  5.6  5.2 
   P10 C10  P10  C10 
Visit 1  5.3  7.1  6.0  7.2 
Visit 2  5.3  6.2  5.1  6.4 
   P11 C11  P11  C11 
Visit 1  4.7  5.7  4.5  6.4 
Visit 2  5.7  6.7  5.4  6.6 
   P12 C12  P12  C12 
Visit 1  5.5  5.9  5.4  6.3 
Visit 2  5.4  5.6  5.6  5.7 
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Appendix 18 
 
Dot plots to show distribution of pH data 
 
 
6.6 6.3 6.0 5.7 5.4 5.1 4.8
Cellulitic legs visit 1
 
7.2 6.8 6.4 6.0 5.6 5.2 4.8 4.4
Cellulitic legs visit 2 
 
 
 
6.8 6.4 6.0 5.6 5.2 4.8 4.4
Contralateral  legs visit 1
 
7.2 6.9 6.6 6.3 6.0 5.7 5.4 5.1
Contralateral  legs visit 2
    
 
      
6.9 6.6 6.3 6.0 5.7 5.4 5.1 4.8
Control legs visit 1
 
6.9 6.6 6.3 6.0 5.7 5.4 5.1
Control legs visit 2
 
 
 
7.0 6.5 6.0 5.5 5.0 4.5
 Contralateral control legs visit 1
 
6.6 6.3 6.0 5.7 5.4
Contralateral control legs visit 2
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Appendix 19 
 
Dot plots to show distribution of ankle circumference measurements (cms) 
(n = 11) 
 
 
39 36 33 30 27 24 21
Cellultiic legs visit 1
 
39 36 33 30 27 24 21
Cellulitic legs visit 2
 
 
 
39 36 33 30 27 24 21
Contralateral legs visit 1
 
39 36 33 30 27 24 21
Contralateral legs visit 2
  
 
 
39 36 33 30 27 24 21
Control legs visit 1
 
39 36 33 30 27 24 21
Control legs visit 2
      
 
 
39 36 33 30 27 24 21
Contralateral control legs visit 1
 
39 36 33 30 27 24 21
Contralateral control legs visit 2
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Appendix 20 
 
Dot plots to show distribution of mid calf circumference measurements (cms) 
(n = 11) 
 
 
50 45 40 35 30
Cellulitic legs visit 1
 
50 45 40 35 30
Cellulitic legs visit 2
 
 
  
50 45 40 35 30
Contralateral legs visit 1
 
50 45 40 35 30
Contralateral legs visit 2
 
  
 
50 45 40 35 30
Control legs visit 1
 
50 45 40 35 30
Control legs visit 2
 
    
 
50 45 40 35 30
Contralateral Control legs visit 1
 
50 45 40 35 30
Contralateral control legs visit 2
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Appendix 21 
 
Dot plots to show distribution of upper calf circumference measurements (cms) 
(n = 11) 
 
 
51 48 45 42 39 36 33 30
Cellulitic leg visit 1
 
51 48 45 42 39 36 33 30
Cellulitic leg visit 2
 
 
  
51 48 45 42 39 36 33 30
Contralateral leg visit 1
 
51 48 45 42 39 36 33 30
Contralateral leg visit 2
 
  
 
51 48 45 42 39 36 33 30
Control legs visit 1
 
51 48 45 42 39 36 33 30
Control legs visit 2
 
  
 
51 48 45 42 39 36 33 30
Contralateral control legs visit 1
 
51 48 45 42 39 36 33 30
Contralateral control legs visit 2
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Appendix 22 
 
Significance tests for leg measurements (cms) taken at the ankle  
 
N = 11 
Mean 
(SD) 
Min-Max 
N = 11 
Mean 
(SD) 
Min-Max 
 
95% mean CI 
(A - B) 
 
Test  DF  P 
value 
A = Cell 
legs (1)  
29.5 
(5.45) 
21.5 – 39 
B = Contra 
legs (1) 
26.4 
(4.92) 
21 – 36 
-0.80 – 6.98  PT  10  0.11 
               
A = Cell 
legs (1)  
29.5 
(5.45) 
21.5 – 39 
B = Control 
legs (1)  
22.2 
(0.96) 
20 – 23.5 
3.40 – 11.14  PT  10  0.002 
              
A = Cell 
legs (1)  
29.5 
(5.45) 
21.5 – 39 
B = Cell 
legs (2) 
28.2 
(4.47) 
21 - 35 
-0.653 – 3.199  PT  10  0.172 
              
A = Cell 
legs (2) 
28.2 
(4.47) 
21 - 35 
B = Contra 
legs (2) 
26.1 
(3.94) 
20 – 33.5 
-0.61 – 4.89  PT  10  0.114 
              
A = Cell 
legs (2) 
28.2 
(4.47) 
21 - 35 
B = Control 
legs (2) 
22.1 
(0.83) 
21 – 23.5 
2.94 – 9.33  PT  10  0.002 
              
A = Contra 
legs (1) 
26.4 
(4.92) 
21 – 36 
B = Contra 
control legs 
(1) 
22.3 
(0.88) 
21 – 23.5 
0.71 – 7.57  PT  10  0.023 
              
A = Contra 
legs (1)  
26.4 
(4.92) 
21 – 36 
B = Contra 
legs (2) 
26.1 
(3.94) 
20 – 33.5 
-1.85 – 2.491  PT  10  0.751 
              
A = Contra 
legs (2) 
26.1 
(3.94) 
20 – 33.5 
B = Contra 
control legs 
(2)  
22.4 
(1.1) 
20.5 – 23.0 
0.72 – 6.65  PT  10  0.020 
              
A = Control 
legs (1) 
22.2 
(0.96) 
20 – 23.5 
B = Control 
legs (2)  
22.1 
(0.83) 
21 – 23.5 
-0.203 – 0.475  PT  10  0.391 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N = numbers compared (column 1 and column 3) 
(1)  =  visit 1    (2)  =  visit 2 
 
CI = confidence interval ( A = parameter column 1, B = compared parameter column 3)  
PT = Paired T-test 
DF = degrees of freedom 
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Appendix 23 
 
Significance tests for leg measurements (cms) taken at mid calf level  
 
 
N = 11 
Mean 
(SD) 
Min-Max 
N = 11 
Mean 
(SD) 
Min-Max 
95% mean CI 
(A - B  Test  DF  P 
value 
A = Cell 
legs (1)  
40.1 
(7.2) 
31.5 - 53 
B = Contra 
legs (1) 
36.6 
(4.6) 
37 – 42.5 
-0.53 – 7.44  PT  10  0.082 
              
A = Cell 
legs (1)  
40.1 
(7.2) 
31.5 - 53 
B = Control 
legs (1)  
33.2 
(2.75) 
28 - 37 
2.49 – 11.33  PT  10  0.006 
              
A = Cell 
legs (1)  
40.1 
(7.2) 
31.5 - 53 
B = Cell 
legs (2) 
40.3 
(7.68) 
29.5 - 53 
-2.66 – 2.30  PT  10  0.873 
              
A = Cell 
legs (2) 
40.3 
(7.68) 
29.5 - 53 
B = Contra 
legs (2) 
37.5 
(5.87) 
28.5 - 46 
-0.38 – 5.83  PT  10  0.079 
              
A = Cell 
legs (2) 
40.3 
(7.68) 
29.5 - 53 
B = Control 
legs (2) 
33.6 
(0.91) 
29 – 39.5 
1.63 – 11.64  PT  10  0.014 
              
A = Contra 
legs (1) 
36.6 
(4.6) 
37 – 42.5 
B = Contra 
control legs 
(1) 
33.3 
(2.7) 
29 - 39 
0.64 – 6.0  PT  10  0.020 
              
A = Contra 
legs (1)  
36.6 
(4.6) 
37 – 42.5 
B = Contra 
legs (2) 
37.5 
(5.87) 
28.5 - 46 
-2.717 – 
0.899  PT 10 0.289 
              
A = Contra 
legs (2) 
37.5 
(5.87) 
28.5 - 46 
B = Contra 
control legs 
(2)  
33.6 
(2.4) 
30.5 - 38 
-0.03 – 7.94  PT  10  0.051 
              
A = Control 
legs (1) 
33.2 
(2.75) 
28 - 37 
B = Control 
legs (2)  
33.6 
(0.91) 
29 – 39.5 
-1.398 – 
0.489  PT 10 0.308 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N = numbers compared (column 1 and column 3) 
(1)  =  visit 1    (2)  =  visit 2 
 
CI = confidence interval ( A = parameter column 1, B = compared parameter column 3)  
PT = Paired T-test 
DF = degrees of freedom 
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Appendix 24  
 
Patient leg measurements (mm) 
 
 
 
Cell Leg 
ankle 
Cell leg  
mid calf 
Cell leg  
upper calf
Contra leg 
ankle 
Contra leg  
mid calf 
Contra leg  
upper calf 
P1         
Visit 1  25.5  32.5  34.0 21.0 28.5  29.5 
Visit 2  21.0  30.0  30.0 22.5 29.5  29.5 
P2         
Visit 1  27.0  43.0  41.5 25.0 42.5  39.0 
Visit 2  25.0  37.0  39.5 25.0 39.0  41.0 
P3         
Visit 1  26.5  36.5  45.5 36.5 37.5  43.5 
Visit 2  27.0  45.0  45.0 27.0 41.5  44.5 
P4         
Visit 1  35.0  47.0  52.0 28.0 40.5  41.0 
Visit 2  33.0  47.0  46.0 28.5 41.5  41.0 
P5         
Visit 1  35.5  53.0  46.5 22.5 38.5  38.0 
Visit 2  35.0  53.0  48.0 22.5 38.5  38.5 
P6         
Visit 1  32.5  44.0  47.0 30.5 39.5  43.0 
Visit 2  33.0  44.5  47.5 33.5 44.0  46.5 
P7         
Visit 1  25.0  31.5  32.0 21.0 31.0  33.0 
Visit 2  27.5  29.5  36.5 22.5 30.5  35.5 
P8         
Visit 1  27.0  39.0  39.0 26.5 35.5  39.0 
Visit 2  25.5  37.5  39.0 27.0 37.5  38.0 
P9         
Visit 1  29.5  36.5  40.5 27.0 31.0  38.0 
Visit 2  28.0  32.0  35.0 27.5 28.5  38.5 
P10        
Visit 1  Unable to measure because of bandages  
Visit 2  Not done 
P11        
Visit 1  39.5  49.0  45.0 31.0 41.5  45.5 
Visit 2  32.0  46.0  47.0 30.5 46.0  47.0 
P12        
Visit 1  21.5  39.0  44.5 21.5 37.0  41.0 
Visit 2  23.5  41.5  42.5 20.5 36.5  39.5 
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Control leg measurements (mm) 
 
 
 
Cont leg 
ankle 
Cont leg 
mid calf 
Cont leg  
upper calf 
Contra cont 
 leg ankle 
Contra cont leg  
mid calf 
Contra cont leg 
upper calf 
C1           
Visit 1  22.0  33.0  36.5 22.0  33.0  38.0 
Visit 2  22.5  35.0  36.5 23.5  36.5  38.0 
C2           
Visit 1  23.5  34.5  37.0 23.5  33.0  40.5 
Visit 2  23.5  33.0  38.0 23.0  34.5  38.0 
C3           
Visit 1  21.5  30.0  37.5 21.5  32.0  37.5 
Visit 2  22.0  29.0  36.0 21.0  31.5  37.0 
C4           
Visit 1  23.5  36.5  39.5 23.5  39.0  37.0 
Visit 2  23.5  39.5  39.5 23.5  38.0  36.5 
C5           
Visit 1  20.5  33.0  33.0 21.0  34.0  35.0 
Visit 2  21.0  33.5  34.5 20.5  33.5  35.5 
C6           
Visit 1  22.5  36.0  36.5 21.5  36.0  36.5 
Visit 2  22.0  35.0  37.0 22.0  34.5  38.5 
C7           
Visit 1  22.5  28.0  38.0 22.0  31.0  37.0 
Visit 2  22.0  29.5  37.5 23.5  32.0  38.5 
C8           
Visit 1  22.5  32.5  36.0 23.5  29.0  36.5 
Visit 2  22.0  32.5  35.0 22.5  30.5  34.5 
C9           
Visit 1  21.0  31.5  35.5 22.0  31.0  35.0 
Visit 2  21.0  33.0  36.0 22.0  30.5  36.0 
C10          
Visit 1  21.5  38.5  37.5 22.0  34.5  34.5 
Visit 2  21.5  37.5  38.0 22.0  36.0  37.0 
C11          
Visit 1  22.0  33.0  38.0 22.0  34.0  38.0 
Visit 2  21.5  33.0  39.0 21.5  33.0  39.0 
C12          
Visit 1  23.0  37.0  40.0 22.5  34.5  41.5 
Visit 2  22.0  37.0  40.0 23.5  35.0  41.0 
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Appendix 26 
 
Patient/Volunteer Dermascan Results area A and area B. (Average of 3 
measurements in mms) 
 
 
 
 
 
  
Lt 
visit 1    
Rt  
visit 1    
Lt  
visit 2    
Rt  
visit 2    
  
Area A 
mms 
Area B 
mms 
Area A 
mms 
Area B 
mms 
Area A 
mms 
Area B 
mms 
Area A 
mms 
Area B 
mms 
P1  0.23  2.3 0.18  1.36  0.18  1.87 0.2  1.44 
P2  0.3 1.8 0.2  2.0 0.3  1.9  0.2  2.0 
P3  0.26 1.6  0.28  2 0.17  1.7  0.22  1.7 
P4  0.25 1.8  0.3  1.6 0.23  1.5       
P5  0.27 1.3  0.39  1.36 0.23  1.33  0.29  1.29 
P6  0.3  2.14 0.24 2.2             
P7                         
P8  0.22  2.49 0.24 2.2  0.23  2.31 0.22  2.22 
P9              0.26  2.01 0.23  2.17 
P10   0.23  3.09 0.2  1.27 0.24  2.05   0.27   1.21 
P11  0.18   0.27  1.87  0.31  1.9    
P12             
            
C1  0.16  1.51 0.17 1.75 0.16  1.7 0.19  1.67 
C2  0.18 2.04 0.18  1.7 0.23  2.01  0.2  1.7 
C3  0.26 1.66 0.24  1.56 0.23  1.76  0.22  1.76 
C4        0.22  1.76        0.25  1.7 
C5        0.24  1.39        0.2  1.26 
C6  0.56  1.7 0.34  1.64  0.4  1.5 0.33  1.8 
C7       0.2  2.26 0.24  1.77 
C8       0.28  1.56 0.24  1.53 
C9  0.26  1.4        0.21  1.5       
C10  0.23  1.39 0.29 1.62 0.3  1.43 0.25  1.43 
C11  0.22  1.91 0.25 1.46 0.2  1.47 0.17  1.37 
C12  0.20  1.45 0.35 1.22 0.28  1.47 0.26  1.41 
 
Measurements for cellulitic legs and matched controls are highlighted. 
Soma data are missing – unable to perform tests or measure accurately or 
equipment was not functioning. 
Numbers entered into the data analysis: 
Area A = 7 pairs 
Area B = 6 pairs 
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Appendix 27 
 
Dot plots to show distribution of ultrasound thickness measurements 
Area a (mms)  
(n = 7) 
 
 
0.54 0.48 0.42 0.36 0.30 0.24 0.18
Cellulitic legs visit 1
 
0.54 0.48 0.42 0.36 0.30 0.24 0.18
Cellulitic legs visit 2
 
 
  
0.54 0.48 0.42 0.36 0.30 0.24 0.18
Contralateral legs visit 1
 
0.54 0.48 0.42 0.36 0.30 0.24 0.18
Contralateral legs visit 2
 
  
 
0.54 0.48 0.42 0.36 0.30 0.24 0.18
Control legs visit 1
 
0.54 0.48 0.42 0.36 0.30 0.24 0.18
Control legs visit 2
 
    
 
0.54 0.48 0.42 0.36 0.30 0.24 0.18
Contralateral control legs visit 1
 
0.54 0.48 0.42 0.36 0.30 0.24 0.18
Contralateral control legs visit 2
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Appendix 28 
 
Significance tests for ultrasound measurements (area a) mms 
 
 
N = 7 
Mean 
(SD) 
Min-Max 
N = 7 
Mean 
(SD) 
Min-Max 
 
 
95% mean CI 
(A - B) 
 
Test  DF  P 
value 
 
A = Cell 
legs (1)  
 
0.264 
(0.07) 
0.2 – 0.39 
 
B = Contra 
legs (1) 
 
0.241 
(0.04) 
0.18 – 0.30 
-0.047 – 0.092  PT  6  0.452 
               
Cell 
legs (1)   0.2 – 0.39  Control 
legs (1)   0.16 – 0.56    WSR    0.438 
               
 
A = Cell 
legs (1) 
 
0.264 
(0.07) 
0.2 – 0.39 
 
B = Cell 
legs (2) 
 
0.227 
(0.03) 
0.18 – 0.29 
-0.019 – 0.094  PT  6  0.158 
               
 
A = Cell 
legs (2) 
 
0.227 
(0.03) 
0.18 – 0.29 
 
B = Contra 
legs (2) 
 
0.235 
(0.04) 
0.17 – 0.30 
-0.059 – 0.042  PT  6  0.692 
               
A = Cell 
legs (2) 
 
0.227 
(0.03) 
0.18 – 0.29 
 
B = Control 
legs (2) 
 
0.251 
(0.08) 
0.16 – 0.40 
-0.072 – 0.023  PT  6  0.257 
               
A = 
Contra 
legs (1) 
 
0.241 
(0.04) 
0.18 – 0.30 
 
B = Contra 
control legs 
(1) 
 
0.262 
(0.07) 
0.17 – 0.35 
-0.098 – 0.553  PT  6  0.520 
               
 
A = 
Contra 
legs (1)  
 
0.241 
(0.04) 
0.18 – 0.30 
 
B = Contra 
legs (2) 
 
0.235 
(0.04) 
0.17 – 0.30 
-0.041 – 0.053  PT  6  0.777 
               
A = 
Contra 
legs (2) 
 
0.235 
(0.04) 
0.17 – 0.30 
 
B = Contra 
control legs 
(2) 
 
0.24 
(0.05) 
0.17 – 0.33 
-0.056 – 0.054  PT  6  0.951 
               
Control 
legs (1)  0.16 – 0.56  Control 
legs (2)   0.16 – 0.40    WSR    1.0 
 
 
 
 
 
 
 
N = numbers compared (column 1 and column 3) 
(1)  =  visit 1    (2)  =  visit 2 
 
CI = confidence interval ( A = parameter column 1, B = compared parameter column 3)  
PT = Paired T-test 
WSR = Wilcoxon Signed Ranks Test (exact 2 tailed test) 
DF = degrees of freedom 
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Appendix 29 
 
Dot plots to show distribution of ultrasound thickness measurements 
Area b (mms) 
(n = 6) 
 
 
3.0 2.7 2.4 2.1 1.8 1.5 1.2
Cellulitic legs visit 1
 
3.0 2.7 2.4 2.1 1.8 1.5 1.2
Cellulitic legs visit 2
 
  
 
3.0 2.7 2.4 2.1 1.8 1.5 1.2
Contralateral legs visit 1
 
3.0 2.7 2.4 2.1 1.8 1.5 1.2
Contralateral legs visit 2
 
  
 
3.0 2.7 2.4 2.1 1.8 1.5 1.2
Control legs visit 1
 
3.0 2.7 2.4 2.1 1.8 1.5 1.2
Control legs visit 2
 
 
         
3.0 2.7 2.4 2.1 1.8 1.5 1.2
Contralateral control legs visit 1
 
3.0 2.7 2.4 2.1 1.8 1.5 1.2
Contralateral control legs visit 2
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Appendix 30  
 
Patient/Volunteer LDI scores (Mean flux within AOI) 
 
 
 
Cellulitic Leg   Matched 
Control  Contralateral Leg  Matched 
Control 
  P1 C1  P1  C1 
Visit 1  338 132  101  113 
Visit 2  149 113  92  135 
  P2 C2  P2  C2 
Visit 1  354 204  114  182 
Visit 2  113 181  114  210 
  P3 C3  P3  C3 
Visit 1  533 187  154  224 
Visit 2  207 154  118  246 
  P4 C4  P4  C4 
Visit 1  162 178  45  138 
Visit 2  21 147  16   
  P5 C5  P5  C5 
Visit 1  489 152  153   
Visit 2  89 230  176   
  P6 C6  P6  C6 
Visit 1  519 132  97  113 
Visit 2  168 113  96  135 
  P7 C7  P7  C7 
Visit 1  266 93  240  101 
Visit 2  256 110  263  115 
  P8 C8  P8  C8 
Visit 1  138 147  107  132 
Visit 2  112 213  102  180 
  P9 C9  P9  C9 
Visit 1  246 128  133   
Visit 2  164 167  228   
  P10 C10  P10  C10 
Visit 1  500 135  153  131 
Visit 2  436 109  280  126 
  P11 C11  P11  C11 
Visit 1  567 214  140  164 
Visit 2  207 128  205  119 
  P12 C12  P12  C12 
Visit 1  340 124  174  140 
Visit 2  195 128  155  147 
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Appendix 31 
 
Dot plots to show distribution from Laser Doppler Imaging (mean flux values) 
(n = 12, *n = 10) 
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500 400 300 200 100 0
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500 400 300 200 100 0
Control legs visit 1
 
500 400 300 200 100 0
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500 400 300 200 100 0
Contralateral control legs visit 2*
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Appendix  32 
 
Patient/Volunteer LDI Scores 
 
   Cellulitic Leg 
 Matched 
Control 
Contralateral 
Leg 
Matched 
Control 
  P1 C1  P1  C1 
Visit 1  3  2  2  2 
Visit 2  2  2  2  2 
  P2 C2  P2  C2 
Visit 1  3  2  2  2 
Visit 2  2  2  2  2 
  P3 C3  P3  C3 
Visit 1  4  2  2  2 
Visit 2  2  2  2  2 
  P4 C4  P4  C4 
Visit 1  2  2  1  2 
Visit 2  1  2  1   
  P5 C5  P5  C5 
Visit 1  4  2  2   
Visit 2  2  2  2   
  P6 C6  P6  C6 
Visit 1  4  2  2  2 
Visit 2  2  2  2  2 
  P7 C7  P7  C7 
Visit 1  3  2  3  2 
Visit 2  3  2  3  2 
  P8 C8  P8  C8 
Visit 1  2  2  2  2 
Visit 2  2  2  2  2 
  P9 C9  P9  C9 
Visit 1  3  2  2   
Visit 2  2  2  2   
  P10 C10  P10  C10 
Visit 1  4  2  2  2 
Visit 2  3  2  2  2 
  P11 C11  P11  C11 
Visit 1  4  2  2  2 
Visit 2  2  2  2  2 
  P12 C12  P12  C12 
Visit 1  3  2  2  2 
Visit 2  2  2  2  2 
 
1 = Low relative flux 
  2 = Normal relative flux 
3 = High relative flux 
  4 = Very high relative flux 
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Appendix 33  
 
Patient/Volunteer Venous refilling times (secs) 
 
   
Cellulitic 
Leg 
 Matched 
Control 
Contralateral 
Leg 
Matched 
Control 
P1 C1  P1  C1 
> 25  > 25  > 25  > 25 
P2 C2  P2  C2 
> 25  > 25  > 25  > 25 
P3 C3  P3  C3 
7 18 7  18 
P4 C4  P4  C4 
Unable to measure 
P5 C5  P5  C5 
> 25  23  > 25  23 
P6 C6  P6  C6 
Unable to measure 
P7 C7  P7  C7 
5 18 7  >  25 
P8 C8  P8  C8 
23  > 25  > 25  > 25 
P9 C9  P9  C9 
16  > 25  14  > 25 
P10 C10  P10  C10 
11  > 25  5  > 25 
P11 C11  P11  C11 
20  > 25  11  > 25 
P12 C12  P12  C12 
11 20  7  12 
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Appendix 34 
 
Dot plots to show distribution of venous refilling times (VRT) in secs 
(n = 10) 
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Appendix 35 
 
Patient/Volunteer LDF Scores 
 
 
 
Cellulitic
Leg 
 Matched 
Control 
Contralateral 
Leg 
Matched 
Control 
P1 C1  P1  C1 
1 1  1  1 
P2 C2  P2  C2 
1 1  1  1 
P3 C3  P3  C3 
2 2  2  2 
P4 C4  P4  C4 
Patient unable to perform test 
P5 C5  P5  C5 
1 1  1  1 
P6 C6  P6  C6 
Patient unable to perform test 
P7 C7  P7  C7 
2 2  2  1 
P8 C8  P8  C8 
2 1  1  1 
P9 C9  P9  C9 
2 1  2  1 
P10 C10  P10  C10 
2 1  2  1 
P11 C11  P11  C11 
2 1  2  1 
P12 C12  P12  C12 
2 2  2  2 
 
1 = Competent, 2 = Incompetent 
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Appendix 36 
 
Table of routine blood results (patients) 
 
 
   CRP  WBC  Neutrophils  Lymphocytes 
Normal 
range 0-6  mg/L 
4 -11 
(10^9/L) 
2 -7.5 
(10^9/L) 
1.5 -4  
(10^9/L) 
P1    
episode  490.0  13.7  12.0  0.9 
FU visit  2.0 6.0  4.0  1.6 
P2    
episode  138.0 8.9  6.9  1.1 
FU visit  5.0 6.6  3.7  1.7 
P3    
episode 3.0  4.2  2.2  1.4 
FU visit  4.0  4.5  2.3  1.3 
P4   
episode  198.0 9.6  7.1  1.7 
FU visit  4.0 6.3  3.8  1.8 
P5    
episode  171.0 10.2  7.7  1.4 
FU visit  0.0 5.6  3.3  1.5 
P6    
episode  51.0  12.7  8.2  3.3 
FU visit  14.0 10.9  6.9  3.0 
P7   
episode  10.0 5.6  4.2  0.6 
FU visit  3.0 5.0  3.8  0.6 
P8    
episode  18.0 4.2  1.9  1.1 
FU visit  1.0 4.4  1.9  1.5 
P9   
episode  56.2 7.7  5.8  1.4 
FU visit  2.0 6.5  4.5  1.5 
P10  
episode  283.0  14.3  11.5  1.3 
FU visit  3.0 9.7  6.0  2.6 
P11  
episode  98.0 10.1  6.8  2.0 
FU visit  5.0 9.0  5.4  2.5 
P12   
episode  4.0 5.7  4.2  1.0 
FU visit  3.0 7.0  5.1  1.2 
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Appendix  37  
 
Table of blood results (controls) 
 
 CRP  WBC  Neutrophils  Lymphocytes 
Normal 
range 
0-6 
mg/L 
4-11 
(10^9/L) 
2-7.5 
(10^9/L) 
1.5-4  
(10^9/L) 
C1    
 first visit  1.0 6.0  4.0  1.6 
FU visit  1.0 5.2  2.9  1.6 
C2    
 first visit  0.0 5.9  2.5  2.5 
FU visit  0.0 6.1  2.5  2.6 
C3    
 first visit  0.0 5.8  3.3  1.8 
FU visit  4.0 4.5  2.3  1.3 
C4    
first visit  4.0 7.2  4.4  2.0 
FU visit  4.0 7.2  4.3  2.1 
C5    
first visit  0.0 4.8  3.2  1.1 
FU visit  0.0 6.4  4.2  1.4 
C6    
first visit  2.0 5.3  3.2  1.6 
FU visit  2.0 6.2  3.6  2.0 
C7   
first visit  0.0 6.9  4.0  2.2 
FU visit  0.0 7.2  3.9  2.4 
C8    
first visit  0.0 5.3  3.0  1.5 
FU visit  0.0 4.3  2.5  1.2 
C9    
first visit  0.0 5.5  3.4  1.4 
FU visit  0.0 5.6  3.5  1.5 
C10    
first visit  2.0 4.3  2.4  1.5 
FU visit  3.0 4.4  2.5  1.5 
C11   
first visit  0.0 4.6  2.8  1.6 
FU visit  2.0 5.2  3.1  1.6 
C12  
first visit  6.0 4.5  2.7  0.9 
FU visit  5.0 4.4  2.4  1.0 
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Appendix 38 
 
Dot plots to show distribution of CRP (mg/mL) 
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150 120 90 60 30 0
Patients visit 2
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Dot plots to show distribution of total white cell count (10^9/L)   
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Appendix 39 
 
Dot plots to show distribution of neutrophils (10^9/L) 
 
  
8 7 6 5 4 3
Patients visit 1
 
8 7 6 5 4 3
Patients visit 2
 
    
  
8 7 6 5 4 3
Controls visit 1
 
8 7 6 5 4 3
Controls visit 2
 
  
 
Dot plots to show distribution of lymphocytes(10^9/L)   
 
  
3.0 2.5 2.0 1.5 1.0 0.5
Patients visit 1
 
3.0 2.5 2.0 1.5 1.0 0.5
Patients visit 2
 
  
  
3.0 2.5 2.0 1.5 1.0 0.5
Controls visit 1
 
3.0 2.5 2.0 1.5 1.0 0.5
Controls visit 2
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Appendix 40  
 
Significance tests for CRP (mg/L) 
 
N = 12 
Mean 
(SD) 
Min-Max 
N = 12 
Mean 
(SD) 
Min-Max 
 
95% mean CI 
(A - B) 
 
Test DF  P 
value 
A =  
Patients (1)  
122.5 
(140.6) 
3 - 490 
B =  
Patients (2) 
3.83 
(3.54) 
0 - 14 
 WSR    0.001 
              
A =  
Controls (1)  
1.25 
(1.96) 
0 - 6 
B =  
Controls (2)  
1.75 
(1.87) 
0 – 5.0 
-1.335 – 0.335  PT  11  0.214 
              
A =  
Patients  (1)  
122.5 
(140.6) 
3 - 490 
B =  
Controls (1) 
1.25 
(1.96) 
0 - 6 
 WSR    0.001 
              
A =  
Patients (2) 
3.83 
(3.54) 
0 - 14 
B =  
Controls (2) 
1.75 
(1.87) 
0 – 5.0 
-0.22 – 4.39  PT  11  0.072 
 
Significance tests for WBC (10^9/L) 
 
N = 12 
Mean 
(SD) 
Min-Max 
N = 12 
Mean 
(SD) 
Min-Max 
 
95% mean CI 
(A - B) 
 
Test DF  P 
value 
A =  
Patients (1)  
8.91 
(3.53) 
4.2 - 14 
B =  
Patients (2) 
6.79 
(2.06) 
4.4 – 10.9 
0.490 – 3.743  PT  11  0.015 
              
A =  
Controls (1)  
5.64 
(0.993) 
4.3 – 7.2 
B =  
Controls (2)  
5.633 
(1.15) 
4.3 – 7.2 
-0.480 – 0.496  PT  11  0.971 
              
A =  
Patients  (1)  
8.91 
(3.53) 
4.2 - 14 
B =  
Controls (1) 
5.64 
(0.993) 
4.3 – 7.2 
0.91 – 5.62  PT  11  0.011 
              
A =  
Patients (2) 
6.79 
(2.06) 
4.4 – 10.9 
B =  
Controls (2) 
5.633 
(1.15) 
4.3 – 7.2 
-0.263 – 2.580  PT  11  0.100 
 
 
 
 
 
 
 
 
 
 
 
N = numbers compared (column 1 and column 3) 
(1)  =  visit 1    (2)  =  visit 2 
 
CI = confidence interval ( A = parameter column 1, B = compared parameter column 3)  
PT = Paired T-test 
WSR = Wilcoxon Signed Ranks Test (exact 2 tailed test) 
DF = degrees of freedom 
      
 
 
 
 = significant (P = 0.05)   206
 
Appendix 41  
 
Patient/Volunteer cytokine values (pg/ml) 
 
 
  IFN-λ IL-1β  IL-2 IL-4 IL-5 
  P1 C1 P1 C1 P1 C1 P1 C1 P1 C1 
Visit 1  2.79 0.68 0.08 0.15 0.34 0.10 0.43 0.10 0.08 0.21 
Visit 2  0.54 0.89 0.17 0.15 0.31 0.15 0.37 0.09  0.03 0.31 
  P2 C2 P2 C2 P2 C2 P2 C2 P2 C2 
Visit 1  17.4  6.1  0.53 0.18 2.43 0.54 4.62 2.12  369.3 0.14 
Visit 2  16.4 5.49 0.69 0.35 3.02 0.62 5.69 2.04  448.7 0.14 
  P5 C5 P5 C5 P5 C5 P5 C5 P5 C5 
Visit 1  0.76 1.0 0.19  0.02 0.10 0.11 0.38 0.50 0.08 0.09 
Visit 2  0.12 1.70 0.07 0.15 0.10 0.26 0.62 0.47 0.13 0.16 
  P6 C6 P6 C6 P6 C6 P6 C6 P6 C6 
Visit 1  1.32 1.30 0.00 0.10 1.82 0.22 0.32 0.25 0.16 0.30 
Visit 2  1.62  0.30  0.01  0.03 2.77 0.21 0.16  0.15 0.27 0.27 
  P7 C7 P7 C7 P7 C7 P7 C7 P7 C7 
Visit 1  2.51  0.34 0.19 0.00 0.33 0.08 0.15  0.14 0.09 0.01 
Visit 2  0.74 0.77 0.28 0.05 0.43 0.13 0.22 0.03 0.16 0.16 
             
            
  IL-8 IL-10  IL-12p70  IL-13  TNF-α 
  P1 C1 P1 C1 P1 C1 P1 C1 P1 C1 
Visit 1  1.05 0.35 0.54 0.37 0.20  0  1.63 1.39 2.09 0.93 
Visit 2  1.12 0.73 0.26 0.47  0 0.09  0.03 1.65 1.70 1.50 
  P2 C2 P2 C2 P2 C2 P2 C2 P2 C2 
Visit 1  1.66  0.75 1441.0 0.65 3511.0 1.16 972.0 2.12  7.09  0.89 
Visit 2  2.19  0.17 1559.0 0.74 4624.0 1.38 1213.0 1.85  5.46  1.08 
  P5 C5 P5 C5 P5 C5 P5 C5 P5 C5 
Visit 1  1.75 0.44 0.34 0.14 0.95 0.05 0.98 0.28 2.42 0.73 
Visit 2  0.61 0.46 0.25 0.67 1.22 0.31 0.31 0.65 1.72 1.26 
  P6 C6 P6 C6 P6 C6 P6 C6 P6 C6 
Visit 1  1.70 0.61 0.19 0.67 0.93 0.23 0.66 1.21 2.07 5.43 
Visit 2  0.43 0.31 0.95 0.45 3.85 0.06 3.99 0.54 3.47 4.58 
  P7 C7 P7 C7 P7 C7 P7 C7 P7 C7 
Visit 1  3.90 0.81 0.63 0.21 0.10  0  0.34 0.47 3.13 2.35 
Visit 2  0.48 3.27 0.83 0.47 0.26 0.02 0.89  0 3.50  5.05 
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Appendix 42 
 
Dot plots to show distribution of IFN-γ (pg/ml) 
(n = 5) 
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Patients visit 1
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Dot plots to show distribution of IL-1β (pg/ml) 
(n = 5) 
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Patients visit 2
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Controls visit 1
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Controls visit 2
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Appendix  43 
 
Dot plots to show distribution of IL-2 (pg/ml) 
(n = 5) 
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Dot plots to show distribution of IL-4 (pg/ml) 
(n = 5) 
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Appendix  44 
 
Dot plots to show distribution of IL-5 (pg/ml) 
(n = 5) 
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Dot plots to show distribution of IL-8 (pg/ml) 
(n = 5) 
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Appendix 45 
 
Dot plots to show distribution of IL-10 (pg/ml) 
(n = 5) 
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Dot plots to show distribution of IL-12p70 (pg/ml) 
(n = 5) 
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Appendix 46 
 
Dot plots to show distribution of IL-13 (pg/ml) 
(n = 5) 
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Dot plots to show distribution of TNF-α (pg/ml) 
(n = 5) 
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Appendix 47 
 
Significance tests for serum IFN-λ results (pg/ml) 
 
N = 5  Min-Max  N = 5  Min-Max  Test  P 
value 
 
Patients (1)  
 
0.76 – 17.4 
 
Patients (2)  0.12 – 16.4  WSR  0.125 
          
Controls (1)   0 – 6.1  Controls (2)   0 – 5.49  WSR  1.0 
          
Patients  (1)   0.76 – 17.4  Controls (1)  0 – 6.1  WSR  0.188 
          
Patients (2)  0.12 – 16.4  Controls (2)  0 – 5.49  WSR  0.813 
 
 
Significance tests for serum IL-1β results (pg/ml) 
 
N = 5 
Mean 
(SD) 
Min-Max 
N = 5 
Mean 
(SD) 
Min-Max 
95% mean CI 
(A - B)  Test 
 
DF  P 
value 
A =  
Patients (1)  
0.198 
(0.20) 
0 – 0.53 
B =  
Patients (2) 
0.224 
(0.23) 
0 – 0.6 
-0.137 – 0.085  PT  4  0.552 
               
A =  
Controls (1)  
0.086 
(0.08) 
0. – 0.18 
B =  
Controls (2) 
0.14 
(0.13) 
0 – 0.35 
0.191 – 0.839  PT  4  0.338 
               
A =  
Patients  
(1)  
0.198 
(0.20) 
0 – 0.53 
B =  
Controls (1) 
0.086 
(0.08) 
0. – 0.18 
-0.125 – 0.349  PT  4  0.261 
               
A =  
Patients (2) 
0.224 
(0.23) 
0 – 0.6 
B =  
Controls (2) 
0.14 
(0.13) 
0 – 0.35 
-0.099 – 0.267  PT  4  0.272 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N = numbers compared (column 1 and column 3) 
(1)  =  visit 1    (2)  =  visit 2 
 
CI = confidence interval ( A = parameter column 1, B = compared parameter column 3)  
PT = Paired T-test 
WSR = Wilcoxon Signed Ranks Test (exact 2 tailed test) 
DF = degrees of freedom 
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Appendix 48 
 
Significance tests for serum IL-2 results (pg/ml) 
 
N = 5 
Mean 
(SD) 
Min-Max 
N = 5 
Mean 
(SD) 
Min-Max 
 
95% mean CI 
(A - B) 
 
Test  DF  P 
value 
A =  
Patients (1)  
1.005 
(1.05) 
0.10 – 2.43 
B =  
Patients (2) 
1.32 
(1.44) 
0.10 – 3.02 
-0.857 – 0.213  PT  4  0.170 
               
A =  
Controls (1)  
0.21 
(0.19) 
0.08 – 0.54 
B =  
Controls (2)  
0.27 
(0.20) 
0.13 – 0.62 
-0.136 – 0.008  PT  4  0.070 
               
A =  
Patients  (1)  
1.005 
(1.05) 
0.10 – 2.43 
B =  
Controls (1) 
0.21 
(0.19) 
0.08 – 0.54 
-0.299 – 1.887  PT  4  0.114 
               
A =  
Patients (2) 
1.32 
(1.44) 
0.10 – 3.02 
B =  
Controls (2) 
0.27 
(0.20) 
0.13 – 0.62 
-0.581 – 2.685  PT  4  0.148 
 
Significance tests for serum IL-4 results (pg/ml) 
 
N = 5  Min-Max  N = 5  Min-Max  Test  P 
value 
Patients (1)   0 – 4.62  Patients (2)  0 – 5.69  WSR  0.625 
          
Controls (1)   0 – 2.12  Controls (2)   0 – 2.04  WSR  0.250 
          
Patients  (1)   0 – 4.62  Controls (1)  0 – 2.12  WSR  0.375 
          
Patients (2)  0 – 5.69  Controls (2)  0 – 2.04  WSR  0.125 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N = numbers compared (column 1 and column 3) 
(1)  =  visit 1    (2)  =  visit 2 
 
CI = confidence interval ( A = parameter column 1, B = compared parameter column 3)  
PT = Paired T-test 
WSR = Wilcoxon Signed Ranks Test (exact 2 tailed test) 
DF = degrees of freedom 
      
 
 
 
 = P value close to 0.05   214
 
 
Appendix 49 
 
Significance tests for serum IL-5 results (pg/ml) 
 
N = 5 
Mean 
(SD) 
Min-Max 
N = 5 
Mean 
(SD) 
Min-Max 
95% mean CI 
(A - B)  Test  DF 
 
P 
value 
 
Patients (1)   0.1 – 369.3  Patients (2)  0 – 448.7    WSR    0.313 
               
A =  
Controls (1)  
0.148 
(0.114) 
0 – 0.3 
B =  
Controls (2)  
0.208 
(0.076) 
0.14 – 0.31 
-0.155 – 0.035  PT  4  0.154 
               
Patients  (1)   0.1 – 369.3  Controls (1)  0 – 0.3    WSR    1.0 
               
Patients (2)  0 – 448.7  Controls (2)  0.14 – 0.31    WSR    1.0 
 
Significance tests for serum IL-10 results (pg/ml) 
 
N = 5 
Mean 
(SD) 
Min-Max 
 
N = 5 
Mean 
(SD) 
Min-Max 
 
95% mean CI 
(A - B) 
 
Test  DF 
 
P 
value 
 
Patients (1)   0 - 1441  Patients (2)  5 - 1559    WSR    0.438 
               
A =  
Controls (1)  
0.408 
(0.245) 
0.140– 0.67 
B =  
Controls (2)  
0.560 
(0.135) 
0.45 – 0.74 
-0.492 – 0.188  PT  4  0.282 
               
Patients  (1)   0 - 1441  Controls (1)  0.140– 0.67    WSR    0.438 
               
Patients (2)  5 - 1559  Controls (2)  0.45 – 0.74    WSR    0.438 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N = numbers compared (column 1 and column 3) 
(1)  =  visit 1    (2)  =  visit 2 
 
CI = confidence interval ( A = parameter column 1, B = compared parameter column 3)  
PT = Paired T-test 
WSR = Wilcoxon Signed Ranks Test (exact 2 tailed test) 
DF = degrees of freedom 
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Appendix  50 
 
Significance tests for serum IL-13 results (pg/ml) 
 
N = 5 
Mean 
(SD) 
Min-Max 
 
N = 5 
Mean 
(SD) 
Min-Max 
 
95% mean CI 
(A - B) 
 
Test  DF 
P 
value 
 
Patients (1)   0 - 972  Patients (2)  0 – 1213    WSR    0.625 
               
A =  
Controls (1)  
1.09 
(0.743) 
0.28 – 2.12 
B =  
Controls (2)  
0.938 
(0.784) 
0 – 1.85 
-0.408 – 0.720  PT  4  0.485 
               
Patients  (1)   0 - 972  Controls (1)  0.28 – 2.12    WSR    0.438 
               
Patients (2)  0 – 1213  Controls (2)  0 – 1.85    WSR    0.438 
 
Significance tests for serum TNFα results (pg/ml) 
 
N = 5  Min-Max  N = 5  Min-Max  Test 
P 
value 
 
Patients (1)   2.07 – 7.09  Patients (2)  1.7 – 5.46  WSR  0.625 
           
Controls (1)   0.73 – 5.43  Controls (2)   1.08 – 5.05  WSR  0.438 
           
Patients  (1)   2.07 – 7.09  Controls (1)  0.73 – 5.43  WSR  0.438 
           
Patients (2)  1.7 – 5.46  Controls (2)  1.08 – 5.05  WSR  1.0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N = numbers compared (column 1 and column 3) 
(1)  =  visit 1    (2)  =  visit 2 
 
CI = confidence interval ( A = parameter column 1, B = compared parameter column 3)  
PT = Paired T-test 
WSR = Wilcoxon Signed Ranks Test (exact 2 tailed test) 
DF = degrees of freedom 
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Appendix 51  
 
Patient/Volunteer IgE Scores (iu/mL) 
 
 
  Patients Controls 
  P1 C1 
Visit 1  8.4 9.3 
Visit 2  11.2 15.2 
  P2 C2 
Visit 1  474 46.1 
Visit 2  373 33.5 
  P3 C3 
Visit 1  7.3 22.1 
Visit 2  6.3 13.1 
  P4 C4 
Visit 1  0 111 
Visit 2  21.3 107 
  P5 C5 
Visit 1  86 476 
Visit 2  59 677 
  P6 C6 
Visit 1  256 574 
Visit 2  208 641 
  P7 C7 
Visit 1  0 26.1 
Visit 2  113 18.7 
  P8 C8 
Visit 1  10.4 0 
Visit 2  8.3 13.2 
  P9 C9 
Visit 1  0 950 
Visit 2  38.1 1260 
  P10 C10 
Visit 1  68.7 10.8 
Visit 2  20.0 6.8 
  P11 C11 
Visit 1  189.0 31.2 
Visit 2  114.0 30.7 
  P12 C12 
Visit 1  7.4 14.0 
Visit 2  10.2 13.0 
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Appendix 52 
 
Dot plots to show distribution of serum IgE iu/mL 
(n = 12) 
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Appendix 53 
 
 
Significance tests for IgE results 
 
 
N = 12  Min-Max 
  N = 12  Min-Max 
  Test 
P 
value 
 
Patients (1)   0 - 474  Patients (2)  6.3 - 373  WSR  0.556 
          
Controls (1)   0 - 950  Controls (2)   7 - 1260  WSR  0.424 
          
Patients  (1)   0 - 474  Controls (1)  0 - 950  WSR  0.556 
          
Patients (2)  6.3 - 373  Controls (2)  7 - 1260  WSR  0.424 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N = numbers compared (column 1 and column 3) 
(1)  =  visit 1    (2)  =  visit 2 
 
WSR = Wilcoxon Signed Ranks Test (exact 2 tailed test) 
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